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I.

ABSTRACT
Acute kidney injury (AKI) is defined by the rapid loss of kidney function due to tissue

damage. It affects 10-30 % of hospitalized patients and is independently associated with increased
morbidity and mortality. Ischemia-reperfusion injury (IRI) is the most common pathoetiological
mechanism of AKI, whereby tissue injury is mediated by reactive oxygen species. Ischemic AKI
leads to the rapid upregulation of a transmembrane protein, kidney injury molecule-1 (KIM-1) on
the apical membrane of proximal tubular epithelial cells (TECs). Previous work from our group
and others demonstrated that the extracellular domain of KIM-1 specifically binds to
phosphatidylserine on apoptotic cells, thereby transforming KIM-1-expressing TECs into semiprofessional phagocytes for apoptotic corpses. The pathophysiological role of KIM-1 in AKI and
relevant signalling mechanisms have not yet been elucidated. Using an in vivo model of AKI in
mice genetically deficient in Kim-1, we reveal that Kim-1 expression protects mice from tissue
damage and renal dysfunction after AKI. To uncover the signalling pathways downstream of KIM1 in TECs, we performed protein-protein interaction studies to uncover two signalling partners,
the alpha subunit of the heterotrimeric G12 protein (Gα12), and the dynein light chain protein
(Tctex-1). We provide evidence that KIM-1 interacts with both Gα12 and Tctex-1, using coimmunoprecipitation, GST-pull down and confocal microscopy co-localization studies. We show
that KIM-1 upregulation during IRI suppresses endogenous Gα12 activation and down-stream
effectors. Further, we reveal that KIM-1-inhibition of Gα12, and the down-stream mediator RhoA,
are crucial for TEC-mediated clearance of apoptotic cells. Tctex-1 is bound to KIM-1 during the
early stages of phagocytosis becoming dissociated at later stages. Here, siRNA mediated studies
informed us that Tctex-1 expression is necessary for phagocytic uptake of apoptotic cells. Finally,
given our data showing that TECs isolated from Kim-1-deficient mice were virtually incapable of
phagocytosis, it can be inferred that our findings regarding Gα12 and Tctex-1 do not solely apply
to phagocytosis by KIM-1, but to all other mechanisms of uptake of apoptotic cells by TECs. In
summary, our results suggest an important protective role of KIM-1 in ischemic AKI that is
mediated via non-phagocytic and phagocytic mechanisms. The work described in this thesis
provides several novel mechanistic insights into the functional role of KIM-1 and suggest potential
therapeutic targets for future development.
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Chapter 1
Introduction

The introduction was written by Ola Ziyad Ismail and edited by Dr. Gunaratnam

1

1.1. THE KIDNEY
The kidney is one of the most important organs in the body, as it is responsible for filtering
the body’s metabolic waste while retaining precious nutrients. Each kidney is made up of about 1
million functional units, referred to as nephrons (Kurts et al., 2013). Structurally, each nephron
consists of a glomerulus and a long tubular structure. The glomerulus is the filtration unit of the
kidney and consists of fenestrated endothelial cells, a glomerular basement membrane, and visceral
epithelial cells called podocytes, which collectively form the glomerular filtration barrier (Kurts
et al., 2013). This barrier is highly selective, allowing only water and small molecules (less than
60 kDa) to pass from the bloodstream into what is known as Bowman’s space that leads into the
tubular lumen. The process of filtration of blood through the glomerulus is known as ultrafiltration
or glomerular filtration, which is often quantified as the glomerular filtration rate or GFR. A
decrease in kidney function is defined by a reduction in the GFR. Changes in serum creatinine
concentration, an inert metabolite that is filtered freely with no distal reabsorption and minimal
tubular secretion, can be used to estimate the GFR (Bellomo et al., 2004).
The tubule of the nephron consists of various differentiated segments: from proximal to
distal these are the proximal convoluted tubule, the loop of Henle, the distal convoluted tubule,
and the collecting duct. The collecting ducts ultimately lead to the renal pelvis where urine collects
(Eckardt et al., 2013). The tubular lumen is surrounded by renal tubular epithelial cells (TECs).
These TECs are responsible for reabsorbing the majority of filtered water, small proteins, amino
acids, carbohydrates, electrolytes, and water soluble vitamins. Other organic molecules and drug
metabolites are non-absorbed along with some water to form the urine. The secretory and
reabsorptive function of TECs allow for tight regulation of plasma osmolality, blood pressure,
acid-base and electrolytes balance. Distal parts of the tubule also partake in this process. In addition
to the reuptake of filtered macromolecules, the tubular epithelium also plays a role in hormone
homeostasis (Eckardt et al., 2013). The kidneys’ fibroblasts are also responsible for producing
erythropoietin, a vital hormone that is induced in response to hypoxia and regulates erythropoiesis.
Finally, the kidney produces the hormone renin, which induces angiotensin and aldosterone
production to regulate electrolyte and acid-base balance and blood pressure. In summary, the
kidneys play excretory, metabolic and endocrine functions that dictate homeostasis. Importantly,
life cannot be sustained in the absence of functional kidneys and thus patients with end-stage
kidney disease (ESRD) require some form of dialysis or kidney transplantation to sustain life.
2

The main cell type in the kidney is tubular epithelial cells (TECs), with the remainder
consisting of endothelial cells, smooth muscle cells, podocytes, and various cells within the
interstitium, such as resident innate immune cells and fibroblasts. Proximal TECs form a “leaky”
epithelium due to the expression of pore-forming claudin proteins (Claudins 2 and 10) in the tight
junctions (Muto et al., 2010). Proximal TECs also express abundant energy-dependent
transporters, whose high energy demand is met by oxidative phosphorylation (Gstraunthaler et al.,
1985). This is a key feature that causes the proximal tubular region to be most susceptible to
ischemic injury.

1.2. ACUTE KIDNEY INJURY
1.2.1.

Definition
Acute kidney injury (AKI), previously known as acute renal failure, is defined as the abrupt

decrease in renal function over a period of hours to days, leading to the inability of the kidney to
excrete waste products and maintain fluid and electrolyte homeostasis (Thadhani et al., 1996).
However, a precise clinically diagnostic definition of AKI is still in development. Currently, most
clinical definitions rely on serum creatinine, but newer definitions are being developed to identify
early injury using biomarkers well before perturbations in serum creatinine are noticed (Kellum et
al., 2002; Levey et al., 1988). To date, finding perfectly sensitive and specific markers for early
AKI have been problematic, given the significant variation in etiology and patient populations
affected. The first evidence-based consensus study to define AKI was done in 2004 (Bellomo et
al., 2004; Kellum et al., 2002). It encompasses what is known as RIFLE criteria, which stands for
three levels of increasing AKI severity (Risk, Injury, Failure), and outlines two outcome variables
(Loss and End-stage) based on urine output and GFR level. The RIFLE criteria was later modified
by the Acute Kidney Injury Network (AKIN) (Mehta et al., 2007) to improve sensitivity of AKI
diagnosis (Akcan-Arikan et al., 2007; Mehta et al., 2007). In 2012, the Kidney Disease: Improving
Global Outcomes group (KDIGO) released yet newer guidelines for diagnosing and staging AKI
(Work et al., 2012) (Table 1.1).
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Table 1. 1. The current staging of AKI as determined by the Kidney Disease: Improving
Global Outcomes (KDIGO) foundation.
Modified from source; Work, Kidney Disease: Improving Global Outcomes (KDIGO) Acute
Kidney Injury, & Group. (2012). KDIGO Clinical Practice Guideline for Acute Kidney Injury.
Kidney Int. Supplementary, 2(1), 138.
Stage

Serum Creatinine

Urine Output

1

1.5-1.9 times baseline OR,
≥0.3 mg/dl (≥26.5 µmol/l) increase
2.0-2.9 times baseline
3.0 times beaseline OR,
Increase in serum creatinine to ≥4.0
mg/dl (≥353.6 µmol/l) OR,
Initiation of renal replacement
therapy OR,
In patients <18 years, decrease in
estimated GFR to <35 ml/min per
1.73 m2

<0.5 ml/kg/h for 6-12 hours

2
3

4

<0.5 ml/kg/h for ≥12 hours
<0.3 ml/kg/h for ≥24 hours OR,
Anuria for ≥12 hours

1.2.2.

Etiology
Ischemia-reperfusion injury (IRI) and nephrotoxins are the most common causes of AKI

in humans (Thadhani et al., 1996). IRI occurs with the significant reduction or cessation of blood
flow (ischemia), resulting in immediate oxygen deprivation (hypoxia) and accumulation of toxic
metabolic products, followed by restoration of blood flow (reperfusion) with production of reactive
oxygen species (J. V. Bonventre et al., 2011). In patients, the reduction of blood flow is most
commonly caused by low blood pressure (hypotension). Septic shock is the most common cause
of AKI in hospitalized patients, accounting for >50 % of AKI cases in intensive care unit (ICU)
patients (Hoste et al., 2007;Lopes et al., 2010; Uchino et al., 2005). Sepsis results in altered blood
flow to vital organs including the kidneys, and is responsible for inadequate delivery of oxygen
and metabolic substrates to cells. In this setting, ischemic AKI is exacerbated by the administration
of vasoconstrictive drugs that are the cornerstone of treatment for septic shock (Sharfuddin et al.,
2011). Another common cause of ischemic AKI is cardiovascular surgery, where up to one fifth
of patients will develop the condition (Pickering et al., 2015). Overall, ischemia is the major cause
of AKI and can be caused by many specific conditions (Figure 1.1), and is influenced heavily by
the health status of a patient or the existence of co-morbidities.
Ischemic AKI can also occur due to secondary causes that influence systemic
haemodynamics. Examples include cardiorenal syndrome, whereby a primary cardiac disorder
compromises cardiac output and renal perfusion (McCullough et al., 2013; Ronco, 2010), and
hepatorenal syndrome in which acute or chronic liver failure results in exaggerated splenic
vasodilation and renal hypoperfusion (Garcia-Tsao et al., 2008; Gines et al., 2009).
In addition, AKI may also be caused by extrinsic toxins (Joseph V. Bonventre et al., 2004;
Lameire et al., 2008). Nephrotoxic agents can cause injury either by directly damaging TECs, or
indirectly by altering renal hemodynamics (Perazella, 2012). For example, aminoglycosides are
directly toxic to proximal tubule cells (Perazella, 2012; Schetz et al., 2005), while angiotensin
converting enzyme inhibitors decrease GFR by causing vasoconstriction of the glomerular blood
vessels. About ten percent of AKI is caused by post-renal etiologies that are defined by obstruction
to urine flow beyond the kidney (Basile et al., 2012). Examples of this are benign prostatic
hyperplasia compressing the urethra, or metastatic cancer compressing the ureters (Campbell et
al., 2014). Other rarer causes of AKI include renal inflammation (i.e. interstitial nephritis) due to
medication allergy, infection, or autoimmunity (Choudhury et al., 2006; Basile et al., 2012).
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Figure 1.1. Pathophysiological conditions and medications leading to acute kidney injury
Modified from Bonventre, J. V and Yang, L. Cellular pathophysiology of ischemic acute kidney
injury. Review. J Clin Invest. 2011: 121 (11): 4210-21
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1.2.3.

Animal models
The most widely used animal model of human AKI is the rodent ischemia-reperfusion

model. It consists of transiently clamping and un-clamping the renal vascular pedicle to mimic IRI
in humans (Heyman et al., 2009; Heyman et al., 2002). Two types of ischemia can be employed;
i) cold ischemia to mimic what happens during organ preservation in renal transplantation, and ii)
warm ischemia to mimic ischemic injury that occurs during shock or organ retrieval of the native
kidney (Heyman et al., 2002; Prowle et al., 2009). In renal transplantation, cold ischemia starts
when the organ is perfused with cold perfusion solution after procurement, and lasts until the
temperature of the organ reaches the physiologic temperature (Jang et al., 2015). Warm ischemia
begins when perfusion is restored after anastomosis (Alejandro et al., 1995; Halazun et al., 2007).
An alternative model to IRI is the nephrotoxic model where animals are administered a
nephrotoxic agent such as cisplatin, a chemotherapeutic agent, which causes nephrotoxic AKI with
some pathophysiological similarities to the IRI model (Yap et al., 2012). A limitation of animal
models is that they cannot capture the impact of co-morbidities and demographics that are well
recognized to influence the development, course, and prognosis of AKI in humans (Bihorac et al.,
2009; Zarjou et al., 2011; Grams et al., 2015; James et al., 2015). For example, one of the most
important risk factors for the development of AKI is prior history of chronic kidney disease (Ishani
et al., 2009; Xue et al., 2006).
1.2.4.

Epidemiology of acute kidney injury
Despite advances in the diagnosis and management of AKI, it remains associated with high

mortality and morbidity for patients. AKI affects between 10-20 % of all hospitalized patients
worldwide depending on the definition used, with prevalence in the intensive care unit reaching
over 30 % (Chertow et al., 2005; Susantitaphong et al., 2013). Almost 25 % of patients with AKI
die, with in-hospital mortality and prolonged hospitalization being proportionally increased with
the degree of kidney dysfunction in AKI (Hoste et al., 2007; Chertow et al., 1995). Worldwide,
AKI affects approximately 13.3 million people each year, and is believed to contribute to 1.7
million deaths annually (Lewington et al., 2013; Mehta et al., 2015). Population-based studies
suggest that AKI confers a large economic burden to the health care system. Greater than one
million hospitalizations in the United States are complicated by AKI, accounting for ten billion in
excess costs (Wald et al., 2015).
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In spite of advances in current therapeutic strategies to resolve AKI, the high mortality rate
associated with AKI remains unchanged (Bihorac et al., 2009; Chertow et al., 2005; Chronopoulos
et al., 2010). While the metabolic derangements resulting from severe AKI can be managed with
dialysis, there is little evidence that renal replacement therapies change long-term prognosis (Lo
et al., 2009; Metcalfe et al., 2002; Wald et al., 2009). Further, a significant proportion of surviving
patients suffer long-term sequelae, including the development of chronic kidney disease (CKD)
and end-stage renal disease (ESRD) (Chawla et al., 2012; Hsu, 2012; Coca et al., 2012). One recent
study found that patients who appear to recover from their need for dialysis after an initial AKI
episode have a 3-fold risk of eventually needing dialysis again for ESRD, compared to patients
without AKI (Wald et al., 2009). There is now strong experimental evidence suggesting a
pathogenic link between AKI and CKD (Coca et al., 2012; Venkatachalam et al., 2015).
Whether the increase in mortality observed with AKI is causal or due to other factors is
unclear, but emerging evidence suggests that AKI may lead to systemic inflammation and
contribute to remote organ dysfunction (Awad et al., 2009; Klein et al., 2008; Vieira et al., 2007).
Animal studies show that AKI can lead to remote organ dysfunction in the lungs (K. D. Liu, 2009;
Rabb et al., 2003), the heart (K. J. Kelly, 2003; Kramer et al., 1999), the liver, the intestines, and
the brain (M. Liu et al., 2008; Pratschke et al., 2001).
1.2.5.

Pathophysiology
The pathophysiology of AKI is highly complex and varied depending on its etiology (J.

V. Bonventre et al., 2011). As discussed above, the major pathoetiologies include ischemia,
toxins, obstruction, and inflammation. For the purposes of this thesis, we will focus on ischemic
AKI, the major cause of AKI in humans. The clinical course of ischemic AKI has been divided
into several phases: initiation, extension, maintenance, and recovery. The cellular alterations
taking place in the kidney at each phase are summarized in Table 1.2 (Molitoris et al., 2004;
Sutton et al., 2002).
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Table 1. 2. Summary of the different phases of acute kidney injury and the
cellular pathophysiology occurring at the tubular and vascular endothelial cell
levels.
AKI- Acute Kidney Injury, ATP- Adenosine Triphosphate, ROS- Reactive Oxygen
Species, KIM-1- Kidney injury molecule-1, GPNMB -Transmembrane
glycoprotein NMB.
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During the initiation phase, cells are exposed to the ischemic insult. This directly leads to
pathogenic effects that occur during the extension phase, resulting in a reduced GFR and altered
kidney function. Depending on the severity of the injury (for example, the duration of ischemia),
cells may experience different fates ranging from sub-lethal injury to different forms of cell death.
One of the main mechanisms of cell death during IRI is via ATP depletion and altered tubule cell
metabolism (Devarajan, 2006; Togel et al., 2014). The proximal tubular epithelial cells of the S3
segment of the nephron are most sensitive to ischemic injury, due to their high metabolic rate,
dependence on oxidative phosphorylation, and the unique architecture of the blood supply in the
kidney (Basile et al., 2012; Bastin et al., 1987; Uchida et al., 1988). When oxidative stress occurs,
tubular cells fail to efficiently convert from oxidative to glycolytic metabolism, resulting in ATP
depletion and cell injury through multiple mechanisms. ATP depletion leads to an increase in free
intracellular calcium (Schrier et al., 1987), which in turn causes activation of proteases,
phospholipases, and cytoskeletal derangements (Devarajan, 2005). Importantly, ATP depletion
causes the production of reactive oxygen molecules (Paller et al., 1984). Reactive oxygen
molecules activate many intermediates that cause protein oxidation (Andreoli et al., 1997), lipid
peroxidation (Zager, 1996), and DNA damage, triggering apoptotic cell death (Safirstein, 1997;
Ueda et al., 1992). ATP depletion also results in the loss of cell polarity, due to apical and
basolateral mislocalization of polarized proteins (Devarajan, 2006; Molitoris, 2004). For example,
mislocalization of the vital Na+/K+-ATPase pumps (Molitoris, 1993; Molitoris et al., 1991), causes
bidirectional transport of sodium and water across the epithelial membrane, leading to high
fractional excretion of sodium often seen early in ischemic AKI in patients (Sharfuddin et al.,
2011). Mislocalization of β1 integrin, a basolateral protein (Zuk et al., 1998), leads to subsequent
detachment of viable cells from the tubular basement membrane during the extension phase.
Experimental evidence suggests that this process of detachment contributes to cast the formation
and obstruction within the tubular lumen, which is believed to further impair GFR (Molina et al.,
2005; Yang et al., 2015).
In addition, ATP depletion causes alteration of the apical cytoskeleton due to dissociation
of actin-stabilizing proteins, including tropomyosin and ezrin (Ashworth et al., 2003; Ashworth et
al., 2004). The dissociation of these proteins allows the actin depolymerizing factor, cofilin, to
sever apical F-actin. Sequentially, this leads to the formation of membrane-bound or free floating
extracellular vesicles that are either internalized or released into the tubular lumen (Ashworth et
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al., 1999). Disruption of the apical cytoskeleton also results in the loss of tight and adherence
junctions (Devarajan, 2006; Sharfuddin et al., 2011). Specifically, the loss of interaction between
the tight junction proteins Neph1 and zonula occludens-1 (ZO-1) results in a loss of tubular
integrity, which is associated with proteinuria in rat model of renal ischemic injury (Wagner et al.,
2008). The loss of tight junctions is important as it leads to impaired barrier function of the tubular
epithelium, which magnifies the pathological effects of kidney dysfunction during the extension
phase by contributing to the back leak of glomerular filtrate (e.g. filtered creatinine or urea) (Kwon
et al., 1998).
The initiation phase also damages vascular endothelial cells (Basile et al., 2012), where
disruption of actin cytoskeleton and junctional complexes occurs in a similar manner to that
described above for TECs (Devarajan, 2006; Molitoris et al., 2004). This results in collapse of the
perivascular matrix, increasing microvascular permeability, thus allowing fluids to be lost into the
interstitium and impairing capillary flow during the extension phase (J. V. Bonventre et al., 2011;
Sutton et al., 2002). Injured endothelial cells also increase production of vasoconstrictors such as
endothelin, and decrease the production of vasodilators such as nitric oxide (Conger et al., 1991;
Goligorsky et al., 2004). Additionally, stressed endothelial cells express a variety of adhesion
molecules, such as intracellular adhesion molecule-1 (ICAM-1), P-selectin and E-selectin, which
promote endothelial-leukocyte interactions to promote inflammation (Devarajan, 2006; K. J. Kelly
et al., 1994; Linas et al., 1995). The combination of endothelial cell expression of adhesion
molecules, production of vasoconstrictors, and increased vascular permeability significantly
contributes to progression into the extension phase.
It was previously thought that if the injury was sublethal, complete restitution and recovery
could occur after the cessation of the IRI insult. However, new evidence illustrates that
dysfunctional endothelial and tubular cells substantially contribute to the extension phase,
propagating tissue damage (Devarajan, 2006; Molitoris et al., 2004). The extension phase is
marked by inflammatory responses that are not only initiated by endothelial dysfunction, but
according to recent evidence, by injured TECs (Joseph V. Bonventre et al., 2004; Friedewald et
al.,2004; Yang et al., 2015). Together, these injured cells are responsible for the generation of
proinflammatory cytokines (e.g. TNF-α, TGF-β, IL-6) and chemotactic cytokines (e.g. monocyte
chemoattractant protein-1 (MCP-1), RANTES, IL-18) (Joseph V. Bonventre et al., 2004; Daha et
al., 2000; Donnahoo et al., 2000; Ishibashi et al., 1999; Segerer et al., 2000). In humans, plasma
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levels of the proinflammatory cytokines IL-6 and IL-8 have been shown to predict mortality in
AKI patients (Kielar et al., 2005; Simmons et al., 2004). Injured TECs also express toll-like
receptors 2 and 4 (TLR2 and TLR4) that enable them to recognize extracellular danger signals and
trigger inflammatory responses from within (Leemans et al., 2005; Wu et al., 2007). The sum of
effects mediated by the proinflammatory mediators produced by TECs and endothelial cells causes
an escalation of inflammation via recruitment of leukocytes and inflammatory cells (Friedewald
et al., 2004). Ultimately, the ensuing inflammatory response to the initial ischemic injury to cells
serves to cause secondary tissue damage.
1.2.6.

Mechanisms of cell death during acute kidney injury
During the extension phase, lethally injured TECs die either by apoptosis, regulated

necrosis, or necrosis, depending on the level of ATP depletion and extent of cellular injury (Figure
1.2) (Basile et al., 2012; Lieberthal et al., 1998; Schumer et al., 1992).
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Figure 1.2. Different forms of cell death occurring in ischemic acute kidney injury and
their contribution to inflammation.
The different forms of cell death occurring during ischemic acute kidney injury are divided into:
programmed cell death (apoptosis), regulated necrosis (necroptosis, ferroptosis, or pyroptosis),
and necrosis. The immunogenicity (ability to provoke an immune response) of each of these
forms of death is based on the ensuing morphological consequence to the dying cell. All forms of
cell death, except apoptosis, are known to release damage associated molecular patterns
(DAMPs), such as High mobility group box 1 (HMGB1). Additional DAMPs released are
indicated with morphological consequences of cell death forms. This figure likely oversimplifies
the entire spectrum of cell death that occurs during tissue injury.
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Apoptosis or programmed cell death is an energy-dependent mechanism that results in
nuclear shrinkage, chromatin fragmentation and cell breakdown (J. F. Kerr, 2002; Padanilam,
2003; Wyllie et al., 1980). The apoptotic cell membrane remains intact but often several proteins
or modified lipids that are usually localized on the inner cellular membrane are exposed on the
plasma membrane outer leaflet. These serve as “eat me” signals to allow for their phagocytic
clearance by professional or semi-professional phagocytes (Fadok et al., 1998; Ravichandran et
al., 2007). For example, the membrane phospholipid, phosphatidylserine, which is displayed by
apoptotic cells before cellular fragmentation and formation of apoptotic bodies, is the most widely
studied “eat me” signal to date (Fadok et al., 1998; Fadok et al., 1992). Since apoptosis usually
occurs during normal cell turnover, there is little effect of this form of cell death on the surrounding
tissue and it is largely considered to be a non-immunogenic form of cell death (Figure 1.2).
Interestingly, blocking apoptotic pathways in mice subjected to ischemic AKI resulted in reduced
inflammation and tissue damage (Daemen et al., 1999).
In contrast, necrosis is considered to be the most immunogenic form of cell death. It begins
with cellular and organelle swelling, followed by loss of plasma membrane integrity, with the
consequent release of cytoplasmic and nuclear material outside the cell (Majno et al., 1960). The
intracellular material released from necrotic cells contains highly immunogenic proteins, referred
to as damage associated molecular patterns (DAMPs), such as ATP, IL-1α, and HMGB1, doublestranded DNA (Kono et al., 2008; Leach et al., 1998). Extracellular DAMPs are recognized by
specific pattern recognition receptors (PRRs), such as TLR-4 expressed by various cell types
including tubular cells (Jang et al., 2009). Cells responding to the DAMPs via PPRs produce even
more proinflammatory mediators further amplifying the renal inflammatory response during
ischemic AKI (Wu et al., 2007; B. Zhang et al., 2008).
Recently, many forms of regulated necrosis have been linked to ischemic AKI. Necroptosis
is one type of regulated necrosis and is defined as necrotic cell death that is dependent on receptorinteracting protein kinase 3 (RIPK3) (Linkermann et al., 2012; Tait et al., 2013). Upon the
activation of RIPK3, it phosphorylates the Mixed Lineage Kinase domain-Like protein (MLKL)
which leads to subsequent plasma-membrane rupture. Blocking RIPK3 signaling has been shown
to be protective in ischemic AKI in animal models (Linkermann et al., 2012; Linkermann, et al.,
2013; Tristao et al., 2012; L. Zhang et al., 2013). Other regulated necrotic cell death pathways
implicated in AKI include pyroptosis and ferroptosis (Linkermann, Chen, et al., 2014). Pyroptosis
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is unique in that it results in the maturation of proinflammatory cytokines, such as IL-1β and IL18, via caspase-1 activation which brings about more inflammatory responses than necroptosis
(Miao et al., 2011; Yang et al., 2014). Following 12 hours of IRI, the levels of pyroptosis-related
proteins, such as caspase-1, were significantly elevated in renal tubular epithelial cells (Yang et
al., 2014). Ferroptosis is an iron-dependent, oxidative, non-apoptotic form of cell death which
involves glutathione metabolism (Dixon et al., 2012; Skouta et al., 2014). Ferroptosis was shown
to mediate necrotic tubular cell death in renal IRI, since blocking ferroptosis via chemical inhibitor
(ferrostatin) resulted in the protection from severe IRI as seen by lower serum creatinine and less
histological damage (Linkermann, Skouta, et al., 2014). On the other hand, mice deficient in the
proximal tubular cell-specific ferritin heavy chain showed greater mortality and worse renal injury
following cisplatin-induced AKI (Zarjou et al., 2013). Due to the different forms of cell death
involved and their respective roles in promoting tissue damage in AKI via promoting
inflammation, the extension phase is thought to be a promising window for early diagnosis and
active therapeutic interventions in AKI.
1.2.7.

Various inflammatory cells in acute kidney injury
During the extension phase, various immune cells infiltrate the kidney. Based on animal

studies, neutrophils are the earliest leukocytes to be recruited into injured endothelium (Willinger
et al., 1992), followed by macrophages (Jang et al., 2015; Ysebaert et al., 2000). These
macrophages are known to produce proinflammatory cytokines that stimulate the activity of other
leukocytes and parenchymal cells (Duffield, 2010). Interestingly, depletion of kidney and spleen
macrophages in mice prior to renal IRI was shown to prevent AKI, while adoptive transfer of
macrophages re-established the AKI response (Day et al., 2005). Additionally, monocytes have
been shown to migrate to inflamed kidney tissues and differentiate into M1-type macrophages or
dendritic cells, which further participate in inflammatory responses (L. Li et al., 2008). Dendritic
cells (DCs) are also thought to have a role in AKI; depletion of DCs leads to a lower level of TNF
produced by kidneys (Dong et al., 2007; Tadagavadi et al., 2010). Another innate immune cell that
has been seen to infiltrate ischemic kidney during AKI is the natural killer cell, which has been
shown to orchestrate more neutrophil infiltration via production of interferon-gamma (IFN-γ) (L.
Li et al., 2007).
T cells have also been shown to be involved in AKI. Depletion of T cells was shown to
protect mice from ischemic AKI (Yokota et al., 2002; Ysebaert et al., 2004). Interestingly, T15

regulatory cells have been shown to traffic into the ischemic kidney (M. Liu et al., 2009), and have
been proposed to promote repair during the maintenance phase though modulation of
proinflammatory cytokines by other T-cells subsets (Kinsey et al., 2010; Kinsey et al., 2009). The
inflammatory response triggered at the initiation stage involves the activation of complement
systems, which contributes to the amplification of tissue damage from inflammation (Arumugam
et al., 2004; Quigg, 2003). The majority of the existing research has implicated the alternative
pathway (Thurman et al., 2003) and mannose-binding lectin pathway of complement activation in
AKI (de Vries, Kohl, et al., 2003; De Vries, Matthijsen, et al., 2003; de Vries et al., 2004).
1.2.8.

Mechanisms of repair and regeneration after acute kidney injury
While there are numerous injurious pathways activated in AKI, several intra-renal

protective mechanisms are also upregulated during the extension phase that help to limit tissue
damage and potentiate repair during the maintenance and recovery phases. Injured but surviving
TECs upregulate many genes that promote tissue repair and curtail inflammatory responses (Wen
et al., 2010). For example, Kidney Injury Molecule-1 (KIM-1) is specifically upregulated on TECs
following ischemic injury (Ichimura et al., 1998). KIM-1 is a phagocytic receptor that recognizes
phosphatidylserine on apoptotic and necrotic cells, allowing their uptake by TECs (Ichimura et al.,
2008). This uptake has been shown to clear apoptotic cells, preventing them from undergoing
secondary necrosis, and mediating down-stream anti-inflammatory responses triggered by
extracellular DAMPs in proximal TECs (see section 1.3.4). These included the NF-кB pathway,
infiltration of immune cells, and production of inflammatory cytokines (Yang et al., 2015).
Another important repair protein that is upregulated on injured TECs is the transmembrane
glycoprotein NMB (GPNMB) (B. Li, Castano, et al., 2010; Sharfuddin et al., 2011). GPNMB is
important in the recruitment of autophagy protein LC3 to phagosomes and the fusion of lysosomes
with phagosomes. The latter plays an important role in uptake and degradation of apoptotic cells.
Mice with mutated GPNMB exhibited increased inflammation, impaired repair and more apoptotic
cell accumulation in response to renal ischemia (B. Li, Castano, et al., 2010). Other proteins
involved in repair and regeneration during the maintenance and recovery phase expressed by TECs
include heme oxygenase (Nath, 2006) and heat shock proteins (Z. Wang et al., 2011).
Additionally, recruitment of regulatory T cells has been shown to promote repair through
the modulation of proinflammatory cytokines produced by other T cells (Kinsey et al., 2010;
Kinsey et al., 2009; Sharfuddin et al., 2011), whereby the depletion of regulatory T cells subsets
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(Foxp3+) resulted in increased accumulation of leukocytes and inflammatory cytokines within the
kidney (Gandolfo et al., 2009).
During the maintenance phase, the fate of the kidney is likely determined by a balance
between cells that survive injury or die from it, as only surviving cells can promote repair
(Humphreys et al., 2011; Humphreys et al., 2008, Berger et al., 2014). The recovery phase aims
to improve GFR, and regenerate the vascular and tubular epithelium (Basile et al., 2012).
Understanding the process of regeneration and proliferation after ischemic AKI is still a work in
progress, with much debate surrounding the source of these proliferating cells (Kramann et al.,
2015). Mesenchymal stem cells were thought to be the source of proliferative cells, since they
could differentiate into renal epithelium and endothelium in vitro (Bussolati et al., 2005). Several
groups have previously shown that infusing mesenchymal stem cells improved renal function
following injury and even protected from injury if cells were infused before the ischemic insult
(De Broe, 2005; Lange et al., 2005; Togel et al., 2005). More recently, research by Duffield et al.
and Humphrey et al. have contradicted these findings. Their groups showed that terminally
differentiated proximal TECs were solely responsible for the dedifferentiation, proliferation and
redifferentiation necessary to regenerate the kidney tubular epithelium (Duffield et al., 2005;
Duffield et al., 2011; Humphreys et al., 2011; Humphreys et al., 2008; Kramann et al., 2015).
Whether endothelial progenitor cells originate from hematopoietic stem cells or mesenchymal
stem cells and their role remains unclear (Reinders et al., 2006; Tongers et al., 2007). Regardless
of the source of the endothelial progenitor cells, they are recruited to injured renal
microvasculature to repair and improve the functional recovery of the kidney following AKI
(Becherucci et al., 2009; B. Li, Cohen, et al., 2010).
Emerging evidence strongly suggests that repair mechanisms following AKI are mostly
incomplete and, when injury is severe, could lead to CKD (Basile et al., 2012; Devarajan, 2006).
Hallmarks of incomplete recovery are persistent tubulointerstitial inflammation, fibroblast
proliferation, excess extracellular matrix deposition, and chronic macrophage and fibrosis
activation (Duffield, 2010; Hsu, 2012; Ko et al., 2008; Venkatachalam et al., 2010; Venkatachalam
et al., 2015). Overall, the cellular pathophysiology of ischemic AKI is a highly complex field of
research that is continuously developing. It is hoped that understanding the injury and repair
pathways involved in ischemic AKI will eventually lead to the development of novel therapeutic
strategies to ameliorate AKI and potentially prevent its systemic consequences.
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1.2.9.

Biomarkers for acute kidney injury
A biomarker is defined as a biological “characteristic that is objectively measured and

evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic
responses to a therapeutic intervention” (Biomarkers Definitions Working, 2001). When patients
develop AKI, they are asymptomatic until most of the kidney function is compromised. To date, a
rise in serum creatinine and/or fall in urine output have been the most widely used markers of
kidney function (Levey et al., 1988; Work et al., 2012). Unfortunately, the rise in serum creatinine
is often delayed until much damage has occurred and is generally an unreliable indicator of kidney
dysfunction (Coca et al., 2008). Other biomarkers traditionally used in conjunction with serum
creatinine and urine output have been serum urea (Beier et al., 2011), and the chemical analysis of
urine, including urine sediment (Kanbay et al., 2010), fractional excretion of sodium (Chawla et
al., 2008) and fractional excretion of urea (Carvounis et al., 2002). None of the currently used
diagnostic markers provide information about the severity or nature of kidney injury or whether
the repair and recovery process has started. This information might aid clinicians to make better
therapeutic decisions when it comes to AKI in patients.
This knowledge gap has promoted a new area of research that aims to implement specific
biomarkers to detect kidney injury prior at the onset of AKI, well before it is detected by increased
serum creatinine (Bellomo et al., 2012; Devarajan et al., 2010). Several new biomarkers, such as
cystatin C (Ahlstrom et al., 2004; Herget-Rosenthal et al., 2004; Moore et al., 2010), L-type fatty
acid-binding protein (L-FABP) (Deitch, 1998; Nakamura et al., 2009; Zarjou et al., 2011),
Interleukin-18 (IL-18) (Bagshaw et al., 2007; Bellomo et al., 2007; Parikh et al., 2005), Netrin-1
(Ramesh et al., 2010; Reeves et al., 2008), neutrophil gelatinase-associated lipocalin (NGAL)
(Haase et al., 2009; Mishra et al., 2005), and Kidney injury molecule-1 (KIM-1) (Ichimura et al.,
2004; Sabbisetti et al., 2013; Vaidya et al., 2009) have been proposed as early biomarkers for AKI
diagnosis and prognostication (Figure 1.3).
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Figure 1.3. Emerging and traditional biomarkers of acute kidney injury during the
different stages of disease progression
Kidney injury occurs before the kidney function is lost, as determined by the decreased
glomerular filtration rate (GFR). Different markers detected in serum or urine during early
kidney injury due to ischemic, toxic or septic insults serve as early detection markers. An
increase in diagnostic markers might be parallel or prior to the loss of kidney function as
determined by traditional biomarkers of decreased GFR, increased levels of serum creatinine and
decreased urea. Following the loss of kidney injury, some traditional and new biomarkers could
provide a prognostic assessment of outcome after AKI and possibility of kidney failure in
patients. NGAL= neutrophil gelatinase-associated lipocalin, KIM-1= kidney injury molecule-1,
IL-18= interleukin-18, L-FABP= liver fatty-acid-binding protein. Modified from Bellomo, R.,
Kellum, J.A, Ronco, C. Acute kidney injury. Lancet 2013:280:756-66
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A few of these biomarkers have shown promising results in detecting AKI of various
etiologies (Bagshaw et al., 2010; Parikh et al., 2005). Both NGAL and KIM-1 are among the
highly upregulated genes in the early post-ischemic kidney and after nephrotoxic injury (Mishra
et al., 2005; Mishra et al., 2003; Mishra, Mori, Ma, Kelly, Barasch, et al., 2004). NGAL is an irontransporting protein that is co-localizaed with endosomal markers (Bao et al., 2010).
Adminstration of recombinant NGAL has been shown to protect from apoptosis and enhance
tubular cell proliferation following murine IRI (Mishra, Mori, Ma, Kelly, Yang, et al., 2004; Mori
et al., 2005). In addition, NGAL is expressed by tubular cells undergoing proliferation following
injury, which suggests that is might play a role in the mainentance and recovery phase of AKI
(Yang et al., 2002). These exciting functional data have led to a number of human translational
studies to evaluate blood and urine level of NGAL as novel biomarker for AKI (Bolignano et al.,
2008; Hirsch et al., 2007). A standardized commercial bedside biomarker kit for NGAL has now
been approved by the Food and Drug Administration for the early detection of AKI in the United
States.
KIM-1 is another promising candidate biomarker of AKI, as its expression is dependent on
kidney injury (Ichimura et al., 2008; Ichimura et al., 1998). This type 1 transmembrane receptor
undergoes spontaneous ectodomain shedding upon expression on the apical membrane of proximal
TECs which enables its detection in the urine of patients and rodents with AKI (Han et al., 2002;
Han et al., 2009; Ichimura et al., 2004; Sabbisetti et al., 2013). Recently, Sabbisetti, et al., showed
that KIM-1 is also elevated in the plasma of patients who developed AKI following cardiac surgery
(Sabbisetti et al., 2014). In addition, KIM-1 levels also predicted the progression to end-stage renal
disease in diabetic patients with elevated serum KIM-1, presumably due to recurrent AKI in the
setting of CKD. In conclusion, both NGAL and KIM-1 are sensitive and specific biomarkers of
tubular injury, and are considered to be part of the potential panel of AKI biomarkers to be used
at the bedside in the future. This thesis will focus on understanding the physiological function of
KIM-1 and its downstream cell signalling in proximal TECs in AKI.
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1.3. KIDNEY INJURY MOLECULE-1
1.3.1.

Classification and structure
Kidney injury molecule-1 (referred to as KIM-1 in humans and Kim-1 in rodents) was first

identified by Ichimura, et al. in a cDNA screen for genes upregulated in the post-ischemic rat
kidney (Ichimura et al., 1998). KIM-1 mRNA and protein expression is undetectable in the normal
kidney, but increases dramatically during ischemic or toxic AKI (Ichimura et al., 2004; Vaidya et
al., 2009; Vaidya et al., 2010). It belongs to the T cell immunoglobulin mucin (TIM) gene family,
which includes TIM-1, TIM-3 (DeKruyff et al., 2010; Nakayama et al., 2009), and TIM-4
(Kobayashi et al., 2007; Santiago, Ballesteros, Martinez-Munoz, et al., 2007) in humans, and eight
members (Tim 1-8) in mice (Kuchroo et al., 2003). Human TIM-1, TIM-3 and TIM-4 are
functional orthologs of mouse Tim-1, Tim-3 and Tim-4, respectively. KIM-1 is referred to as Tcell immunoglobulin and mucin domain-containing protein-1 (TIM-1) when expressed by immune
cells, and KIM-1 when expressed on cells that originate from the kidney (including kidney
cancers), but both are in fact the product of the same gene (HAVCR1) (Kuchroo et al., 2003).
KIM-1 was first discovered as the hepatitis A virus cellular receptor 1 (HAVcr-1) in monkey cells
(Kaplan et al., 1996). HAVcr-1 was later found to exist in humans, serving as the cellular receptor
for Hepatotropic picornavirus, which causes acute liver disease in humans (Feigelstock et al.,
1998). In 1998, murine Kim-1 was identified on injured renal proximal TECs and exhibited some
degree of homology to the HAVcr1 gene (Ichimura et al., 1998). In 2001, McIntire et al. performed
positional cloning to identify a novel susceptibility gene locus for asthma and allergy (T-cell and
airway phenotype regulator), and discovered TIM-1 within the Tapr locus as the susceptibility
gene (McIntire et al., 2001). The genetic sequence of TIM-1 indicated that both TIM-1 and
HAVcr-1 encoded for the same protein. In mice, the Tim gene family is located on chromosome
11B1.1, and in humans it is located on chromosome 5q33.2 (McIntire et al., 2001). Both regions
have been linked to asthma, allergy and autoimmunity (McIntire et al., 2004; McIntire et al., 2003;
Umetsu et al., 2005).
Notably, TIM-1 is an extremely polymorphic gene with over one thousand identified
genetic variants, accounted for by single nucleotide polymorphisms, insertions or deletions
(McIntire et al., 2003; Rodriguez-Manzanet et al., 2009). TIM-1 variants have been linked to an
individual’s susceptibility to allergy, asthma (Gao et al., 2005; Matricardi et al., 1997; Matricardi
et al., 2000), eczema (Graves et al., 2005), Hepatitis A infection (H. Y. Kim et al., 2011), HIV
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progression to AIDS (Wichukchinda et al., 2010) and filovirus infection (Kuroda et al., 2014).
Given that TIM-1 is expressed on different immune cells, it is perhaps not surprising that
polymorphisms of TIM-1 have also been associated with susceptibility to other autoimmune
diseases such as rheumatoid arthritis (Chae, Song, Heo, et al., 2003; Chae, Song, Lee, et al., 2003;
Chae et al., 2004), multiple sclerosis (Grabmer et al., 2010; Khademi et al., 2004), and systemic
lupus erythematosus leading to lupus nephritis (W. X. Li et al., 2011; Y. Wang et al., 2008).
Structural studies reveal that all TIM proteins (including KIM-1) are similar. They are all
type I cell surface glycoproteins made up of an N-terminal immunoglobulin variable domain (IgV)
with six cysteines, a mucin domain with O-linked and N-linked glycosylation close to the cellular
membrane, a single transmembrane domain, and a cytoplasmic domain with tyrosine
phosphorylation motif(s) (Ichimura et al., 1998; Santiago, Ballesteros, Martinez-Munoz, et al.,
2007) (Figure 1.4). In addition, the mucin domain is rich in threonine, serine, and proline residues
that play a role in O-linked glycosylation (Kuchroo et al., 2003). TIM-4 is unique in that it contains
an Arg-Gly-Asp (RGD) motif in its IgV domain and has a shorter cytoplasmic domain that lacks
a key cell signalling motif (Meyers, Chakravarti, et al., 2005; Santiago, Ballesteros, MartinezMunoz, et al., 2007; Shakhov et al., 2004). Hence, TIM-4 is believed to interact with a signalling
intermediate or a co-receptor to transduce signals in cells (Flannagan et al., 2014; D. Park et al.,
2009). The N-terminal cysteine-rich region of the Ig domain of TIM-1, along with the mucindomain account for the high sequence identity of about 40 % between mouse and human TIM-1
(Ichimura et al., 1998; Kuchroo et al.,2003; Thompson et al., 1998). The number of O-linked
glycosylation sites varies from 37 in mouse Tim-1 to 56 in human TIM-1, which contributes to the
size difference seen between them (Human KIM-1 ~119 kDa and mouse Kim-1 ~60 kDa) (Bailly
et al., 2002; Freeman et al., 2010).
The extracellular domain of KIM-1 bears similarity to the immunoglobulin superfamily,
which is characterized by an extracellular domain containing an immunoglobulin (Ig), and a mucin
domain (Shimizu et al., 1993; Van Klinken et al., 1995). Molecules belonging to the
immunoglobulin superfamily usually function as membrane receptors or adhesion molecules. This
group includes mucosal addressin cell adhesion molecule 1 (MAdCAM-1), CD34, TACTILE
(CD96), and HAVcr-1 which is the homolog of KIM-1 (Ichimura et al., 1998; Van Klinken et al.,
1995). The MAdCAM-1 protein is most similar to KIM-1, as it contains four cysteine residues in
the Ig domain and KIM-1 contains six cysteines (Ichimura et al., 1998). The IgV-like domain of
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KIM-1 shares functional characteristics with sialic acid-binding immunoglobulin-type lectins
(SIGLECs) and C-type-lectins (Wilker et al., 2007). These similarities could suggest a potential
role for KIM-1 in cell trafficking and adhesion. Surprisingly, TIM-1/KIM-1 has been shown to
contain a signal peptide for trafficking through clathrin-coated vesicles from the endoplasmic
reticulum to the cell surface (Balasubramanian et al., 2012). The signal peptide-deleted TIM-1
mutant failed to undergo glycosylation and failed to enter vesicles for proper targeting to the cell
surface.
The crystal structure of TIM-1 has been solved. The IgV domain contains a distinct narrow
cleft that is formed by the four cysteines residues that bridge the CC’ loop to the GFC β sheet
(Santiago, Ballesteros, Tami, et al., 2007). Additionally, the crystallographic analysis uncovered
that both murine and human TIM-1 can partake in homophilic interaction (TIM-1-TIM-1
interactions), which may be a reflection of its function as an adhesion molecule. When the crystal
structure of phosphatidylserine (TIM-1 ligand) bound to TIM-1 was solved, the IgV domain was
found to form a metal-ion-dependent ligand-binding site (MILIBS), where the ion is predicted to
be calcium (Santiago, Ballesteros, Martinez-Munoz, et al., 2007). This MILIBS has asparagine
and aspartic acid residues that engage in metal coordination, which is highly conserved in all TIM
family members, except for mouse Tim-2 (Santiago, Ballesteros, Martinez-Munoz, et al., 2007).
The open confirmation of the IgV domain requires that the hydrophobic aromatic phenylalanine
and tryptophan residues remain on the tip of the CC’FG loop to allow the lipid chain of
phosphatidylserine (PS) to penetrate the narrow cleft for binding of PS to TIM-1 (Kobayashi et
al., 2007; Santiago, Ballesteros, Martinez-Munoz, et al., 2007; Santiago, Ballesteros, Tami, et al.,
2007). Mutations in the aromatic residues of the FG loop within the MILIBS abrogate its binding
to PS (Kobayashi et al., 2007; Santiago, Ballesteros, Martinez-Munoz, et al., 2007). Mutations in
MILIBS also affect TIM-1 trafficking to the cell-surface, resulting in the accumulation of mutant
TIM-1 on the plasma membrane (Balasubramanian et al., 2012).
KIM-1 has been shown to undergo spontaneous membrane-proximal cleavage, releasing a
soluble 90 kDa fragment of KIM-1 into the urine or the conditioned media of the TECs expressing
the full-length protein (Z. Zhang et al., 2007) (Figure 1.4). It is this property that has made soluble
KIM-1 an attractive non-invasive diagnostic biomarker for tubular injury (Han et al., 2002). In
cells expressing KIM-1, the cleavage was found to be mediated by ERK activation and that
activation of p38 MAP kinase resulted in accelerated cleavage of KIM-1 (Bailly et al., 2002; Z.
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Zhang et al., 2007). Recently, our lab showed that KIM-1 is cleaved by TNF-α-converting enzyme
(TACE) or ADAM 17 (a disintegrin and metalloproteinase), which is a Zn2+-dependent cell surface
protease (Gandhi et al., 2014). We also showed that reactive oxygen species generated during IRI,
accelerate KIM-1 shedding. Interestingly, we found that excess apoptotic cells can accelerate
KIM-1 cleavage, and that the shed KIM-1 binds to apoptotic cells, competitively inhibiting their
phagocytic uptake by TECs expressing KIM-1. This may be akin to a negative feedback loop.
When KIM-1 is shed, a 14 kDa fragment containing its transmembrane and cytosolic domains
remains bound (retained transmembrane KIM-1) to the plasma membrane (Z. Zhang et al., 2007).
This cytoplasmic domain of human KIM-1 contains two putative tyrosine phosphorylation sites at
position 350 and 356. Phosphorylation at tyrosine 350 is required for TIM-1 to mediate costimulatory signalling in T cells (Binne et al., 2007; de Souza et al., 2005) and likely in renal
proximal TECs (Yang et al., 2015).
It is important to note that human KIM-1 has two splice variants, KIM-1a and KIM1b
(Bailly et al., 2002). The KIM-1a variant is expressed in liver and contains a short cytosolic domain
which lacks the above tyrosine phosphorylation motif, whereas, the KIM-1b variant encodes the
full-length protein and is expressed elsewhere including the kidney. HAVcr-1 corresponds to the
KIM-1a splice variant, while TIM-1 on immune cells corresponds to KIM-1b (Bailly et al., 2002;
Kaplan et al., 1996; Rees et al., 2008). In this thesis, we will be focusing on the KIM-1b variant
and refer to it henceforth as KIM-1.
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Figure 1.4. Human KIM-1 structural domains and the peptide sequence of its
alternatively spliced variants.
A: KIM-1 is type-1-transmembrane glycoprotein with an IgV like domain, mucin domain
(glycosylation indicated by blue lines in the mucin domain), transmembrane domain and
a cytoplasmic domain that contains tyrosine phosphorylation motifs (indicated as P).
KIM-1 (KIM-1b) is expressed on renal proximal tubule epithelial cells after injury. It is
cleaved by TNF-α-converting enzyme (TACE) or ADAM 17 (a
disintegrin and metalloproteinase) into soluble shed KIM-1 (90 kDa) and a membranebound cytoplasmic fragment (14 kDa). B: Peptide sequence alignment of two human
KIM-1 variants, KIM-1a (HAVcr-1) and KIM-1b (KIM-1). KIM-1b has a tyrosinephosphorylation motif, QAEDNIY, highlighted in orange. This motif is missing in the
KIM-1a variant. The human KIM-1b (KIM-1) variant size is 359 amino acids, whereas
the human KIM-1a (HAVcr-1) protein is 334 amino acids. Modified from (Bailly et al.,
2002).
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1.3.2.

KIM-1 expression
When KIM-1 was first identified in the kidney, it was noted to be expressed on the

proliferating (bromodexoyurindine-positive) and dedifferentiated (vimentin-positive) epithelial
cells in regenerating proximal tubules in post-ischemic rat kidney (Ichimura et al., 1998). KIM-1
is expressed on the apical membrane of injured proximal tubule cells, predominantly in the S3
segment within the corticomedullary region (van Timmeren, Vaidya, et al., 2007; van Timmeren,
van den Heuvel, et al., 2007), where injury is most likely to occur as mentioned earlier. Since its
identification, a large number of studies have been conducted on KIM-1 in humans with different
etiologies of AKI. These have confirmed that KIM-1 expression on injured tubules or shedding in
the urine serves as a sensitive and specific biomarker for AKI (Han et al., 2002; Sabbisetti et al.,
2013; Sabbisetti et al., 2014; Vaidya et al., 2010; Vaidya et al., 2006; Vaidya et al., 2008). Various
studies in humans and mice show that KIM-1 is also highly upregulated following AKI caused by
nephrotoxins, (Ichimura et al., 2004), such as cisplatin (Amin et al., 2004), folic acid (Waanders
et al., 2009), cyclosproine (Perez-Rojas et al., 2007), and iodinated contrast agents (Jost et al.,
2009). This has made it an attractive biomarker to screen for nephrotoxicity of therapeutic
compounds that are in development by the pharmaceutical industry (Han et al., 2002; Ichimura et
al., 2004; van Timmeren, Vaidya, et al., 2007).
Both tubular KIM-1 (~119 kDa) and urinary soluble KIM-1 (~90 kDa) have also been
detected in patients with different proteinuric, inflammatory and fibrotic renal diseases. KIM-1 has
been detected in CKD patient biopsies, and its expression is often associated with tubulointerstitial damage, inflammation, fibrosis and a dedifferentiated tubular phenotype (Rennert,
2011; Vaidya et al., 2011; van Timmeren, van den Heuvel, et al., 2007). In the setting of CKD,
whether KIM-1 is a marker of acute injury, inflammation, or fibrosis is not known. Recent
evidence of KIM-1-expression on renal transplants with interstitial fibrosis and tubular atrophy
supports the notion that it is involved in chronic kidney injury (Nogare et al., 2015; van Timmeren,
Vaidya, et al., 2007; Yeung et al., 2011; Schroppel et al., 2010 ). In murine models, Kim-1 is
upregulated in the kidneys of mice subjected to obstructive AKI (fibrosis model) (Humphreys et
al., 2013) and polycystic kidney disease (Kuehn et al., 2002). Consequently, the upregulation of
KIM-1 expression following renal injury and its persistent expression in the case of chronic injury
has made it a useful as a non-invasive biomarker. Interestingly, KIM-1 has been shown to be highly
expressed in human renal cell carcinoma specimen and cell lines isolated from cancer patients,
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suggesting that it might additionally be related to cancer progression (Han et al., 2005; Shalabi et
al., 2013).
The wide range of stimuli that lead to KIM-1 upregulation makes it a very interesting
protein to study from the point of view of gene regulation. Recently, some of the transcriptional
regulators that control KIM-1 expression in the kidney were identified (Ajay et al., 2014).
Following tubular injury in rat and human kidneys, or oxidative stress in human TECs, the
checkpoint kinase 1 (Chk1) is phosphorylated and this allows it to interact with the signal
transducer and activator of transcription-3 (STAT3). STAT3 is subsequently phosphorylated and
binds to the KIM-1 promoter to upregulate its transcription.
Interestingly, when Kim-1 expression was measured in various mouse tissues by
quantitative RT-PCR, its RNA expression was highest in the lymph node and kidney, weakly
expressed in the spleen, lung, and thymus, and undetectable in the heart or liver (Umetsu et al.,
2005). This suggests that Kim-1/Tim-1 expressing immune cells are enriched in lymph nodes. In
terms of expression by immune cells, mouse Tim-1 is expressed on activated T cells, but not naïve
CD4+ T cells (Freeman et al., 2010; McIntire et al., 2001; Umetsu et al., 2005). Following
differentiation of T-cells into effector cells, Tim-1 is expressed by Th2, Th1 and Th17 cells
(Angiari et al., 2014; Nakae, Iikura, et al., 2007; Nakae, Iwakura, et al., 2007; Sizing et al., 2007).
Tim-1 is also expressed by germinal B cells and is considered a hallmark characteristic of these
cells (S. H. Wong et al., 2010). A number of groups have recently demonstrated that Tim-1 is a
marker of regulatory B cells that produce IL-10 (Ding et al., 2011; Xiao et al., 2015; Xiao et al.,
2012). In regards to expression by innate immune cells, Tim-1 is expressed on mast cells (Nakae,
Iikura, et al., 2007) and invariant natural killer T cells (H. S. Kim et al., 2010; Lee et al., 2010).
The wide expression pattern of Tim-1 might explain the different functions carried by KIM-1/TIM1. Whether the HAVCR1 gene is regulated differently in immune cells compared to the kidney
remains unknown.
1.3.3.

Extrarenal KIM-1 function
A significant body of work supporting an extra-renal function of KIM-1/TIM-1 was

published long before its role in the kidney began to be elucidated. TIM-1 was first shown to be
a co-stimulatory molecule for naïve CD4+ T cell activation and proliferation (de Souza et al.,
2005; Encinas et al., 2005; Umetsu et al., 2005) and an inhibitor of Th2 cell differentiation (Xiao
et al., 2007). Most of the studies that supported TIM-1’s co-stimulatory function focussed on
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rodent models and used indirect strategies (e.g. monoclonal antibodies to Tim-1) to determine its
function. These studies are somewhat limited, since the amount of anti-Tim-1 antibody
administered, the binding affinity of the antibody, and antibody binding site on Tim-1 could have
affected the interpretation of the findings (Meyers, Sabatos, et al., 2005; Sizing et al., 2007;
Waanders et al., 2010). For example, in the mouse model of OVA-induced lung inflammation,
administration of monoclonal antibody against the mucin domain of Tim-1 exacerbated immune
responses (Sizing et al., 2007). This was proposed to occur through the activation of T-cells to
produce Th2 cytokines, which drive eosinophil and mast cell activation, and trafficking into the
lung thereby amplifying the inflammation. On the other hand, administering Tim-1 antibodies
against the IgV domain blocked inflammation through inhibition of T-cells activation.
Additionally, Kim-1 was found to be expressed on natural killer T (NKT) cells, which allowed
NKT to bind to apoptotic cells triggering their activation, proliferation, and cytokine production
(H. S. Kim et al., 2010; Lee et al., 2010). This in turn led to exacerbated airway hyper-reactivity
in a mouse model of asthma. Surprisingly, despite expressing Kim-1, NKT cells have not been
reported to mediate phagocytosis of apoptotic cells. Nonetheless, these experiments did reinforce
the role of Tim-1 in asthma and airway hypersensitivity previously proposed by genetic studies
placing Tim-1 in the Tapr (asthma susceptibility) locus (McIntire et al., 2001).
In 2010, the first sets of genetically modified mice with either Tim-1 deficiency or Tim-1
transgene expression on either T or B cells were generated (S. H. Wong et al., 2010). The
findings in this paper were surprising, because very low levels of Tim-1 were found to be
expressed on activated T cells or Th2 cells, which was contradictory to what had been published
previously. The expression of Tim-1 on T-cells did not stimulate Th2 differentiation and
production of Th2 cytokines when activated. However, Tim-1 expression was seen on B-cells
following B-cell receptor stimulation, and this was shown to be dependent on phosphoinositide3-kinase and the nuclear factor-кB pathway (NF-кB). Interestingly, Tim-1 was found to be
expressed on germinal center B cells which was previously unknown at that time. These new
findings have brought the previous findings using monoclonal antibodies to study Tim-1 function
into question.
The discovery of Tim-1 expression on B-cells sparked interest in its possible role in Bcell biology. Administration of a low-affinity TIM-1-specific antibody promoted prolonged islet
survival in an allograft transplant model (Ding et al., 2011). Tim-1 is expressed by a majority of
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IL-10 producing regulatory B-cells. Given that: 1) Tim-1 is expressed on B regulatory cells (S.
H. Wong et al., 2010); 2) Tim-1 is a phosphatidylserine receptor for apoptotic cells (Ichimura et
al., 2008; Ichimura et al., 1998; Kobayashi et al., 2007); and 3) apoptotic cell-binding induces
generation of B regulatory cells, but not phagocytosis (Gray et al., 2007; Yeung et al., 2015), the
role of Tim-1 binding to apoptotic cells on B regulatory cells to mediate immune response has
been studied. The generation of mice lacking the mucin domain of Tim-1 (Tim-1Δmucin) provided
an in-depth understanding of the role of Tim-1 in immune tolerance. B regulatory cells
expressing Tim-1Δmucin were unable to bind apoptotic cells leading to a reduction in IL-10
production and accelerated allograft rejection (Yeung et al., 2015). In another study, these Tim1Δmucin mice developed autoimmune disease as characterized by the increase in T-cells, activation
of dendritic cells, elevation of serum Ig, and generation of autoantibodies such as those to
dsDNA (Xiao et al., 2012). These results suggest that the role of Tim-1 in mediating immune
responses is dependent on binding apoptotic cells. Recently, it was shown that defective (Tim1Δmucin) or mutant Tim-1 led to more inflammatory mediators with increased proinflammatory
cytokines, increased in Th1 and Th17 production, and reduced generation of regulatory T-cells
(FoxP3+) (Xiao et al., 2015). This caused an enhancement of the severity of experimental
autoimmune encephalomyelitis. Therefore, Tim-1 expression on B regulatory cells plays a
critical role in maintaining self-tolerance and inhibiting the development of autoimmune disease
(Nozaki et al., 2014; Sattler et al., 2014; Xiao et al., 2015; Xiao et al., 2012; Yeung et al., 2015).
The extracellular domain of TIM-1 characterizes it as a member of the immunoglobulin
superfamily, and was recently implicated in leukocyte adhesion and trafficking akin to SIGLECs
and C-type lectins (Angiari et al., 2014). Tim-1 expression on Th1 and Th17 cells enables them
to bind to endothelial P-selectin, increasing their recruitment into inflamed tissues. In addition,
Th1 and Th17 cells from the Tim-1-mucin domain mutant (Tim-1Δmucin), as well as the Ig-like
domain mutant of Tim-1, showed reduced ability to traffic into inflamed tissue of the skin and
central nervous systems in models of skin hypersensitivity and experimental autoimmune
encephalomyelitis, respectively.
In conclusion, Tim-1 plays complex and varied roles in mammals that are largely
dependent on which tissues it is expressed. The function of Tim-1 also depends on the
microenvironment in which Tim-1 is expressed, and whether this microenvironment contains any
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of its ligands, such as apoptotic cells. Moreover, Tim-1 seems to have a double-edged function in
immune cells, where it could mediate development of inflammatory responses or tolerance.
1.3.4.

Renal function of KIM-1
KIM-1 was first identified as a gene that is specifically upregulated following renal IRI

(Ichimura et al., 1998). Given its expression pattern on proximal TECs, it was proposed to have a
role in the restoration of the morphological integrity of renal tubules (Ichimura et al., 1998).
Almost 10 years after its identification in the kidney, several groups identified KIM-1 as a receptor
for the “eat me” signal, phosphatidylserine, which enables proximal tubular cells expressing KIM1 to recognize and engulf apoptotic cells (Ichimura et al., 2008; Kobayashi et al., 2007). Because
KIM-1 also binds to a variety of other ligands, including low-density lipoprotein,
phosphatidylethanolamine, and necrotic cell debris, KIM-1 is classified as a type B scavenger
receptor (Ichimura et al., 2008). Based on in vitro data, it was hypothesized that KIM-1 functions
to remove dead tubular cell debris, preventing them from obstructing the lumen and triggering
inflammation, which would impede tissue repair (Ichimura et al., 2012; Waanders et al., 2010).
A vastly different role for KIM-1 in promoting survival has been proposed by another
group: KIM-1 was shown to protect against cell death using an in vitro model of ischemic injury
via depletion of ATP and glucose (Balasubramanian et al., 2012). During ischemic stress, KIM-1
was shown to interact with and target the pro-apoptotic orphan nuclear receptor, NUR77, for
lysosomal degradation, thereby preventing apoptosis. Most importantly, silencing KIM-1 or
mutating the phosphatidylserine binding pocket of KIM-1 resulted in increased NUR77 abundance
and decreased renal cell survival following ischemic injury in vitro. While this study hinted at a
potential effective mechanism for KIM-1 in AKI, the in vivo relevance of this finding is uncertain.
Remarkably, transgenic overexpression of Kim-1 in kidney TECs in the absence of a
cellular injury stimulus had been shown to cause rapid kidney failure in mice by promoting
progressive renal fibrosis (Humphreys et al., 2013). These transgenic mice spontaneously
developed interstitial kidney inflammation with fibrosis, marked by tubular dedifferentiation,
microcytic tubular dilation and fibrosis. The chronic expression of Kim-1 on TECs was shown to
spontaneously increase the level of proinflammatory cytokines such as monocytes chemotactic
protein-1 (MCP-1), which was believed to have caused the abnormal leukocyte infiltration in the
absence of tissue injury. The development of kidney failure in these mice was associated with the
classic extrarenal manifestations that can be seen in patients with CKD, such as hypertension,
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anemia, and early death. The conflicting findings observed between the Tim-1Δmucin and the Kim1 transgenic overexpression mice suggest that both the level and context of renal KIM-1 expression
profoundly influences whether it has a protective or damaging effects.
Following renal insult and upregulation of KIM-1 (Ichimura et al., 1998), there is evidence
of low levels of immune cell infiltration into the kidney (Nozaki et al., 2012; Nozaki et al., 2011;
Rong et al., 2011). Most of these infiltrating immune cells are located in the outer medulla, tubular
wall and tubular basement membrane (Yang et al., 2015). Surprisingly, it was identified that KIM1 is a ligand for the leukocyte mono-immunoglobulin (Ig)-like receptor 5 (LMIR5) or CD300B,
which is expressed by myeloid cells (Yamanishi et al., 2010). LMIR5-TIM-1 interaction increased
the accumulation of LMIR5 expressing neutrophils in the renal interstitium of mice subjected to
renal IRI. This, in turn, led to the activation of LMIR5 expressing mast cells, which augmented
tissue damage following IRI (Yamanishi et al., 2010). Several groups have utilized inhibitory
monoclonal antibodies against Tim-1 to determine whether inhibiting Tim-1 would have an effect
on kidney injury (Nozaki et al., 2014; Nozaki et al., 2012; Nozaki et al., 2011). In a mouse model
of cisplatin-induced nephrotoxicity, inhibiting Tim-1 on T- cells resulted in less renal injury and
histological damage, reduced leukocyte infiltration, and lower levels of proinflammatory cytokines
(Nozaki et al., 2011). Similarly, in a model of induced crescentic glomerulonephritis or glomerular
injury, inhibition of Tim-1 resulted in reduced injury, leukocyte accumulation, and inflammatory
response mediated by Th1 and Th17 (Nozaki et al., 2012). These studies all suggest a role for
KIM-1 in the recruitment of inflammatory cells and propagation of further tissue damage, either
via Tim-1 expressed on immune or kidney epithelial cells.
Though the above studies provided much insight into the potential roles of KIM-1 in kidney
injury by using Tim-1Δmucin mice or antibodies blocking of KIM-1, none of them have directly
addressed whether KIM-1 expression plays a role in ischemic AKI in vivo. Given that these studies
have proposed opposing roles for KIM-1, it remains to be determined whether KIM-1 is protective
or harmful in AKI. In this thesis, we aim to determine the function of KIM-1 using Kim-1-deficient
mice (S. H. Wong et al., 2010).
1.3.5.

Renal KIM-1 signalling
Though much research has been done to help understand the physiological role of KIM-1

in the kidney, very little is known about its capacity to mediate intracellular signalling in TECs.
Understanding these pathways might be key for designing novel therapeutic targets needed to
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ameliorate acute kidney injury. As discussed above, the extracellular domains of KIM-1 have been
shown to bind to phosphatidylserine on apoptotic and necrotic cell debris (Ichimura et al., 2008),
nuclear receptor NUR77 (Balasubramanian et al., 2012), and leukocyte mono-immunoglobulin
(Ig)-like receptor 5 (LMIR5)/CD300b (Yamanishi et al., 2010) in TECs. However, none of these
studies uncovered KIM-1 intracellular signalling proteins that mediate the renal functions of KIM1. To uncover the signalling mechanism by which KIM-1 binds and engulfs apoptotic cells, we
immunoprecipitated KIM-1 from human embryonic kidney-293 (HEK-293) cells expressing HAtagged KIM-1 after stimulation with PS containing liposomes and performed mass spectrometry
to determine associated proteins. Using this method, we identified the alpha subunit of the
heterotrimeric G12 protein Gα12 (M. P. Strathmann et al., 1991), a novel KIM-1 interacting
protein. Independently, using a yeast two-hybrid system (in collaboration with Dr. Tony Zervos,
University of Central Florida) and a HeLa cell cDNA library, we identified another novel KIM-1
interacting protein, the dynein light chain protein Tctex-1 (Lader et al., 1989). Both of these
proteins are interesting candidates that we will briefly cover in the rest of the introductory chapter.
In Chapter 2 and 3, we will study the role of Gα12 in KIM-1 expressing cells in ischemic AKI and
the phagocytic process. In Chapter 4, we will study the role of Tctex-1 in KIM-1-expressing cells.

1.4. ALPHA SUBUNIT OF HETEROTRIMERIC G12 PROTEIN
1.4.1. Classification, structure and expression
Heterotrimeric guanine nucleotide-binding proteins (G proteins) are signal transducers that
link extracellular stimuli to intracellular effectors that mediate cellular responses to the stimulus
(Suzuki et al., 2009). Extracellular signals are typically received via members of the seventransmembrane domain receptors known as G protein-coupled receptors (GPCRs). Alternatively,
they can be associated with other receptors or modulators to mediate non-canonical functions. As
heterotrimers, these proteins consist of a guanine-nucleotide binding subunit Gα, and closely
associated β and γ subunits (usually referred to as Gβγ) (Neer, 1995). In the inactive state, a single
α subunit is bound to a GDP molecule in association with a Gβγ subunit (Figure 1.5). Upon ligand
binding to the associated GPCR or indirect activation of the G protein by other modulators, the
GDP molecule is exchanged for a GTP molecule on the α subunit. A family of proteins called
GTP-exchange factors or GEFs catalyzes this process. The GDP-GTP exchange causes a
conformation changes in the switch regions of the α subunit (Dhanasekaran et al., 1996; Fields et
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al., 1997), allowing it to dissociate from the Gβγ subunit. Both the GTP-bound α subunit and Gβγ
subunits are “free” to interact and activate various downstream effectors. Meanwhile, the activated
α subunit hydrolyzes the bound GTP to GDP via its intrinsic GTPase activity, which can be
accelerated by GTPase activating proteins (GAPs). Once Gα is in an inactive form (GDP-bound),
it dissociates from its effectors and reassociates with Gβγ subunits to start the cycle again.
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Figure 1.5. The G protein cycle.
A: In the inactive state, the G-protein coupled receptor (GPCR) is not associated with
ligand. The G protein α subunit is bound to GDP molecule and is associated with Gβγ
subunit close to the plasma membrane. B: Upon ligand binding to GPCR, GPCR
undergoes a conformational change that allows the exchange of GDP to GTP on the α
subunit. This change causes dissociation of the α subunit from the Gβγ subunit. Both the
GTP-bound α subunit and Gβγ subunit can then interact with and activate various
downstream effectors. Activation of the Gα subunit can also occur via a guanine
nucleotide exchange factor (GEF) mechanism, which is independent of the GPCR (noncanonical pathway). C: Once the ligand dissociates from the GPCR, the Gα subunit
hydrolyzes the bound GTP to GDP through its intrinsic GTPase activity, which is
accelerated by GTPase activating proteins (GAPs). When the Gα subunit becomes
inactive, it dissociates from its effectors and reassociates with the Gβγ subunit, ending the
activation of downstream effectors.
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In humans, there are at least 21 Gα subunits encoded by 16 genes, six Gβ subunits encoded
by five genes, and 12 Gγ subunits encoded by 18 genes (Downes et al., 1999; Oldham et al., 2008).
The heterotrimeric G proteins are divided into four subfamilies based on the amino acid sequence
similarity of the Gα subunits: Gαs, Gαi, Gαq and Gα12 (Simon et al., 1991; M. Strathmann et al.,
1989). The G12 class of G proteins consists of Gα12 and Gα13, which share about 67 % amino
acid sequence identity between them and less than 45 % identity with other α subunit groups
(Dhanasekaran et al., 1996; M. P. Strathmann et al., 1991; Vara Prasad et al., 1994). In 1991, the
G12 class of proteins became the last and the fourth class to be identified (M. P. Strathmann et al.,
1991). They both have an approximate molecular mass of 44 kDa and are insensitive to ADPribosylation by pertussis toxin. Both Gα12 and Gα13 are phosphorylated by protein kinase C,
which serves to block any interaction with the Gβγ subunit (Kozasa et al., 1996; Offermanns et
al., 1996; Suzuki et al., 2009). In contrast to other Gα subfamilies, both Gα12 and Gα13 are only
post-translationally modified by palmitoylation near their N-termini (Jones et al., 1998;
Ponimaskin et al., 2000; Veit et al., 1994). This modification is important for the association of
Gα13 with plasma membrane (Bhattacharyya et al., 2009) and for the localization of Gα12 to lipid
rafts (Waheed et al., 2002). The N-terminal regions of both Gα12 and Gα13 share only 16 % amino
acid identity (Dhanasekaran et al., 1996). This sequence difference is believed to determine their
relative subcellular localization. Gα12 is mostly localized to the plasma membrane (Waheed et al.,
2002), but contains a mitochondrial targeting sequence that allows it to be associated with
mitochondria under certain circumstances, where it is involved in mitochondrial motility and
membrane permeability (Andreeva et al., 2008). On the other hand, Gα13 is localized to the cytosol
and only translocate to the plasma membranes upon activation (Yamazaki et al., 2005). In addition
to being involved in localization, the N-terminal sequences have also been shown to determine
their selective coupling to various receptors (Yamaguchi et al., 2003). Although Gα12 and Gα13
interact with different effectors and receptors, they are both activated by thrombin and
lysophosphatidic acid via the protease-activated receptor and the lysophosphatidic acid receptors
(Aragay et al., 1995; Hains et al., 2006; Q. Wang et al., 2004). Both Gα12 and Gα13 have a
relatively slow rate of intrinsic nucleotide exchange and GTP hydrolysis, which suggests that they
partake in prolonged signalling (Dhanasekaran et al., 1996; Kozasa et al., 1995). Though both
proteins can activate common downstream signalling pathways (Kurose, 2003), significant
differences have been observed between Gα12 and Gα13 knockout mice. Transgenic mice that
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lack Gα13 are embryonically lethal due to their defect in angiogenesis, whereas mice deficient in
Gα12 develop normally (Gu et al., 2002; Offermanns, 2001; Offermanns et al., 1997). This
indicates that Gα12 and Gα13 regulate distinct signalling pathways and cannot completely
compensate for each other in a physiologically significant manner.
Gα12 is similar in structure to all other Gα subfamilies, as it has a GTPase and a helical
domain (Oldham et al., 2006). The GTPase domain is composed of six-stranded β-sheets
surrounded by five α-helices. The five α-helices contain three flexible loops, named Switch I, II
and III (Lambright et al., 1994; Lambright et al., 1996; Wall et al., 1995). These switch regions
undergo significant structural changes when in the GDP (Lambright et al., 1994; Mixon et al.,
1995) or non-hydrolyzable GTP (GTPγS) bound forms (Coleman et al., 1994; Noel et al., 1993).
The GTPase domain also contains sites for binding to the Gβγ dimer, GPCRs, and downstream
effector proteins (Lambright et al., 1996; Oldham et al., 2008; Sondek et al., 1996). On the other
hand, the helical domain, consisting of six α-helices, serves to increase the affinity of Gα for
guanine nucleotides (Remmers et al., 1999; Warner et al., 1998) and increases the GTP hydrolysis
activity of the protein (Markby et al., 1993). It also plays an important role in coupling specific G
proteins to specific effectors (W. Liu et al., 1998). Based on mutagenesis studies, both the amino
and carboxyl termini are structurally and functionally important components of the protein (Suzuki
et al., 2009; Yamaguchi et al., 2003).
The identification of the interaction between Ser/Thr protein phosphatase type 5 (PP5) and
both Gα12 and Gα13 was key to the development of a tool to study the biology of G12 proteins
(Yamaguchi et al., 2002; Yamaguchi et al., 2003). Specifically, Yamaguchi, et al. demonstrated
that the N-terminal regulatory tetratricopeptide repeat (TPR) within PP5 binds selectively to the
GTP-bound forms of Gα12 or Gα13. This feature of PP5 allowed the use of the TPR domain
conjugated to GST (GST-TPR) in the form of a GST pull-down assay to detect the level of active
Gα12 and Gα13 in vitro or ex-vivo as we have done in this thesis (Sabath et al., 2008; Yanamadala
et al., 2007). In addition, the constitutively active Gln (Q)→Leu (L) mutant of the α subunit for
G12 (QL Gα12), which is incapable of GTP hydrolysis, and the wild-type (WT) Gα12 have been
routinely used to test the sufficiency of Gα12 in driving various cellular processes (Vara Prasad et
al., 1994; K. Wong et al., 2006; Zhu et al., 2004).
Gα12 is ubiquitously expressed in all tissues, with lower levels of expression in the
intestine (M. P. Strathmann et al., 1991). This expression pattern is different from Gα13, as its
36

expression levels vary between different tissues. The eye, kidney, liver, lung and testis have
exhibited a higher levels of expression of Gα13 compared to other tissues.
1.4.2. Function
Gα12 interacts with many down-stream effectors that have overlapping functions (P. Kelly
et al., 2007) (summarized in Table 1.2). This allows Gα12 to be involved in a myriad of cellular
processes, such as cell growth, cellular transformation, cell polarity, cell migration, paracellular
permeability, apoptosis, and membrane localization of different proteins (Refer to Table 1.2 for
more information). We will be focusing on the function of Gα12 in the kidney for the purpose of
this thesis.
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Table 1. 3. Various proteins demonstrated to interact with Gα12 and the functional
outcome(s) of these interactions.
Proteins with an asterisk (*) have been shown to interact with both Gα12 and Gα13.
Abbreviation: PP-protein phosphatase, eNOS-endothelial nitric oxide synthase, RGSRegulator of G protein signalling, AKAP-A-kinase anchoring protein, ZO-Zonula
occludens, BTK-Bruton’s tyrosine kinase, Hsp- Heat shock protein, GAP-Guanine
activating protein, SNAP-Soluble NSF-associated protein, GEF-Guanine nucleotide
exchange factor.
Protein

Function

Reference

*Rho specific GEFs
(work as GAP for
Gα12)
LARG
PDZRhoGEF
P115RhoGEF
*Protein
Serine/Threonine
phosphatases 5 (PP5)
Protein phosphatase
2A (PP2A)
Zonula occludens 1
or 2 (ZO-1 or ZO-2)

Stimulate RhoA activation leading to
many down-stream protein activation
effects, such as, phosphorylation of
focal adhesion kinase, paxillin and
p130 Crk-associated substrate

(Tanabe et al.,
2004), (Fukuhara et
al., 2000), (Kuner
et al., 2002),
(Iguchi et al.,
2008), (Needham
et al., 1998)

Activates many different downstream
mediators leading to cell growth,
differentiation, and DNA damage
Activates apoptosis

(Yamaguchi et al.,
2002)

Disrupts tight junction to increase
paracellular permeability

(Meyer et al.,
2003; Meyer et al.,
2002)

*Cadherins

Promotes cell migration via release of
the transcription activator β-catenin

(Meigs et al., 2002;
Meigs et al., 2001)

p120-catenin

Regulates cadherin and β-catenin
interaction
Regulates localization of cadherins

(Noren et al., 2000)

Heat shock protein
90 (Hsp90)

Localizes Gα12 into lipid rafts

(Vaiskunaite et al.,
2001; Waheed et
al., 2002)

*Radixin

Serves as a cross-link between plasma
membrane proteins and the actin
cytoskeleton

(Gohla et al., 1999;
Vaiskunaite et al.,
2000)

Axin (RGS protein)

Mediates WNT signalling to control
cell growth and differentiation

(Stemmle et al.,
2006)

α-SNAP
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(Zhu et al., 2004)

(Andreeva et al.,
2005)

A-kinase anchoring
protein (AKAP) Lbc

Translocates Gα12 into plasma
membrane to activate RhoA

(Diviani et al.,
2001; Niu et al.,
2001)

Bruton’s tyrosine
kinase BTK

Mediates Rho activation by tyrosine
kinase activity (BTK)

(Jiang et al., 1998;
Suzuki et al.,
2003))

Ras specific GTPase
activating protein
(RasGAP1)
*Socius

Downregulates Ras signalling

(Jiang et al., 1998)

Associates with Rho-like Rand protein
to regulate stress-fiber disassembly

(Tateiwa et al.,
2005)

*Endothelial nitric
oxide synthase
(eNOS)
Polycystin-1

Regulates nitric oxide biosynthesis

(Andreeva et al.,
2006)

Regulates apoptosis and cystic cell
growth

(Xu et al., 2015;
Yu et al., 2010;
Yu et al., 2011;
Yuasa et al., 2004)
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Madin-Darby canine kidney (MDCK) cells engineered to allow the inducible expression
of wild type or the constitutively active Gα12 (QL Gα12) have been instrumental in helping
investigators understand the signalling processes downstream of Gα12 in kidneys (Meyer et al.,
2002). Using these cells, Denker and colleagues identified that the tight junction scaffolding
protein, zonula occludens 1 (ZO-1) is a downstream target of Gα12. Moreover, they demonstrated
that constitutively active Gα12 increases paracellular permeability in cells by disrupting the
localization of tight junction proteins (ZO-1, occluding and claudin-1) and adherens junction
proteins (E-cadherin and β-cateinin) (Meyer et al., 2003). Consequently, this leads to significant
reorganization of actin cytoskeletons, and loss of polarity with mislocalization of Na-K-ATPase
molecules. These Gα12-mediated changes were later shown to occur through the Gα12-dependent
activation of Src kinase, and subsequent Src-mediated phosphorylation of the tight junction
proteins and their disassembly from the epithelial barrier (Meyer et al., 2003; Sabath et al., 2006;
Sabath et al., 2008).
The involvement of Gα12 in tight junction dynamics is very important in renal
development and survival after injury (Denker et al., 2011). There are large differences in the
paracellular permeability across the nephron segments due to the diversity of claudin proteins
throughout the tubule. The proximal tubule has the lowest permeability, reflecting the importance
of preventing the filtrate from reentering the circulation via the intercellular spaces (Denker et al.,
2011; Gonzalez-Mariscal et al., 2000; Kiuchi-Saishin et al., 2002; Muto et al., 2010). In AKI,
ischemic and toxic insults lead to the disruption of tight junctions (Kwon et al., 1998; Meyer et
al., 2001; Tsukamoto et al., 1999). Once dysregulated by injury, the tight junctions must
reassemble to re-establish a functional tubule and to avert fibrosis (Denker et al., 2011; Yu et al.,
2008).
Interestingly, Gα12 directly interacts with polycystin-1, encoded by the PKD1 gene (Yu et
al., 2010; Yu et al., 2011; Yuasa et al., 2004), which is mutated in autosomal dominant polycystic
kidney disease. Silencing polycystin-1 (or mutating the PKD1 gene) causes the activation of Gα12
followed by ADAM-10 metalloproteinase maturation and activation to increase shedding of Ecadherin (Xu et al., 2015). This eventually causes the disruption of adherens junction proteins and
loss of polarity causing cystic growth of renal epithelial cells.
As discussed earlier, renal IRI results in TECs undergoing detachment and apoptosis.
Activation of Gα12 via thrombin or constitutively active Gα12 has been shown to stimulate
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apoptosis via its interaction with and activation of protein phosphatase 2A (PP2A) (Yanamadala
et al., 2007;Zhu et al., 2004). This leads to the activation of JNK (c-Jun N-terminal kinase),
followed by degradation of the anti-apoptotic protein Bcl-2, and finally to upregulation of IкBα,
which potently stimulates the apoptosis pathway. Additionally, Gα12 interaction with polycystin1 was found to modulate Gα12/JNK stimulated apoptosis in TECs (Yu et al., 2010; Yu et al., 2011;
Yuasa et al., 2004). The role played by activated Gα12 in triggering apoptosis suggests that Gα12
might be pathogenic under ischemic conditions. Indeed, the activation of Gα12 after IRI was
recently shown to exacerbate tissue damage and renal dysfunction (Yu et al., 2012). Denker and
colleagues elegantly showed that ROS generated during IRI is a potent activator of Gα12 and its
downstream effector, Src kinase (Yu et al., 2012). This study demonstrated that ROS-activated
Src subsequently phosphorylates ZO-1 and occludin, leading to disruption of tight junctions.
Accordingly, Gα12-deficient mice were protected from renal IRI, whereas mice with TECsspecific transgenic overexpression of constitutively active Gα12 (Gα12 QL) exhibited more severe
tissue damage and delayed recovery after IRI (Yu et al., 2012). Collectively these findings reflect
on the adverse effects of Gα12 activation on renal epithelial cells during ischmic AKI and naturally
led us to an interesting avenue of research to understand whether there is a link between KIM-1
and Gα12 signalling during AKI.
In this thesis, we will test if KIM-1 might be protective against renal IRI by inhibiting
Gα12 activation by ROS. We will also explore a novel role for Gα12 in the phagocytosis of
apoptotic cells by proximal TECs via KIM-1.

1.5. TCTEX-1
1.5.1. Structure and expression
Tctex-1, short for t complex-testis expressed-1, was identified in a cDNA screen looking
for candidate genes in the mouse t complex whose aberrant expression may be functionally related
to sterility and transmission ratio distortion (Lader et al., 1989). Later, it was defined as a
component of the light chain of the cytoplasmic dynein motor complex (Hirokawa, 1998;
Hirokawa et al., 1998; Lader et al., 1989; Vallee et al., 2004). Cytoplasmic dynein is a minus-end
directed motor complex on microtubules (Vallee et al., 2004). It is involved in the retrograde or
apical transport of the bound cargoes that take place during processes such as nuclear migration,
golgi and vesicular transport, and mitotic spindle orientation (Vale, 2003). Dynein is comprised of
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two heavy chains (~530 kDa), each with ATPase and motor activity (Mazumdar et al., 1996;
Vallee et al., 1990), two or three intermediate chains (~74 kDa), and a group of light intermediate
(57-61 kDa) and light chain proteins (~8-22 kDa) (S. J. King et al., 2002). Other light chain
proteins include LC8 and LC/roadblock. Human Tctex-1 and murine Tctex-1 share about 94 %
sequence identity (Roux et al., 1994; Watanabe et al., 1996). Typically, the cargo is carried by
dynein on the microtubules by association with another protein, dynactin (Vaughan et al., 1995).
Tctex-1 and LC8 are two of the three dynein light chain subunits that are tightly associated with
dynein intermediate chains to carry out the dynein function (Makokha et al., 2002; Nyarko et al.,
2004).
Based on the crystal structure, Tctex-1 exists in dimeric forms consisting of two α-helices
that are flanked by four β-strands of each monomer (Williams et al., 2005). One β strand crosses
between the monomer to form an intersubunit β sheet at the dimer interface. Tctex-1 exhibits a
tightly controlled dissociation-coupled unfolding mechanism, which indicates the absence of
stable monomer form of Tctex-1under normal circumstances (Talbott et al., 2006). At the dimer
interface, a water channel exists that contains a threonine residue at position 92 (Song et al., 2007).
The phosphorylation of Tctex-1 at Threonine-92 was shown to directly mask the binding site to
the dynein intermediate chain, which mediates the dissociation from dynein as a phosphorylated
dimer (Song et al., 2007). Additionally, another Tctex-1 phosphorylation site exists at Threonine94 (Thr-94), which can be phosphorylated by protein kinase C in vitro (Chuang et al., 2005). This
phosphorylation site allows for the dissociation from the dynein complex to mediate dyneinindependent functions. Another important site of phosphorylation is Serine-82 of Tctex-1, and
phosphorylation at this site has been shown to reduce its binding to dynein, but not its interaction
with specific targets (e.g. rhodopsin) (Yeh et al., 2006). The N-terminus of Tctex-1 consists of 813 amino acids and usually appears splayed away from the structure to mediate binding to
interacting partners (Williams et al., 2005). In addition, Tctex-1 contains four tyrosine residues
that could be post-translationally modified by phosphorylation; however, the role of
phosphorylation at these sites is still unknown (Campbell et al., 1998; Mok et al., 2001).
Tctex-1 has been shown to be differentially expressed in various tissues; the kidney, spleen
and testis have higher levels of Tctex-1 than brain as determined by Western blot (S. M. King et
al., 1996). Immunofluorescence staining of endogenous Tctex-1 suggests that it is localized to the
Golgi apparatus and along microtubules (Tai et al., 1998). This can be disrupted if the cells are
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treated with microtubule depolymerizating drugs (nocodazole) or a Golgi apparatus disruptor (e.g.
Brefeldin A).
1.5.2. Function and interacting partners
Tctex-1 has diverse dynein-dependent and -independent functions in cells (Hirokawa,
1998; Hirokawa et al., 1998; Lader et al., 1989) (Table 1.3). Through dynein-dependent functions,
Tctex-1 is associated with microtubules in order to mediate a range of intracellular motility events,
such as retrograde trafficking in neurons and receptor trafficking (Sachdev et al., 2007; Tai et al.,
1998). On the other hand, Tctex-1 also functions independently of dynein to regulate actin
cytoskeletal dynamics (Chuang et al., 2005). These studies found that phosphorylation of Tctex-1
at Threonine-94 or Serine-82 (Chuang et al., 2005; Machado et al., 2003; Song et al., 2007)
promoted its dissociation from the dynein light chain allowing it to bind to other non-dynein
proteins in order to mediate various effector functions (Chuang et al., 2005; Song et al., 2007).
Interstingly, the role of Tctex-1 in renal TECs or in the kidney has not been elucidated. Our studies
of the interaction of KIM-1 with Tctex-1 will be the first to implicate a role for it in the kidney.
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Table 1. 4. Tctex-1 interacting partners and the functional outcome of their
interactions.
Proteins with an asterisk (*) have been shown to mediate functions independently of
dynein. Abbreviation: Bone morphogenetic receptor type II (BMPR-II), Cluster of
differentiation 5 (CD5), Tropomyosin receptor kinase (Trk), Voltage-dependent anionselective channel 1 (VDAC1), Rho-specific exchange factor (GEF-H1), Lbc's first cousin
(Lfc)
Protein

Function

Reference

Dynein intermediate
chain

Mediates cargo binding and
trafficking

(Mok et al., 2001)

Fyn kinase

Involves in mitosis of lymphocytes

(Campbell et al.,
1998; Kai et al., 1997)

Doc2

Intracellular vesicle transports of
cathepsin D

(Nagano et al., 1998)

Small GTPase FIP-1

Involves in adenoviruse life cycle
and adenovirus mediated inhibition
of tumor necrosis factor alphainduced apoptosis

(Lukashok et al.,
2000)

Rhodopsin

Transports of rhodopsin containing
vesicles

(Tai et al., 1999; Tai
et al., 2001; Yeh et
al., 2006)

Bone morphogenetic
receptor type II
(BMPR-II)

Regulates vascular remodelling in
primary pulmonary hypertension

(Machado et al., 2003)

Parathyroid hormone
receptor

Regulates agonist induced receptor
internalization

(Sugai et al., 2003)

Polio virus receptor
(CD 155)

Retrograde axonal transport of
virus along neuronal cell body

(Mueller et al., 2002;
Ohka et al., 2004)

Cluster of
differentiation (CD 5 )

Regulates vesicles transport in T
and B cells

(Bauch et al., 1998)

Tropomyosin receptor
kinase (Trk) family,
also known as receptor
Tyrosine Kinase
Trk A, TrkB, TrkC

Regulates Trafficking of vesicles
containing nerve growth factor
(ligand for Trk) in neuron

(Yano et al., 2004;
Yano et al., 2000;
Yano et al., 2001)

Voltage-dependent
anion-selective channel
1 (VDAC1)

Involves in trafficking of the
VDAC1 into the membrane and
regulation of mitochondria
permeabilization

(Fang et al., 2011;
Schwarzer et al.,
2002)
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Tastin (Trophininbinding protein)

Regulates spindle assembly and
centrosome integrity during mitosis

(Nadano et al., 2002;
Yang et al., 2008)

*βγ subunit of G
protein

Regulates neurite outgrowth
Regulates RhoA and Rac1
mediated actin cytoskeletal changes

(Meiri et al., 2014;
Sachdev et al., 2007;
Takesono et al., 1999;
Yeh et al., 2013)

Rho-specific exchange
factor (GEF-H1)
(Human) or
Lbc's first cousin (Lfc)
(murine)

Regulates RhoA and Rac1 activity
Regulates actin and microtubule
assembly
Involves in mitotic spindle
assembly

(Conde et al., 2010;
Meiri et al., 2009;
Meiri et al., 2012)
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Earlier studies regarding Tctex-1 revealed that its interaction with Rhodopsin, a GPCR, is
necessary for vesicular transport of rhodopsin from the Golgi apparatus to the apical cell-surface
(Tai et al., 1999; Tai et al., 2001). This Tctex-1-dependent transport mechanism was found to
require the dynein intermediate chain. Phosphorylation of Tctex-1 at Serine-82 causes a reduced
affinity for dynein, but not to rhodopsin (Yeh et al., 2006). This suggested that Tctex-1 is
modulated by phosphorylation to control cargo release once it delivers it to the apical membrane.
This could be the case for KIM-1, where Tctex-1 could be involved in trafficking between the
cell surface and the lysosome or endoplasmic reticulum via clathrin-coated vesicles.
Tctex-1 also plays an important role in actin and microtubule dynamics. This was first
evident in embryonic hippocampal neurons development, where Tctex-1 mediated Rac1
activation through dynein independent function (Chuang et al., 2005; Sachdev et al., 2007).
More recently, Tctex-1 was shown to be a negative regulator of the Rho GEF; Lfc (in mice) or
GEF-H1 (in humans) (Meiri et al., 2009). Tctex-1 interacts with Lfc and this inhibits cortical
neurogenesis and induces disruption of proper mitotic spindle orientation (Conde et al., 2010;
Gauthier-Fisher et al., 2009). Lfc and GEF-H1 are Rho-specific guanine nucleotide exchange
factors (Rho GEF), which interact with microtubules, and their overexpression promotes stress
fiber formation through RhoA activation (Birukova et al., 2006; Krendel et al., 2002; Ren et al.,
1998). Tctex-1 binding to Lfc or GEF-H1 represses their nucleotide exchange activity indirectly
through sequestering of Lfc or GEF-H1 to microtubules (Meiri et al., 2012). In addition, the
phosphorylation of Lfc or GEF-H1 at Serine-885 by protein kinase A is an important step
required to create a high affinity 14-3-3 binding site that inhibits their exchange activity (Meiri et
al., 2009). Once Lfc or GEF-H1 are activated, they are released from microtubules to activate
and modulate actin structures. Hence, Lfc or GEF-H1 mediates cross-talk between actin and
microtubules (Krendel et al., 2002).
Interestingly, Tctex-1 has been identified as an activator of G protein signalling 2
(AGS2), a G protein coupled receptor-independent activator of the heterotrimeric G proteins in
yeast (Takesono et al., 1999). Tctex-1 activates this G protein by binding to the Gβγ subunit
independently of dynein (Sachdev et al., 2007; Takesono et al., 1999). This binding seems to
free the α subunit of the G protein to mediate other down-stream effects, such as neurite
outgrowth in primary hippocampal neurons (Sachdev et al., 2007). Recently, Tctex-1 was
specifically implicated in Gα12 signalling by the Rottapel group in Toronto (Meiri et al., 2014).
46

They elegantly showed that activation of the GPCR for Gα12 allows the interaction between
PP2A and GEF-H1. This interaction leads to dephosphorylation of GEF-H1 on Serine-885 which
triggers the release of GEF-H1 from the inhibitory dynein complex. Subsequently, released GEFH1 becomes free to bind to the Gα12, leading to the disassembly of the heterotrimeric complex.
Meanwhile, the Gβγ subunit binds to Tctex-1, disrupting the anchoring function of Tctex-1 that
sequesters GEF-H1 to microtubules. Ultimately, this leads to the activation of RhoA and stress
fiber formation, which is a hallmark of Gα12 agonists and GEF-H1 activation (Figure 1.6). This
interesting interplay between Gα12 and Tctex-1 may have implications for our work linking
KIM-1 to both Gα12 and Tctex-1 during phagocytosis of apoptotic cells, wherein both actin and
microtubules are suggested to be important. In professional phagocytes, both actin and
microtubules are continuously remodelled during phagocytosis. During engulfment, localized
actin polymerization occurs underneath the cell corpse to help in forming the phagocytic cup and
in the extension of pseudopods, all of which require activation of Rho family of GTPases, RhoA,
Rac and Cdc42 (Castellano et al., 2001; Hochreiter-Hufford et al., 2013). Microtubules are also
involved in the initial process of engulfment since microtubules disruption reduces pseudopods
dynamic (Rosania et al., 1996). Following particle uptake, disassembly of actin filament is more
pronounced with increasing microtubule networks surrounding the engulfed particle (Castellano
et al., 2001; Harrison et al., 2002). This allows for the maturation of the phagosome where
microtubules function as tracks for delivery of the engulfed target to the degradation machinery.
In KIM-1 mediated uptake of apoptotic cells, the exact dynamics of actin and microtubules is not
known. We aim throughout this thesis to understand the link between KIM-1, its interacting
partners and the actin/microtubules cytoskeleton.
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Figure 1.6. Regulation of actin cytoskeleton dynamics by Gα12 or Tctex-1 via Rho
GEF (GEF-H1).
A: In the absence of GPCR stimulation, Tctex-1 is bound to microtubules via the dynein
intermediate chain (DIC). Lfc or GEF-H1 is phosphorylated at Serine-885 by protein
kinase. This creates an inhibitory site (dark blue) which allows for Lfc or GEF-H1 to be
tethered to microtubules via Tctex-1. Under these conditions, heterotrimeric G12 protein
is intact. As such, the α-subunit is in an inactive form (GDP-bound) and the βγ subunit is
at the membrane. B: Upon GPCR stimulation (e.g. Thrombin), PP2A (not shown)
interacts with Lfc or GEF-H1 and this triggers its dephosphorylation and release from the
Tctex-1-dynein complex. LFc or GEF-H1 then binds to active Gα12, which was activated
as a response to ligand dependent activation of the GPCR. Binding of Lfc or GEF-H1 to
Gα12 allows the activation of the down-stream effector, RhoA. On the other hand, the
released βγ subunit binds to Tctex-1 to stabilize it and prevent it from rebinding to Lfc or
GEF-H1.
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1.6. PURPOSE, HYPOTHESIS AND SPECIFIC AIMS
Over the past few years, several research groups have independently provided evidence
suggesting that KIM-1 is sufficient to mediate the phagocytic clearance of apoptotic cells and
necrotic debris (Ichimura et al., 2008; Kobayashi et al., 2007). Until now, in vivo evidence for a
functional role for KIM-1 in AKI has been lacking. Moreover, there has been limited information
regarding whether KIM-1 mediates intracellular signalling in TECs during AKI.
Our hypothesis is that KIM-1 upregulation on TECs protects mice from ischemic AKI and
mediates phagocytic signalling via downstream interaction with Gα12 and Tctex-1. The purpose
of the work described in this thesis is to understand the physiological role of KIM-1 during
ischemic acute kidney injury and uncover the potential signalling mechanisms involved. In
addition, we aim to understand mechanistically how KIM-1 carries out its phagocytic function.
During this study, we have identified two novel KIM-1 interacting proteins, Gα12 and Tctex-1.
The identification of these KIM-1 targets allowed us to focus on three main aims:
1. Role of KIM-1 and Gα12 in renal ischemia-reperfusion injury
2. Role of KIM-1 and Gα12 in KIM-1-mediated phagocytosis
3. Role of KIM-1 and Tctex-1 in KIM-1-mediated phagocytosis
The data presented in Chapters 2, 3 and 4 of this thesis will summarize our research designed to
address these aims.
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2.1. SUMMARY
Ischemic acute kidney injury (AKI) is a serious untreatable condition. Activation of the Gprotein alpha-12 (Gα12) subunit by reactive oxygen species (ROS) is a major cause of tissue
damage during renal ischemia-reperfusion injury. Kidney Injury Molecule-1 (KIM-1) is a
transmembrane glycoprotein that is highly upregulated during AKI, but the physiologic
significance of this is unclear. In this chapter, we show for the first time that KIM-1 inhibits Gα12
activation, and protects mice against renal ischemia-reperfusion injury. We reveal that KIM-1
physically interacts with and inhibits cellular Gα12 activation following inflammatory stimuli
including ROS, by blocking GTP binding to Gα12. Compared to wild type (Kim-1+/+) mice, Kim1 knockout (Kim-1-/-) mice exhibited greater Gα12 and downstream Src activation, both in primary
tubular epithelial cells after in vitro stimulation with H2O2, and in whole kidneys after unilateral
renal artery clamping. Finally, we show that Kim-1-deficient mice had more severe kidney
dysfunction and tissue damage after bilateral renal artery clamping, compared to wild type mice.
Our results suggest that KIM-1 functions as part of an endogenous protective mechanism against
renal ischemia-reperfusion injury through inhibition of Gα12.

2.2. INTRODUCTION
Acute kidney injury (AKI) is a serious medical condition that most often results from
ischemia-reperfusion injury (IRI) and for which there is no effective treatment (Bonventre et al.,
2011; Chertow et al., 2005). Kidney injury molecule-1 (KIM-1) is a cell-surface glycoprotein
receptor (Freeman et al., 2010) that is specifically upregulated on the apical surface of proximal
tubular epithelial cells (TECs) following AKI (Ichimura et al., 1998). It is a highly sensitive and
specific biomarker of tubular injury that is virtually absent in healthy kidneys (Vaidya et al., 2010).
Both mouse and human KIM-1 [also known as T cell immunoglobulin, mucin domain-1 protein
(TIM-1), and hepatitis A virus cellular receptor-1 (HAVCR-1)] are small type I transmembrane
glycoproteins that belong to the TIM gene family (Freeman et al., 2010). Structurally, KIM-1 is
made up of an IgV-like domain, a mucin domain, a transmembrane domain, and an intracellular
domain that has been implicated in T cell signaling (de Souza et al., 2005; Z. Zhang et al., 2007).
The pathophysiologic role of KIM-1 signaling in AKI remains unknown.
Here we reveal a novel interaction between KIM-1 and Gα12. Gα12 is a ubiquitously
expressed G protein belonging to the G12 family of G proteins that has pleiotropic effects on cells
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including inducing proliferation, focal adhesion assembly, cytoskeletal reorganization, apoptosis
and disruption of tight junctions (Dhanasekaran et al., 1996). Recently, Yu et al., (Yu et al., 2012)
demonstrated that activated Gα12 is a pivotal mediator of TEC injury caused by ischemiareperfusion. ROS generated during ischemia-reperfusion stimulates Gα12 to activate Srcdependent injury pathways. Specifically, Gα12-deficient mice were protected from renal IRI,
whereas mice with TEC-specific transgenic overexpression of constitutively active Gα12 (Gα12
QL) exhibited worse tissue damage and delayed recovery after IRI (Yu et al., 2012). Given the
relevance of KIM-1 and Gα12 in AKI, we investigated the biological relationship between these
proteins using in vitro and in vivo models of ischemic AKI.

2.3. EXPERIMENTAL PROCEDURES
2.3.1. Animal preparation and induction of ischemia-reperfusion injury
All mouse experiments were performed according to the animal experimental guidelines
issued by the Animal Care and Use Committee at Western University (refer to the Appendix for
approval certificate). C57BL/6 wild type (Kim-1+/+) mice were obtained from the Charles Rivers
Laboratory. Kim-1 knock out (Kim-1-/-) mice were generously provided to us by Dr. Andrew N.
J. McKenzie (MRC laboratory of Molecular biology, Cambridge, UK). The Kim-1-/- mice were
backcrossed over generations to the C57BL/6 strain and homozygous knockout mice (Kim-1-/-)
were obtained by inter-breeding the heterozygotes (Kim-1+/-). Genomic DNA was isolated from
mice tail digests and genotypes were determined by PCR using primers ASEQ965 5’ATATCTCAGGAA TGGGATTG TGAC-3’ and ASEQ966 5’-CTACTGTATTT
AACTGATTTGAAG-3’. 6-9 week-old male Kim-1+/+ or Kim-1-/- mice weighing 20-25 grams
were subjected to unilateral or bilateral renal pedicle ligation for 25-35 minutes (as indicated) at
32 °C, as described previously (Z. X. Zhang et al., 2010). To assess Gα12 activity in the
ischemic and contralateral kidneys, following reperfusion, the kidneys were removed after being
flushed with cold PBS. Sham controls were treated with the same operative procedure as in the
injury group, but kidneys were not clamped.
2.3.2. Renal function and histology
Serum creatinine was detected by a Jaffe reaction method with an automated CX5 clinic
analyzer (Beckman, Pasadena, CA). Kidney sections (5–6 microns) from animals at 24 and 48
hours (h) after reperfusion or sham surgery were stained with Periodic acid–Schiff (PAS) by a
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trained pathologist-blinded to sample type (Dr. Aaron Haig) and the degree of tubular injury was
graded by light microscopy by a single pathologist blinded to mouse strain using a
semiquantitative score, that examined proximal tubule dilation, brush-border damage,
proteinaceous casts, interstitial widening, and necrosis (0: none, 1: <10 %, 2: 11~25 %; 3: 26-45
%; 4: 46-75 %; 5: >75 %) as described previously (Bakker et al., 2014).
2.3.3. Mass spectrometry
KIM-1 immune complexes were derived from human embryonic kidney-293 (HEK-293)
cells stably overexpressing HA-tagged KIM-1 (Z. Zhang et al., 2007) or vector alone (Otsuka et
al., 2005). Plasmid expressing KIM-1-HA was a kind gift from Prof. Joseph Bonventre (Brigham
and Women's Hospital, Harvard Institutes of Medicine, Boston, MA) and it was generated in a
similar manner as described in Zhang, et al (Z. Zhang et al., 2007). Briefly, the full-length human
KIM-1 with an N-terminal hemagglutinin (HA) tag was generated by PCR using phKIM1.2 as
template and then sub-cloned into the EcoRV site of eukaryotic expression vector pcDNA3
(Invitrogen, Carlsbad, CA). Upon transfection of KIM-1-HA, protein and surface expression was
comparable to endogenous KIM-1 expressed in human renal adenocarcinoma cells (769P) (Figure
2.1A, B). Immunoprecipitation was done with anti-HA antibody (Santa Cruz Biotechnology, Santa
Cruz, CA). SDS-PAGE was used to identify unique bands that co-immunoprecipitated with KIM1 and a target protein band of approximately 38 kDa was excised and subjected to in-gel tryptic
digestion followed by mass spectrometry (MALDI TOF MS) and analyzed by the Taplin mass
spectrometry facility (Harvard Medical School, Cambridge, MA).
2.3.4. Cell lines and culture
Human embryonic kidney-293 (HEK-293) cells stably expressing control vector or human
KIM-1 were cultured at 37 °C in 5 % (vol/vol) CO2 and maintained in DMEM (Invitrogen,
Carlsbad, CA) containing 5 % (vol/vol) fetal bovine serum (FBS) and 800 μg/mL Geneticin
(G418) Sulfate (Santa Cruz Biotechnology, Santa Cruz, CA). Expression of KIM-1 was confirmed
by Western blotting. HEK-293 cells were transfected with truncated version of KIM-1 containing
its cytosolic domain fused to transmembrane domain using Lipofectamine 2000® (Invitrogen,
Carlsbad, CA). Briefly, this plasmid was generated by PCR using the Not1 restriction sites of the
human KIM-1 plasmid (Z. Zhang et al., 2007). The resulting construct containing the
transmembrane and cytosolic domain of KIM-1 was sub-cloned into pFLAG-CMV™-3 (SigmaAldrich, St. Louis, MO, USA). The expression of the construct was confirmed using Western
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blotting (Figure 2.1C). Kidneys isolated from 3-4 week old C57BL/6 Kim-1+/+ or Kim-1-/- mice
were cultured to select for proximal tubular epithelial cells (TECs) as described previously (Sharpe
et al., 2012). Briefly, kidneys were homogenized and the cells isolated were cultured for the first
6 days in serum free DMEM/F-12 mixed media (1:1) (Invitrogen, Carlsbad, CA) supplemented
with 5 % insulin-transferrin-selenium solution, 5 % penicillin-streptomycin solution (Invitrogen,
Carlsbad, CA), 0.5 µg/ml of mouse epidermal growth factor (EGF) (Peprotech, Rocky Hill, NJ),
50 ng/ml hydrocortisone (Invitrogen, Carlsbad, CA). After 6 days, cells were cultured with the
same media mixture supplemented with 5 % FBS as described earlier.

81

Figure 2.1. Protein expression of KIM-1-HA and KIM-1 with truncated KIM-1 containing
its transmembrane and cytosolic domains in HEK-293 cells
A: Human embryonic kidney-293 (HEK-293) cells were transfected with either control vector
(pcDNA3) or HA tagged KIM-1-expressing vector (KIM-1-HA). Cell lysates were compared to
the endogenous level of KIM-1-expression in human renal adenocarcinoma cell line (769P) by
Western blotting using antibodies against full length KIM-1 (extracellular domain), and actin. B:
Surface staining for KIM-1 in HEK-293 cells expressing pcDNA3 or KIM-1-HA as determined
by flow cytometry. C: HEK-293 cells were transfected with either full-length KIM-1 or truncated
flag-tagged KIM-1 construct containing only the transmembrane (TM) and the cytosolic domain
of KIM-1. Lysates from these cells were run on Western blot and probed for full-length KIM-1
(antibody against extracellular domain of KIM-1), the cytosolic domain of KIM-1 (antibody
against cytosolic domain of KIM-1), and actin. Lysate from human renal adenocarcinoma cells
(769P) was used as a positive control. Data represent three independent experiments.
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2.3.5. Western blot
Confluent monolayers of cell lines (HEK-293 or TECs) or kidney cortices were homogenized and
lysed in ice cold lysis buffer and were centrifuged at 15,000 g for 10 minutes. The supernatant was
collected for Western blot analysis. Protein concentrations were determined using the Pierce BCA
Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL), and 50 µg of protein was used as input
for the experiment. 1000 µg of protein was used for immunoprecipitation or GST-TPR pull-down
experiments. Input and immunopreciptated samples were electrophoresed on Mini-PROTEAN
TGX gels 4-20 % (Bio-Rad Laboratories, Hercules, CA) and transferred to a polyvinylidene
difluoride membrane (Millipore, Billerica, MA). Membranes were blocked with blocking buffer
(Tris-buffered saline, 0.1 % Tween-20, and either 5 % nonfat dried milk (Bioshop, Burligton, ON)
or 5 % bovine serum albumin solution (Sigma Aldrich, St. Louis, MO) for 30 minutes and were
then incubated overnight at 4 °C with one of the following primary antibodies: cytosolic domain
of human KIM-1 (PA 4145, Custom antibody, Thermo Fisher Scientific, Rockford, IL) (Ichimura
et al., 1998), extracellular domain of human KIM-1 (Dr. Bonventre, Harvard medical School,
Cambridge, MA)(Bailly et al., 2002), extracellular domain of mouse Kim-1 (AF1817, R&D
systems, Minneapolis, MN), Gα12 (S-20)/actin (I-19)/GAPDH (V-18) or c-Src (N-16) (Santa Cruz
Biotechnology, Santa Cruz, CA), and active Src (pY419-Src) antibody (44-660G, Invitrogen,
Carlsbad, CA). Membranes were washed and incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody (dilution 1:30000, Jackson ImmunoResearch
Laboratories, West Grove, PA) for 1 hour at room temperature in blocking buffer. Proteins were
visualized using SuperSignal West Femto chemiluminescent substrate (Thermo Fisher Scientific,
Rockford, IL). The resulting protein bands were scanned using a Brother scanner (Brother
Electronics, Dollard-des-Ormeaux, QC) and the integrated density of each protein band was
determined using ImageJ Software. Each densitometric graph represents at least three independent
experimental results. To normalize for protein loading, the integrated density of each band was
divided by the integrated density of the actin band in the same lane from the same membrane (Kerr
et al., 1972).
2.3.6. Immunoprecipitation and GST-Gα12 pull-down assay
For immunopreciptation (IP), cells were lysed with ice-cold lysis buffer (25 mM Hepes
(Sigma Aldrich, St. Louis, MO), 150 mM NaCl, 15 mM MgCl2, 1 % Triton X-100, and Miniprotease inhibitors tablet (Roche Diagnostic, Basel, Switzerland)) (Meyer et al., 2003). Following
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protein quantification, immunoprecipitation of 1000 µg of each lysate was done using antibodies
against Gα12, the cytosolic domain of KIM-1 (Z. Zhang et al., 2007), or rabbit IgG control (sc2027, Santa Cruz Biotechnology, Santa Cruz, CA) and protein-A/G Sepharose beads (Santa Cruz
Biotechnology). Lysates (representing 5 % of total lysate) and immunoprecipitation samples were
analyzed by SDS-PAGE and Western blot as described above. For GST-Gα12 pull-downs, KIM1-HA was in vitro translated and S35-labelled in rabbit reticulocytes lysates as described previously
(Zhu et al., 2004). Protein lysates were incubated with 1 gram of GST-Gα12 or GST alone and
eluted after 3 hours incubation. Samples were analyzed by SDS-PAGE and autoradiography
(Biomax; Denville Scientific, Metuchen, NJ).
2.3.7. Gα12 activation assay (GST-TPR pull down)
A construct of GST-fused to the tetratricopeptide repeat (TPR) domain of Ser/Thr protein
phosphatase type 5 (PP5) was kindly provided by Dr. N Dhanasekaran (Temple University, USA)
(Zhu et al., 2004). GST-TPR was purified from Escherichia coli and conjugated to glutathioneagarose beads (Thermo Fisher Scientific, Rockford, IL) as described (Yamaguchi et al., 2002).
GST-TPR conjugated beads were freshly made for each experiment. Kidney homogenates
following ischemia-reperfusion injury or sham surgery, as well as unstimulated cells or cells
stimulated with 5 mM H2O2 (Bio Basic, Amherst, NY) or 2 U/ml alpha-thrombin (Enzyme
Research Laboratories, South Bend, IN) were lysed with ice-cold lysis buffer (50 mM Hepes pH
7.5) (Sigma Aldrich, St. Louis, MO), 1 mM EDTA, 3 mM DTT, 2 mM MgSO4, 1 %
Polyoxyethylene (10) lauryl ether (C12E10), and mini-protease inhibitor tablet (Roche Diagnostic,
Basel, Switzerland) (Yu et al., 2012). Supernatants containing 1 mg of the protein were incubated
with GST-TPR coupled glutathione-agarose beads at 4 °C for 5 hours (Zhu et al., 2004). Where
indicated, cell lysates were loaded with 1 µM non-hydrolyzable GTP analog (GTPγS)
(Cytoskeleton, Denver, CO) following protein quantification and incubated for 15 minutes at room
temperature prior to adding GST-TPR coupled glutathione-agarose beads. Samples were
centrifuged at 5000g for 5 minutes and washed with 1x PBS twice before eluting the bound active
Gα12. Both 50 µg of protein (input) and pull-down samples were analyzed by SDS-PAGE and
Western blotting by probing for Gα12 to represent total (input) and active Gα12 (pull-down) in
these samples.
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2.3.8. Immunofluorescence and confocal microscopy
HEK-293 cells were cultured at subconfluent density on poly-DL-lysine hydrobromide
(Sigma Aldrich, St. Louis, MO) coated glass cover slips. Cells were transfected with GFP-tagged
Gα12 construct (Andreeva et al., 2008) using Lipofectamine 2000® (Invitrogen, Carlsbad, CA).
Cells were fixed with 4 % paraformaldehyde (Sigma Aldrich, St. Louis, MO) and stained for
surface KIM-1 using antibody against extracellular domain of KIM-1 overnight at 4 °C. The slides
were washed and incubated with Alexa555 conjugated secondary antibody (Molecular probes,
Invitrogen, Carlsbad, CA). Coverslips were mounted using Shandon-Mount® (Thermo Fisher
Scientific, Rockford, IL) permanent mounting medium. Mice kidneys following ischemiareperfusion injury or sham surgery were extracted and quartered. The sections were fixed in 4 %
paraformaldehyde overnight for subsequent paraffin embedding. Kidney cortex sections (10 µm)
were sliced at 50-μm intervals using a Leica RM2125 microtome (Leica Microsystems, Buffalo
Grove, IL) and were mounted on glass slides. Sections were blocked with 5 % horse serum
(Invitrogen, Carlsbad, CA) and hybridized overnight at 4 °C with antibodies specific for either the
extracellular domain of mouse Kim-1 (SAB3500252, dilution 1:50, Sigma Aldrich, St. Louis,
MO), or Gα12 (S-20, dilution 1:50, Santa Cruz Biotechnology, Santa Cruz, CA). Sections were
then washed and incubated with the appropriate fluorophore-conjugated secondary antibodies
(dilution 1:100; Invitrogen, Carlsbad, CA). Cover slips were applied to all the sections with
Shandon-Mount® permanent mounting medium before imaging. Samples were viewed with
FLUOVIEW X83I confocal microscopy (Olympus, Tokyo, Japan). Data were acquired and
analyzed using FLUOVIEW FV10 ASW 4.0 viewer and ImageJ software (National Institutes of
Health, Bethesda, MD) was used to determine Pearson’s coefficient for colocalization of KIM-1
and Gα12. Quantification of colocalization was determined for 5 random fields per sample and
was done in 4 independent experiments.
2.3.9. Statistical analysis
Statistical analysis was done using Graph Pad Prism (Graph Pad Software Inc., La Jolla, CA).
Mean or median differences between knockout and wild type mice were compared using unpaired
t-tests or Mann-Whitney-U tests as appropriate; proportions were compared using Chi-squared
tests, and 95 % confidence intervals were calculated using the method of Wilson (Wilson, 1942).
P-values of < 0.05 were considered significant. Error bars represent the standard error of the mean
unless otherwise indicated.
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2.4. RESULTS
2.4.1. KIM-1 interacts with Gα12
To identify putative signalling proteins downstream of KIM-1, we performed massspectrometric analysis on KIM-1 (anti-HA) immunoprecipitates from HEK-293 cells stably
overexpressing KIM-1 fused to a c-terminal HA tag (Z. Zhang et al., 2007) or vector alone as
described in the methods. Of the several target proteins identified at 40 kDa (Table 2.1), we
focused on Gα12 because of its previously described roles in the biology of TECs and AKI (Yu et
al., 2012; Yanamadala et al., 2007).
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Table 2.1. Potential KIM-1 interacting proteins as determined by mass spectrometry.

Interacting proteins

Accession

Peptide sequence identified

number
Homo sapiens guanine nucleotide-binding

Q03113

ILLLGAGESGK

P05089

TGLLSGLDIMEVNPSLGK

Q01105

VEVTEFEDIK

P09972

GVVPLAGTDGETTTQGLDGLSER

Homo sapiens ig kappa chain c region

P01834

TVAAPSVFIFPPSDEQLK

Homo sapiens nucleophosmin numatrin

P06748

FINYVK, GPSSVEDIK,

protein, alpha-12 subunit (g alpha 12)
Homo sapiens arginase 1 (liver-type
arginase)
Homo sapiens set protein (phosphatase 2a
inhibitor i2pp2a) template activating factor
i (taf-i)
Homo sapiens fructose-bisphosphate
aldolase c

VDNDENEHQLSRLR,
MSVQPTVSLGGFEITPPVVLR
Homo sapiens phosphoserine

Q9y617

FGVIFAGAQK

P51991

SSGSPYGGGYGSGGGSGGYGSR

aminotransferase
Homo sapiens heterogeneous nuclear
ribonucleoprotein a3
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To confirm the mass-spectrometry results, we performed pull-down experiments using
S35methionine-labelled KIM-1 from reticulocyte lysates with glutathione S-transferase (GST)
fused to Gα12 to determine if Gα12 can interact directly with KIM-1 (Zhu et al., 2004). We found
that KIM-1 with a c-terminal HA tag was bound to GST-Gα12, but not unconjugated GST (Figure
2.2A). Co-immunoprecipitation of Gα12 and KIM-1 using both anti-KIM-1 and anti-Gα12, but
not the control antibody confirmed this interaction (Figure 2.2B). The cytosolic domain of KIM-1
was sufficient to mediate binding to Gα12, as demonstrated by co-immunoprecipitation of Gα12
with a truncated version of KIM-1 containing its cytosolic domain fused to its transmembrane
domain and an extracellular flag tag (Figure 2.2C) (Z. Zhang et al., 2007). To determine if
activated Gα12 can also interact with KIM-1, we treated KIM-1 expressing HEK-293 cell lysates
with non-hydrolyzable GTP (GTPγS) prior to performing co-immunoprecipitation (Ohga et al.,
1989); GTPγS treatment of Gα12 did not alter the interaction with KIM-1 (Figure 2.2D). To
visualize the interaction of Gα12 with KIM-1, HEK-293 cells were co-transfected with KIM-1 and
GFP-Gα12 and co-localization of both proteins was assessed by confocal microscopy. A
significant proportion of KIM-1 was associated with Gα12 in cells expressing both proteins, as
indicated by Pearson’s coefficient (0.409 ± 0.098, n=7) (Figure 2.2E). In addition, we found colocalization of both murine Kim-1 and Gα12 in kidney tissue sections isolated from C57BL/6 wild
type (Kim-1+/+) mice that were subjected to renal ischemia-reperfusion injury (IRI) (bilateral renal
pedicle clamping for 30 minutes followed by 24 hours of reperfusion) in order to cause Kim-1
upregulation (Figure 2.2F). Taken together, the above data suggest that KIM-1 interacts
constitutively with Gα12 via its cytosolic domain, independent of Gα12 activation.
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Figure 2.2. KIM-1 interacts with Gα12.
A: Autoradiogram of pull-downs with purified GST-Gα12 or GST of in vitro translated S35methionine-labelled HA-tagged-KIM-1. B: Immunopreciptation (IP) of KIM-1 and Gα12 from
lysates of HEK-293 cells stably expressing human KIM-1 using anti-Gα12, anti-KIM-1 (against
the cytosolic domain), or rabbit IgG control antibodies. C: Lysates of HEK-293 cells expressing
a truncated KIM-1 protein comprised of only the transmembrane and cytosolic domains were
subjected to IP with the indicated antibodies. D: Lysates of HEK-293 cells stably expressing
KIM-1 were pretreated with non-hydrolysable GTP (GTPγS) to activate Gα12 and then
subjected to IP. The input lane represents 5 % of the lysate. Both lysates and IP samples were
analyzed by SDS-PAGE and Western blotting for KIM-1 (using an antibody against the
extracellular domain), Gα12, and actin. Results represent three independent experiments. E: Colocalization of both KIM-1 and Gα12 proteins in HEK-293 cells co-transfected with KIM-1 and
GFP-tagged Gα12 constructs. KIM-1 was detected using an antibody against its extracellular
domain (600x, bar represents 20 μm). F: Kidney cortex cross-section from wild type (Kim-1+/+)
mice that were immunofluorescently stained with anti-Kim-1 (Red) and anti-Gα12 antibody
following renal artery clamping for 30 minutes followed by reperfusion for 24 hours (400x, Bar
100μm). Arrows indicate areas with a high degree of co-localization between KIM-1 or Kim-1
and Gα12.
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2.4.2. KIM-1 inhibits Gα12 activation by blocking GTP-binding
It has long been hypothesized that KIM-1 might play a protective role in AKI (Ichimura et
al., 1998). Given that Gα12 activation instigates injury pathways in AKI, we hypothesized that
KIM-1 might suppress endogenous Gα12 activation in TECs. Because Gα12 is activated by
guanine nucleotide exchange, we studied its activation status using a GST-TPR pull-down assay
(Yamaguchi et al., 2002). Figure 2.3A demonstrates that endogenous Gα12 activity is inhibited in
cells expressing KIM-1, but not the control vector (pcDNA). Next, to test if KIM-1 expression
could inhibit Gα12 activation by physiologic ligands that stimulate its cognate GPCRs, we
measured the level of active Gα12 after stimulating HEK-293 cells transiently expressing KIM-1
or control vector with alpha-thrombin (Figure 2.3B) (Yu et al., 2012; Yanamadala et al., 2007).
Given that ROS stimulate Gα12 activation in IRI, we tested whether KIM-1 expression affected
Gα12 activation by H2O2; Gα12 activation was significantly blunted in KIM-1-expressing cells
compared to control cells upon stimulation with either alpha-thrombin or 5 mM H2O2 (Figure
2.3B). Additionally, we didn’t observe any effect of the level of H2O2 used on cell viability (Figure
2.3C and D).
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Figure 2.3. KIM-1 expression inhibits cellular Gα12 activation.
HEK-293 cells were transfected with either control vector (pcDNA) or KIM-1 plasmid in both
panels A and B. A: Cells were left untreated. B: Cells were stimulated with either α-thrombin (2
U/ml) or H2O2 (5 mM) for 30 minutes. Samples in A and B were subjected to the GST-TPR pulldown assay to measure the level of Gα12 activation. Lysates (total) and pull-down (active)
samples were analyzed by SDS-PAGE and Western blotting with antibodies against Gα12, KIM1 and actin as indicated. Densitometric analyses of the ratio of active to total Gα12 relative to
control vector transfected cells are shown as a representation of three independent experiments
(n=3, ***p<0.001). C and D: Proximal tubule epithelial cells isolated from either wild type (C)
or Kim-1 knock out (D) mice were treated with increasing concentrations of H2O2 (mM) as
indicated. Cell death was calculated as the percentage of propidium iodide (PI) positive cells as
detected by flow cytometry in comparison to control treatment (water). n=3, no significant
difference was found between the treatments.
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Based on the above data, we suspected that KIM-1 might block nucleotide exchange on
G12, thereby preventing its activation. To test this, we exposed lysates from HEK-293 cells
transiently transfected with either control vector or vector encoding KIM-1 to GTPγS to
irreversibly lock G12 in the active conformation. We observed significantly less GTP-bound
Gα12 in KIM-1 expressing cells compared to cells not expressing KIM-1 (Figure 2.4A). Similar
results were obtained when we used HEK-293 cells stably expressing KIM-1 or control vector. To
extend these findings to a physiologically relevant in vitro model, we compared Gα12 activation
in primary TECs isolated from previously generated Kim-1-/- mice (Figure 2.4B) to Kim-1+/+ mice.
Concordant with previous reports (Wong et al., 2010), Kim-1-/- mice were phenotypically normal.
Ex vivo culture of TECs from Kim-1+/+ mice resulted in KIM-1 upregulation as previously reported
(Ichimura et al., 1998). As expected, this was absent in TECs isolated from Kim-1-/- mice as
indicated by Western blot of mouse Kim-1 (Figure 2.4 C, D, E). Consistent with data in HEK-293
cells, we observed significantly higher levels of active Gα12 in TEC-lysates from Kim-1-/- mice
compared to TEC-lysates from Kim-1+/+ mice loaded with GTPγS (Figure 2.4C). Similarly, the
level of Gα12 activation was significantly higher in TEC-lysates from Kim-1-/- mice compared to
that from Kim-1+/+ mice upon stimulation with H2O2 (Figure 2.4D). Given that Src was shown to
mediate ROS/Gα12 mediated epithelial injury (Yu et al., 2012), we examined Src activation using
pY419 antibodies (which recognize phosphorylated Src) in the total cell lysates from Kim-1-/- and
Kim-1+/+ TECs after treatment with H2O2. Figure 2.4E shows significantly enhanced Src activation
in TECs from Kim-1-/- mice compared to those from Kim-1+/+ mice after H2O2 stimulation. Taken
together, these data suggested that KIM-1 constitutively inhibits Gα12/Src activation by blocking
GDP-GTP exchange by Gα12.
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Figure 2.4. KIM-1 inhibits Gα12 activation and its down-stream effector Src.
A: HEK-293 cells were transfected with either control vector (pcDNA) or KIM-1 plasmid and
were stimulated with the non-hydrolysable GTP analog (GTPγS) for 15 minutes. B:
Confirmation of genotype using genomic DNA of wild type (+/+), heterozygotes (+/-) and
homozygotes Kim-1 knock out (-/-) C57BL/6 mice by PCR. C: Tubular epithelial cells (TECs)
isolated from wild type (Kim-1+/+) and Kim-1-deficient (Kim-1-/-) mice were stimulated with
GTPγS for 15 minutes. D: TECs were stimulated with H2O2 (5 mM) for 30 minutes. Samples in
A, C, and D were subjected to the GST-TPR pull-down assay to measure the level of Gα12
activation. Lysates (total) and pull-down (active) samples were analyzed by SDS-PAGE and
Western blotting with antibodies against Gα12, human KIM-1 (KIM-1) or mouse Kim-1 (mKim1) and actin where indicated. E: Activated and total Src were detected in total cell lysates from
TECs stimulated with H2O2 by Western blotting using an anti-p-Src (Py419-Src)
phosphospecific antibody and anti-c-Src antibody, respectively. Densitometric analysis of the
ratio of active to total Gα12 (or pY419-Src to c-Src) relative to non-KIM-1 expressing cells or
wild type TECs (+/+). Figure shown is representative of three independent experiments (n=3,
*p<0.05, **p<0.01 and ***p<0.001 compared to control vector (pcDNA), †p<0.05, ††p<0.01
and †††p<0.001 compared to Kim-1-/-). Red arrow point to the mouse Kim-1 band.
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2.4.3. Kim-1-deficient mice exhibit higher Gα12 and Src activation and worse tissue damage
after ischemia-reperfusion injury
To extend these findings to a physiologically important model, we next determined whether
upregulation of KIM-1 by TECs during renal IRI would block Gα12 activation in the kidneys by
ROS. To test this, we subjected Kim-1+/+ and Kim-1-/- mice to 35 minutes of unilateral renal artery
clamping followed by 24 hours of reperfusion and measured Gα12 activation in the affected and
contralateral kidney tissues (Yu et al., 2012). As expected, we observed both an increase in Gα12
activation and an upregulation in Kim-1 expression (Ichimura et al., 1998; Vaidya et al., 2010) in
the reperfused kidneys, but not the contralateral (non-ischemic) kidneys as determined by Western
blot (Figure 2.5A). Predictably, the degree of Gα12 activation after IRI was significantly higher in
the kidneys from Kim-1-/- mice compared to those from the Kim-1+/+ mice. Though there was a
small difference in active Gα12 levels in the contralateral kidneys between Kim-1-/- and Kim-1+/+
mice, this was not significant (p>0.05). In a parallel set of experiments, we also observed increased
Src activation in the total cell lysates from Kim-1-/- kidneys compared to Kim-1+/+ kidneys
subjected to ischemia-reperfusion, which is in keeping with previous work (Figure 2.5B) (Meyer
et al., 2003; Yu et al., 2012).
In view of the pathogenic role of activated Gα12 in IRI (Yu et al., 2012), and the above
data demonstrating that KIM-1 inhibits Gα12 activation, we hypothesized that Kim-1-deficient
mice would show more severe IRI compared to Kim-1+/+ mice. As shown in Figure 2.5C, after 30
minutes of renal ischemia and 24 hours of reperfusion, renal function was significantly worse in
Kim-1-/- compared to Kim-1+/+ mice (mean creatinine 198 vs. 87 µmol/L, respectively, p<0.01,
n=9 per group). Kim-1-/- mice also exhibited worse histological renal damage compared to Kim1+/+ mice (Figure 2.5D). After 48 hours of reperfusion, 7/11 Kim-1-/- while 0/5 Kim-1+/+ mice had
died (p<0.05) (Figure 2.5E). When we reduced ischemia time to 25 minutes, Kim-1+/+ mice
maintained near-normal renal function (mean creatinine 17 µmol/L, n=11), while Kim-1-/- mice
developed severe renal impairment (mean creatinine 111 µmol/L, n=12) (p<0.001) after 48 hours
of reperfusion (Figure 2.5F). Tissue injury was also greater in Kim-1-/- than Kim-1+/+ mice (Figure
2.5G). After 168 hours of reperfusion, there remained a significant difference in renal function
between Kim-1+/+ mice (mean creatinine 17 µmol/L) and Kim-1-/- mice (mean creatinine 43
µmol/L) (p<0.01), though 4/19 Kim-1-/- while 0/14 Kim-1+/+ mice had died (p=0.067) (Figure
2.5H). Histology is provided in Figure 2.5I.
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Figure 2.5. Kim-1-deficient mice exhibit increased renal Gα12 activation and tissue damage
after IRI.
A: Wild type (Kim-1+/+) and Kim-1-deficient (Kim-1-/-) mice underwent unilateral renal pedicle
clamping for 35 minutes, followed by 24 hours of reperfusion. Active Gα12 was measured in
renal cortical lysates obtained from clamped and contralateral kidneys by GST-TPR pull-down
assay, followed by SDS-PAGE and Western blotting for active and total Gα12, mouse Kim-1
(mKim-1) and GAPDH. B: The level of active phosphorylated Src (pY419) compared to total
Src was measured by Western blot in renal cortical lysates from mice treated as in (A). Samples
were analyzed by SDS-PAGE and Western blot for indicated antibodies. Densitometric analysis
of the ratio of active Gα12 to total Gα12 (or pY419-Src to c-Src) is shown as a representation of
three independent experiments (n=3/group, †p<0.05, ††p<0.01). C-I: Independent groups of Kim1+/+ and Kim-1-/- mice underwent sham surgery or bilateral renal pedicle clamping for 30 minutes
(n=5-11/ group, C-E) or 25 minutes (n=7-12/ group, F-I), followed by 24, 48 or 168 hours (h) of
reperfusion. C and F: Kidney function was determined by plasma creatinine levels. D and G:
Quantification of tubular damage in whole kidneys after 48 hours of reperfusion (n=9/group). E
and H: Percent survival after reperfusion. †p<0.05, ††p<0.01 and †††p<0.001, §p=0.078, ‡p=NS.
I: Representative PAS stained kidney sections after 48 hours of reperfusion (Sham represents
Kim-1-/-) (200x, Bar=0.10mm). Arrows indicate a major histological difference (tubule dilation)
between Kim-1+/+ and Kim-1-/- following injury.
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2.5. DISCUSSION
AKI is a serious medical condition for which the pathogenic mechanisms are not well
understood and for which there is no known treatment. It has been recently discovered that Gα12
has a crucial pathogenic role in renal IRI (Meyer et al., 2003; Yu et al., 2012). Specifically, ROS
stimulates Gα12 to activate tubular injury pathways, including disruption of tight junctions via Src
activation. To our knowledge, regulation of this pathway has never been described. Here, we
show that KIM-1 blocks GTP binding onto Gα12, and thus functions to reduce the level of active
Gα12. In support of this finding, we found that Kim-1-/- mice exhibited exaggerated Gα12 and Src
activation in vivo during renal IRI, compared to Kim-1+/+ mice. In addition, we observed worse
renal dysfunction and histology after bilateral pedicle clamping in Kim-1-/- as compared to Kim1+/+ mice. Taken together, our findings suggest that KIM-1 protects against Gα12-mediated tissue
damage during ischemic AKI. Whether KIM-1 has additional, Gα12-independent effects on TECs
that protect from IRI is an area of further study (Ichimura et al., 2012).
Our results provide particular insight into the regulation of G-protein signalling. Gα12, like
all G proteins, is a molecular switch that is activated by GTP binding (upon GDP dissociation) and
inactivated when bound-GTP is hydrolyzed to GDP (Dhanasekaran et al., 1996). We found that
KIM-1 reduces binding of GTPγS to Gα12. To our knowledge, KIM-1 is the first guanine
nucleotide dissociation inhibitor against Gα12 to be identified (Siderovski et al., 2005).
Interestingly, the cytosolic domain of KIM-1 does not contain the 19-amino-acid sequence
GoLoco motif that is typical of guanine nucleotide dissociation inhibitors (Kimple et al., 2002).
The residues responsible for KIM-1 inhibition of Gα12 are unknown. It is conceivable that
targeting Gα12 using an exogenous chemical inhibitor might ameliorate renal IRI (Yu et al., 2012).
However, such an inhibitor does not exist and may in fact be toxic given that Gα12 is expressed
ubiquitously and also regulates many crucial cellular functions (Dhanasekaran et al., 1996).
Our results suggest that KIM-1 represents a natural, endogenous mechanism to protect
against tissue damage during renal IRI. Given that KIM-1 is expressed by TECs only during the
injury and returns to undetectable baseline levels upon renal recovery, after day seven post-IRI
(Ko et al., 2010), Gα12 inhibition by KIM-1 is likely transient. Interestingly, the upregulation of
KIM-1 seems to overlap with Gα12 activation by ROS during ischemia-reperfusion. The down
regulation of KIM-1 after AKI is equally important as conditional overexpression of KIM-1 in
TECs in the absence of an injury stimulus results in kidney fibrosis (Humphreys et al., 2013). It
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has been proposed that antagonizing KIM-1 signalling may represent a novel therapeutic target to
ameliorate renal fibrosis in chronic kidney disease (CKD). However, our identification of KIM-1
in regulating Gα12 and in protection against renal dysfunction during IRI suggest that caution is
warranted in targeting KIM-1 in CKD, as such a therapeutic agent may exacerbate AKI episodes
which have been linked to progression of CKD (Chawla et al., 2014). It would also be interesting
to know if transiently overexpressing KIM-1 during IRI would further protect against tissue
damage. We speculate that strategies to enhance KIM-1 expression or function may be particularly
important in patients with polymorphic variants of KIM-1 that might confer reduced ability to
inhibit Gα12.
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3.1. SUMMARY
Kidney injury molecule-1 (KIM-1) is a receptor for the “eat me” signal phosphatidylserine,
which is present on apoptotic cells. The specific upregulation of KIM-1 by injured tubular
epithelial cells (TECs) enables them to clear apoptotic cells thereby protecting from AKI.
Recently, we discovered that KIM-1 binds directly to the alpha subunit of heterotrimeric G12
protein (Gα12) and inhibits its activation by reactive oxygen species during renal ischemiareperfusion injury (Chapter 2). Here we investigated if Gα12 has a role in KIM-1-mediated
phagocytosis. We showed that KIM-1 remains bound to Gα12 and suppresses Gα12 activity during
phagocytosis. When we silenced Gα12 expression by siRNA, KIM-1-mediated engulfment of
apoptotic cells was increased significantly; in contrast overexpression of constitutively active
Gα12 (QL Gα12) resulted in the opposite effect. Inhibition of RhoA, a key effector of Gα12, using
a chemical inhibitor or expression of dominant-negative RhoA had the same effect as inhibition of
Gα12 on phagocytosis. Consistent with this, silencing Gα12 suppressed active RhoA in KIM-1expressing cells. Finally, using primary TECs from Kim-1+/+ and Kim-1-/- mice, we confirmed that
phagocytosis depends on KIM-1 expression, and that this process is enhanced by silencing Gα12.
Our data reveal a previously unknown role of Gα12 in regulating phagocytosis in renal TECs.
These results may have many implications given the known harmful role of Gα12 in acute kidney
injury.

3.2. INTRODUCTION
The process of apoptosis or programmed cell death serves to rid the body of damaged and
senescent cells that arise during both physiologic and pathologic conditions, such as acute tissue
injury (Elliott et al., 2010). The final common step of apoptosis is the removal of the cell corpses
by phagocytes without triggering inflammation (Manfredi et al., 2002). Renal proximal tubular
epithelial cells (TECs) are particularly susceptible to apoptosis and necrosis during acute kidney
injury (AKI) caused by ischemia and toxins (Sanz et al., 2008; Shiratsuchi et al., 1997). During
AKI (Yang et al., 2015; Ichimura et al., 1998), proximal tubular epithelial cells (TECs) become
transformed into semi-professional phagocytes and rapidly clear apoptotic cells through a process
known as phagocytosis or efferocytosis (deCathelineau et al., 2003). This process is crucial to
regulate inflammation, as uncleared apoptotic cells obstruct the tubular lumen or undergo
secondary necrosis and trigger inflammation which can impede repair (deCathelineau et al., 2003;
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Erwig et al., 2006; Fadok et al., 1998; Ren et al., 1998; Rosen et al., 1999; Yang et al., 2015).
Phagocytes recognize apoptotic cells via cell-surface engulfment receptors that directly or
indirectly bind to “eat me” signals displayed on the surface of apoptotic cells (Erwig et al., 2008;
Lauber et al., 2004). Ligand-binding leads to receptor activation, which then brings about a series
of complex downstream signalling pathways that ultimately result in reorganization of the cell
cytoskeleton enabling engulfment, internalization and degradation of the bound corpses
(Castellano et al., 2001; Hochreiter-Hufford et al., 2013). The Rho family of small GTPases such
as RhoA and Rac1 have been implicated in the regulation of cytoskeletal remodelling in
professional and semi-professional phagocytes (Lauber et al., 2004; Machacek et al., 2009;
Nakaya et al., 2006; Ren et al., 1998). Like all G proteins, RhoA and Rac1 cycle between GDPbound inactive, and GTP-bound active conformations regulated by GTP exchange factors (GEFs)
or GTPase activating proteins (GAPs), respectively (Geyer et al., 1997; Ridley, 1999, 2001).
Although both RhoA and Rac1 belong to same family, they differ in their action: Rac1 induces
polymerization of actin leading to membrane ruffles and filopodia formation, while RhoA induces
actin assembly into bundles and stress fibers (Hall et al., 2000). While the activation of Rac1 seems
to be an evolutionarily conserved event in phagocytosis (including apoptotic cell engulfment)
(Kinchen et al., 2005; Kinchen et al., 2007; Ravichandran et al., 2007), there is some controversy
regarding the inhibitory role for RhoA in phagocytosis (Erwig et al., 2006; Olazabal et al., 2002;
Ravichandran et al., 2007; Zhou et al., 2001).
Several groups have previously identified kidney injury molecule-1 (KIM-1) as a
phagocytosis receptor that is upregulated on the apical surface of proximal tubular proximal cells
(TECs) following injury (Han et al., 2002; Ichimura et al., 1998). TIM-1 is a receptor for
phosphatidylserine, one of the most well characterized apoptotic cell “eat-me” signals (Fadok et
al., 1998; Ravichandran et al., 2007; Wang et al., 2003). Both mouse (termed Kim-1) and human
KIM-1, also known as T cell, immunoglobulin and mucin domain-1 protein (TIM-1), are small
type I transmembrane glycoproteins that belongs to the TIM gene family (Freeman et al., 2010).
The human TIM family consists of TIM-1 (Feigelstock et al., 1998; Ichimura et al., 1998; McIntire
et al., 2001; Santiago et al., 2007), TIM-3 (DeKruyff et al., 2010; Nakayama et al., 2009), and
TIM-4 (Kobayashi et al., 2007; Santiago et al., 2007), which are conserved between mouse and
man, and they all bind directly to phosphatidylserine (Freeman et al., 2010; Ichimura et al., 2008;
Kobayashi et al., 2007; Santiago et al., 2007). KIM-1/TIM-1 is expressed on mast cells, regulatory
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B cells, activated CD4 T cells, and TECs following AKI (Freeman et al., 2010; Han et al., 2002).
KIM-1 contains an IgV‐like domain, a mucin‐like domain, a transmembrane region, and an
intracellular tail that has been implicated in cell signalling in differentiated T cells (A. J. de Souza
et al., 2005; Anjali J. de Souza et al., 2008; Ichimura et al., 1998; Santiago et al., 2007) and B
cells (Yeung et al., 2015). The crystal structure of the IgV-like domain of KIM-1/TIM-1 has been
solved, and reveals that it forms a conserved binding pocket termed the metal ion-dependent
ligand-binding site (MILIBS) (Cao et al., 2007; DeKruyff et al., 2010; Santiago et al., 2007) that
allows highly specific recognition of phosphatidylserine exposed on the surface of apoptotic cells
(Freeman et al., 2010; Santiago et al., 2007). Cell-surface KIM-1 concentrates at the point of
contact with an apoptotic cell and forms the phagocytic cup (Freeman et al., 2010). We previously
showed that Kim-1-deficient mice succumb to worse tissue injury and mortality after ischemic
AKI (Ismail et al., 2015). Moreover, TECs from mice expressing a mucin-domain deletion mutant
of Kim-1 are unable to bind apoptotic cells, exhibit impaired phagocytic function by TECs and
also succumb to worse AKI (Yang et al., 2015). These data underline the biological importance of
Kim-1-mediated clearance of apoptotic cells by TECs in limiting tissue damage during AKI.
Recently, we uncovered that KIM-1 interacts with the alpha subunit of heterotrimeric G12
proteins (Gα12) and inhibited its activation by ROS during ischemic AKI (renal ischemiareperfusion injury), which is crucial to limiting downstream injury pathways triggered by Gα12
activation in TECs (Ismail et al., 2015). Gα12 belongs to the G12 class of G proteins
(Dhanasekaran et al., 1996; Vara Prasad et al., 1994). It is ubiquitously expressed and has
pleiotropic effects on cells, including inducing proliferation, focal adhesion assembly/disassembly
and cytoskeletal reorganization (Kurose, 2003; Needham et al., 1998). Gα12-driven cytoskeletal
reorganization, including actin stress fiber formation, is mediated through activation of the RhoA
GTPase via Rho guanine nucleotide exchange factors (GEFs) (Tanabe et al., 2004), including
LARG (Fukuhara et al., 2000), PDZ-RhoGEF (Kuner et al., 2002), and p115 RhoGEF (Iguchi et
al., 2008).
Given that Gα12 activation and KIM-1 upregulation occur simultaneously during ischemic
AKI, we investigated the role of Gα12 in KIM-1-mediated phagocytosis using cell culture models
of TECs and primary TECs isolated from mice kidneys. We reveal that activated Gα12 inhibits
phagocytosis and that KIM-1-suppression of Gα12 activation is crucial for TECs to mediate
phagocytosis of apoptotic cells. In addition, we show that the inhibitory effect of Gα12 on
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phagocytosis is mediated by its downstream effector, RhoA. Finally, our data demonstrating that
TECs absolutely require KIM-1 expression for phagocytosis implies that altering Gα12 activity
might be a viable therapeutic strategy to enhance clearance of apoptotic cells following AKI.

3.3. EXPERIMENTAL PROCEDURES
3.3.1. Cell culture and materials
Human Embryonic Kidney 293 (HEK-293) cells and porcine proximal tubule epithelial
cells (LLC-PK1) were cultured at 37 °C in 5 % (vol/vol) CO2 and maintained in DMEM
(Invitrogen, Carlsbad, CA) containing 10 % FBS (Invitrogen, Carlsbad, CA). HEK-293 cells stably
expressing KIM-1-GFP (herein referred to as HEK-293-KIM-1-GFP), KIM-1 (no tag) (HEK-293KIM-1), pcDNA-GFP (HEK-293-pcDNA), as well as, LLC-PK1 stably expressing KIM-1 (LLCPK1-KIM-1) and pcDNA (LLC-PK1-pcDNA) were generated by transfecting with plasmid
constructs encoding either KIM-1 or control vector using Lipofectamine® 2000 (Life
technologies, Thermo Fisher Scientific, Rockford, IL). Several single cell clones were selected
using 800 µg/ml Geneticin (G418) Sulfate (Santa Cruz Biotechnology, Santa Cruz, CA). Cells
expressing a high level of KIM-1 protein determined by Western blotting were used for further
experiment and were maintained in DMEM containing 10 % FBS and 800 µg/ml G418. Primary
proximal tubule epithelial cells (TECs) were isolated from 2-4 week old C57BL/6 Kim-1+/+ and
Kim-1-/- mice and cultured for the first 6 days in serum free DMEM/F-12 mixed media (1:1)
supplemented with 5 % insulin-transferrin-selenium solution (Invitrogen, Carlsbad, CA), 5 %
penicillin-streptomycin solution (Invitrogen, Carlsbad, CA), 0.5 µg/ml of mouse EGF (Peprotech,
Rocky Hill, NJ), and 50 ng/ml hydrocortisone (Thermo Fisher Scientific, Rockford, IL). After 6
days, TECs were cultured with same media mixtures supplemented with 5 % FBS as described
earlier (Sharpe et al., 2012). Chemicals were purchased from Sigma (Sigma Aldrich, St. Louis,
MO) unless stated. The pH-sensitive dye pHrodo™ Red succinimidyl ester (pHrodo™ Red, SE),
Alexa Fluor® 555 Goat Anti-Mouse antibody and DAPI were purchased from Life Technologies
(Molecular probes, Invitrogen, Carlsbad, CA), and Rhodamine phalloidin from Cytoskeleton
(Cytoskeleton, Denver, CO). Gα12 (S-20, 1:500 dilution) and actin (I-19, 1:1000 dilution)
antibodies were from Santa Cruz Biotechnology (Santa Cruz Biotechnology, Santa Cruz, CA), PEconjugated anti-human KIM-1 (1D12, 1:100 dilution) and PE-conjugated rat IgG2b isotype control
(RTK 4530, 1:100 dilution) were purchased from Biolegend. Allophycocyanine (APC)-conjugated
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anti-mouse Tim-1 rat IgG2B (AF1817A, 1:100 dilution) and APC-conjugated rat IgG2B isotype
control (1:100 dilution) were obtained from R&D system Inc. (R&D Systems Inc., Minneapolis,
MN). RhoA specific monoclonal antibodies (ARH03, 1:500 dilution) and non-hydrolysable GTP
analog were purchased from Cytoskeleton (Cytoskeleton, Denver, CO). A custom anti-KIM-1 (PA
4145, cytosolic domain) antibody was generated by immunizing rabbits with a peptide
(CKEVQAEDNIYIENSLYATD) contained within the cytosolic domain of KIM-1 and conjugated
to KLH as previously described (Life technologies, Thermo Fisher Scientific, Rockford, IL)
(Bailly et al., 2002; Gandhi et al., 2014). A KIM-1 antibody against the mucin domain of KIM-1
(AKG7) was kindly provided by Dr. Bonventre (Harvard Medical School, Brigham and Women's
Hospital, Boston, MA). Complete Mini EDTA-free protease inhibitor cocktail tablets were
purchased from Roche (Roche Diagnostic, Basel, Switzerland). Rho inhibitor (cell permeable C3
transferase) was purchased from Cytoskeleton, Rho kinase (ROCK) inhibitor (Y27632) and Rac1
Inhibitor (NSC23766) were purchased from EMD Millipore (EMD Millipore, Billerica, MA).
Plasmid constructs for Gα12, RhoA and Rac1 were kindly provided by Dr. Bradley Denker
(Harvard Medical School, Brigham and Women's Hospital, Boston, MA), while the plasmid
constructs for KIM-1 were provided by Dr. Bonventre (Harvard Medical School, Brigham and
Women's Hospital, Boston, MA). Lipofectamine® 2000 (Life Technologies, Thermo Fisher
Scientific, Rockford, IL) and Dharmafect1 (Thermo Fisher Scientific, Rockford, IL) were used for
transfecting plasmid and siRNA, respectively.
3.3.2. Mice
Wild-type C57BL/6 (Kim-1+/+) mice were obtained from the Jackson Laboratory.
C57BL/6 Kim-1-deficient mice (Kim-1-/-) were obtained from Dr. Andrew N. J. McKenzie (MRC
laboratory of Molecular biology, Cambridge, UK) and these were generated by targeted disruption
of the mouse havcr1 gene in mouse embryonic stem cells as described previously (Wong et al.,
2010). All animal procedures were approved by the Western University Animal Use Subcommittee
in accordance with the regulations of the Canadian Council on Animal Care (refer to appendix for
certificate of approval).
3.3.3. Phagocytosis assay and FACS analysis
To prepare apoptotic cells for the phagocytosis assays, thymocytes were harvested from 3
to 6 week old C57BL/6 mice, and apoptosis was induced by UV exposure for five minutes
followed by incubation overnight at 37 °C in 5 % CO2 in DMEM media supplemented by 10 %
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FBS and 1 % penicillin-streptomycin solution as described previously (Gandhi et al., 2014).
Apoptosis of the thymocytes were verified by flow cytometry analysis showing positive staining
for Annexin V and negative staining for propidium iodide. Apoptotic thymocytes were stained
with pH-sensitive dye pHrodo™ Red succinimidyl ester (pHrodo™ Red, SE) at a final
concentration of 150 nM for 30 minutes at room temperature. Labelled apoptotic cells were
washed twice with 1x PBS to remove excess dye. The pHrodo dye helped in distinguishing
between bound and internalized apoptotic cells, where apoptotic cells exhibit higher fluorescence
upon entry into the acidic compartment of phagolysosomes (Gandhi et al., 2014; Miksa et al.,
2009; Park et al., 2009). The fluorescently-labelled apoptotic cells were counted and 3x106 were
added to each well of 6-well plate (1.5x107 for 10 cm plates) containing phagocytes cells (HEK293 cells, LLC-PK cells or isolated TECs) and incubated for various time points at 37 °C in 5 %
CO2. Cells were then placed on ice for 30 minutes to reduce non-specific binding of apoptotic
cells. The plates were washed three times with ice-cold PBS, and cells were collected with 5 mM
EDTA-PBS, and resuspended with FACS buffer (1x Phosphate-buffered saline (PBS), 2 % calf
serum, and 0.1 % sodium azide) for flow analysis. For KIM-1-surface staining, the cells were
blocked in PBS and 10 % goat serum for 15 minutes, followed by incubation for 30 minutes at
room temperature with either PE-conjugated anti-KIM-1 (1D12, human), or APC-conjugated
anti-Tim-1 (AF1817A, mouse) targeting extracellular domain of KIM-1 or Kim-1 and their
respective isotype control antibodies at a ratio of 1:100. All samples were run on a BD LSR II
flow cytometer using various filters, such as, YG 582/15 (pHrodo red, PI) and B 530/30 (GFP,
FITC) (BD Biosciences, San Jose, CA). The percentage of phagocytosis represents the number
of cells that have internalized the pHrodo red labelled apoptotic cell(s), as indicated by the higher
fluorescence of pHrodo red dye (104-105 on logarithmic scale). Cells with low pHrodo red
fluorescence (<104) were excluded from the percentage of phagocytosis calculation since they
are not internalized.
3.3.4. Immunoprecipitation and Western blot
HEK-293 cells were lysed with ice-cold lysis buffer (25 mM HEPES pH 7.5, 150 mM
NaCl, 15 mM MgCl2, 1 % Triton X-100, and Complete Mini EDTA-free protease inhibitor cocktail
tablets (Roche Diagnostic, Basel, Switzerland). For immunoprecipitation, cell extracts containing
1.0 –1.5 mg of the protein/mL were incubated with 10 ug of Gα12 (S-20), KIM-1 (PA4145), or
rabbit IgG antibody (sc-2027) and 20 µl of protein-A/G Sepharose beads (Santa Cruz
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Biotechnology, Santa Cruz, CA) at 4 °C overnight. Beads were centrifuged, washed three times,
and suspended in 20 μL of SDS sample buffer and heated at 100 °C for five minutes. Lysates
(representing 5 % of total lysate) and immunoprecipitation samples were separated by
electrophoresis under reducing condition and transferred to polyvinylidene difluroide (PDVF)
membranes (EMD Millipore, Billerica, MA). PDVF-membranes were probed with antibodies
specific to surface KIM-1 (AKG7, 1:3 dilution), the cytosolic domain of KIM-1 (PA 4145, 1:1,500
dilution), Gα12 (1:500 dilution), actin (1:1,000 dilution), or RhoA (1:500 dilution). The signal was
visualized using the appropriate horseradish peroxidase-conjugated secondary antibodies and ECL
western blot detection reagent (Luminata forte, EMD Millipore, Billerica, MA) and visualized by
autoradiography (Biomax; Denville Scientific, South Plainfield, NJ).
3.3.5. GST-TPR pull down
The construct encoding the GST-fused TPR domain of PP5 was kindly provided by Dr. N
Dhanasekaran (Temple University, PA, USA). GST-TPR protein was purified from Escherichia
coli as described earlier (Yoshiaki Yamaguchi et al., 2002). Cells were lysed with ice-cold lysis
buffer (20 mM HEPES pH 8.0, 2 mM MgCl2, 1 mM EDTA, 1 mM DTT, 0.5 % Triton x-100, and
complete Mini EDTA-free protease inhibitor cocktail tablets (Roche Diagnostic, Basel,
Switzerland). 1 mg of protein lysate and ≈1 μg of GST-TPR coupled glutathione-agarose beads
were incubated together at 4 °C for five hours. Both lysate and pull-down samples were analyzed
by SDS-PAGE and Western blotting to detect total and active Gα12 in these samples, respectively.
Lysates loaded with non-hydrolyzable GTP analog (GTPγS) or GDP (Cytoskeleton, Denver, CO)
were considered as a positive or negative controls, respectively.
3.3.6. Immunofluorescence and confocal microscopy
HEK-293 cells were cultured at subconfluent density on poly-D-lysine hydrobromide
(Sigma Aldrich, St. Louis, MO) coated glass cover slips, and were transfected with either different
wild type or mutant versions of GFP-tagged Gα12 or siRNA against Gα12. Cells were fixed with
4 % paraformaldehyde, followed by counterstaining of the nucleus with DAPI (0.5 µg/ml). Cellsurface staining for KIM-1 was performed using the monoclonal antibody against the mucin
domain of KIM-1 (AKG). For this, cells were blocked with 1 % BSA in 1x PBS for 1 hour at room
temperature, followed by incubation with anti-KIM-1 overnight. Bound KIM-1 was labelled with
Alexa 555 conjugated anti-mouse at concentration of 1:1000. For actin cytoskeleton staining, cells
were permeabilized with 0.25 % Triton in 1x PBS for five minutes, and then stained with
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rhodamine phalloidin for 0.5 hours according to the manufacturer’s instructions (Cytoskeleton,
Denver, CO). Coverslips were mounted using Shandon-Mount® permanent mounting (Thermo
Fisher Scientific, Rockford, IL) and viewed with a FLUOVIEW X83I confocal microscopy
(Olympus, Tokyo, Japan). Data were acquired and analyzed using FLUOVIEW FV10 ASW 4.0
viewer and ImageJ software (National Institutes of Health, Bethesda, MD) to determine the Van
Steensel’s score for colocalization of KIM-1 and Gα12. Colocalization was quantified based on
five random fields per sample and three independent experiments. Quantification of the number of
apoptotic cells bound was assessed in eight random fields per sample and was done in four
independent experiments. Approximately 100 to 120 cells were counted for each field as
determined by DAPI staining of nucleus.
3.3.7. siRNA of Gα12 in HEK-293 and proximal tubular epithelial cells
ON Target plus® Smart pool siRNA against Gα12-specific and non-targeting pool
(Control siRNA) were purchased from Dharmacon (Thermo Fisher Scientific, Rockford, IL). Cells
were transfected with 50 nM of siRNA using Dharmafect1® for 24 hours before further analysis
of knockdown.
3.3.8. RhoA activation
RhoA activation was determined using Rhotekin-RBD (Rho-binding domain) beads
according to the manufacturer’s instructions (Cytoskeleton, Denver, CO) and as described before
(Yu et al., 2012). Both lysates, and pull-down samples were analyzed by SDS-PAGE and Western
blotting to determine the levels of total and active RhoA in these samples, respectively. Controls
included incubating lysates with GDP (1 mM, negative control) or GTPγS (200 µM, positive
control) for 15 minutes and then adding the beads. The ratio of active-to-total RhoA was
determined based on densitometric analysis of Western blot images. For RhoA activation
measurement after siRNA-mediated knockdown of Gα12, we used the G-LISA RhoA activity
assay kit (Cytoskeleton, Denver, CO), due to its high sensitivity and the low level of the total
protein required to perform the assay.
3.3.9. Quantification and statistics
Western blots were scanned and band intensity quantified using Image J software (National
Institutes of Health, Bethesda, MD). Background was subtracted in these analyses, normalized to
actin and the linear range of response was determining using a standard sample that was serially
diluted. Statistics were done in GraphPad Prism (Graph Pad Software Inc., La Jolla, CA) or IBM
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SPSS statistic 22 (IBM, Armonk, NY). The significance for the percentage of phagocytosis or
immunoprecipitation densitometric analysis over phagocytosis time course was determined using
one-way ANOVA (as indicated). The significance of the results comparing active and total Gα12
or RhoA for cells stimulated with apoptotic cells over a period of time (15, 30, 60 and 90 minutes)
was determined using the analysis of covariance (ANCOVA). All other analyses were done using
an unpaired t-test where indicated. P-value of <0.05 was considered significant. Error bars
represent the standard error of the mean unless otherwise indicated.
3.4. RESULTS
3.4.1. KIM-1 interacts with Gα12 during phagocytosis
KIM-1 is not expressed by healthy TECs, but is upregulated more than any other protein
after AKI (Ajay et al., 2014;Ichimura et al., 1998; Ko et al., 2010). Because it is virtually
impossible to perform mechanistic studies on TEC-phagocytosis in vivo, we did this in vitro using
human embryonic kidney-293 (HEK-293) cells overexpressing KIM-1. Exogenous expression of
KIM-1 in cultured cells is routinely used to mimic KIM-1 that is upregulated on TECs during AKI
in vivo and HEK-293 cells are widely used to study the phagocytic signalling and phagocytic
function of KIM-1 (Gandhi et al., 2014; Ichimura et al., 2008; kobayashi et al., 2007). In addition,
HEK-293 cells were ideal for our studies since they express adequate level of Gα12 for detection
by Western blotting (Figure 3.1A). We failed to detect endogenous Gα12 by Western blotting in
cells that endogenously express KIM-1, such as the human renal adenocarcinoma cell line (769P),
which is also routinely used to study KIM-1-mediated phagocytosis (Gandhi et al., 2014; Ichimura
et al., 2008; Kobayashi et al., 2007). Next, we established assay conditions for our study by
creating HEK-293 cells that stably express C-terminal GFP-tagged human KIM-1 and determining
their efficiency and kinetics of apoptotic engulfment (Ichimura et al., 2008; Ichimura et al., 1998;
Ismail et al., 2015). To distinguish bound from internalized apoptotic cells when using flow
cytometry to detect phagocytosis, targets were labelled with a pH-dependent fluorescent dye
(pHrodo) that exhibits higher fluorescence upon entry of apoptotic cells into the acidic
compartment of phagolysosomes (Gandhi et al., 2014; Miksa et al., 2009; Park et al., 2009). Stable
transfection with GFP-tagged human KIM-1 enabled efficient engulfment of apoptotic cells (40 %
vs. 8 %, p<0.05) relative to cells transfected with GFP-tagged control vector (pcDNA-GFP)
(Figure 3.1B). Phagocytosis was further confirmed using confocal microscopy, where we were
able to visualize the formation of phagocytic cups after co-culture of HEK-293-KIM-1-GFP cells
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with apoptotic cells over the course of phagocytosis (Figure 3.1C). Phagocytic cups were formed
at the cell-surface within 15 minutes of the addition of apoptotic cells. Pretreatment of the
phagocytic cells with the actin polymerization inhibitor cytochalasin D significantly reduced the
uptake of apoptotic cells by KIM-1-expressing HEK-293 cells (Figure 3.1D).
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Figure 3.1. KIM-1-mediates the uptake of apoptotic cells.
A: Various cell lines were screened for KIM-1 and Gα12 expression via Western blot. These
cells include; human embryonic kidney-293 cells (HEK-293), porcine proximal tubular epithelial
cells (LLC-PK1), human renal adenocarcinoma cells (769P), HEK-293 cells transfected with
human KIM-1 and Gα12 served as a positive control. Lysates were obtained, separated by SDSPAGE and immunoblotted (IB) for KIM-1, Gα12 and actin. B: HEK-293 cells stably expressing
either control vector (pcDNA-GFP) or KIM-1-GFP were fed pHrodo-labelled (red) apoptotic
cells for various time points as indicated (hours). The percentage of phagocytosis was
determined by flow cytometry measurement of GFP and high pHrodo red double positive cells
(n=3, *p<0.05, unpaired t-test). C: HEK-293 cells stably expressing KIM-1-GFP were fed
pHrodo-labelled apoptotic cells (red) for various time points (minutes or min). Cells were fixed
and stained with rhodamine-phalloidin to visualize F-actin (red) and DAPI to visualize the
nucleus and apoptotic cells (blue) (600x, bar represents 5 µm). Apoptotic cells labelled with both
pHrodo red and DAPI (blue) appear as purple/pink coloured cells in the merged image. Arrows
indicate the apoptotic cell(s) in the vicinity of KIM-1 expressed on the cells. D: HEK-293 cells
stably expressing KIM-1-GFP were treated with vehicle control (DMSO) or the actin
polymerization inhibitor cytochalasin D (10 μM), and fed fluorescently labelled apoptotic cells
for 90 minutes. The percentage of phagocytosis represents the percentage of KIM-1-GFP
positive cells with high fluorescence of pHrodo red of engulfed apoptotic cells as measured by
flow cytometry (n=3,*p<0.05, unpaired t-test).
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Based on our previous work demonstrating that the cytosolic domain of KIM-1 interacts
with Gα12 in TECs (Ismail et al., 2015), we sought to investigate how this was affected by
phagocytosis. We performed co-immunoprecipitation of Gα12 with KIM-1 during the course of
phagocytosis and found that the interaction is not dependent on apoptotic cell stimulation of HEK293-KIM-1-GFP cells (Figure 3.2A). Importantly, apoptotic cell-stimulation was also not required
for the interaction of KIM-1 with GST-Gα12 in HEK-293 cells stably expressing KIM-1 (Figure
3.2B).
In order to visualize the interaction of Gα12 with KIM-1 in the phagocytic cells, we cotransfected HEK-293 cells with KIM-1 and GFP-tagged Gα12 and examined the kinetics of Gα12KIM-1 co-localization before and after adding apoptotic cells (Figure 3.2C). In keeping with our
previous work (Ismail et al., 2015), we observed co-localization of KIM-1 with Gα12 prior to and
after the addition of apoptotic cells. As determined by quantification of the change in colocalization following stimulation with apoptotic cells using the Van Steensel’s approach (Bolte
et al., 2006), we failed to see any significant difference between unstimulated and stimulated cells
(Figure 3.2D). The above results suggested that KIM-1 constitutively interacts with Gα12 during
the course of corpse engulfment.
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Figure 3.2. KIM-1 interacts with Gα12 during phagocytosis.
A: Human embryonic kidney-293 (HEK-293) cells stably expressing human KIM-1-GFP with
high level of endogenous Gα12 were stimulated with apoptotic cells for indicated time and used
for immunoprecipitation (IP) using antibody against Gα12. The ratio of bound KIM-1 to Gα12
was determined based on densitometric values obtained by Western blotting during apoptotic cell
stimulation (n=3, ns= not significant, one-way ANOVA).B: GST and GST-Gα12 pull-down was
performed on extracts from HEK-293-KIM-1-GFP cells that were left unstimulated or stimulated
with apoptotic cells for 90 minutes. All samples were analyzed by SDS-PAGE followed by
immunoblotting (IB) with antibodies against KIM-1, Gα12 and actin. The input lane represents 5
% of the lysate. The data represents three independent experiments. C: HEK-293 cells were
transfected with wild type KIM-1-and GFP-tagged Gα12 construct and fed pHrodo red
fluorescently labelled apoptotic cells (AC) (blue/red) for 30 minutes prior to fixation. Surface
KIM-1 staining was performed using anti-KIM-1 antibody against the mucin domain (AKG) and
Alexa555-conjugated secondary antibody (600x, bar represent 40 μm). Arrows indicate where
phagocytic cups formed. D: Images of colocalization of both KIM-1 and Gα12 were analyzed
using the Van Steensel’s approach, where the cross correlation function (CCFs) was calculated
with a pixel shift of ±20. The results shown are representative of four images from three
independent experiments (ns= not significant, one-way ANOVA).
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3.4.2. KIM-1 down regulates Gα12 activity during KIM-1-mediated phagocytosis
Phagocytosis involves a series of events that starts with the recognition of ligands on
apoptotic cells by phagocytic receptors on the phagocytic cell (e.g. phosphatidylserine recognition
by KIM-1), which then triggers phagocytic cup formation and subsequently a cascade of
intracellular signalling events that include activation of various GTPases (Elliott et al., 2010;
Kinchen et al., 2007; Ravichandran et al., 2007). Since Gα12 is a GTPase, which cycles between
active (GTP-bound) and inactive (GDP-bound) status, we sought to investigate if Gα12 was
activated during engulfment of apoptotic targets. We measured the ratio of active-to-total Gα12 in
cell lysates using a routinely used active-Gα12 pull-down assay that utilizes the tetratricopeptide
repeat (TPR) domain of a downstream effector of Gα12, Ser/Thr phosphatase type 5 (PP5), fused
to GST (Y. Yamaguchi et al., 2002). Subsequently, we used Western blotting to detect both active
and total Gα12. In KIM-1-expressing cells, we observed a steady decrease (from baseline) in the
level of active Gα12 during phagocytosis (Figure 3.3A). The decrease in active Gα12 was more
pronounced during later stages of phagocytosis (60-90 minutes after adding apoptotic cells). On
the other hand, we observed no significant difference or trend in Gα12 activity in HEK-293 cells
not expressing KIM-1 over the same period of observation (Figure 3.3B). We observed similar
kinetics of Gα12 inactivation when porcine renal TECs (LLC-PK1) stably expressing a C-terminal
HA-tagged KIM-1 were transfected with a Gα12 expression construct, but not in control vector
(pcDNA) transfected cells (Figure 3.3C and D). Together, these data suggested that Gα12 activity
is progressively suppressed in the HEK-293 cells in a KIM-1-dependent manner during
phagocytosis.
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Figure 3.3. KIM-1 down regulates Gα12 activity during KIM-1-mediated phagocytosis.
HEK-293 cells stably expressing KIM-1-GFP (A) or pcDNA (control vector) (B) were fed
apoptotic cells (ACs) for various time points (15, 30, 60, and 90 minutes). Similarly, porcine
renal proximal TECs (LLC-PK1) stably expressing a C-terminal HA-tagged KIM-1 (C) or
control vector (pcDNA) (D) were transfected with a wild-type Gα12 expression construct and
fed apoptotic cells. Cell lysates were subjected to the GST-TPR pull-down assay to measure
active Gα12 as described in the experimental procedure section. Samples were analyzed by SDSPAGE followed by immunoblotting (IB) with antibodies against Gα12 and actin. The total Gα12
lanes represent 5 % of the lysate that used for GST-TPR pull-down. The numbers below blots
represent the respective densitometric ratio of the active Gα12 band to total Gα12 band on the
Western blot image normalized to the untreated sample. Graphs represent the estimated marginal
means for active Gα12 as determined by the analysis of covariance (ANCOVA). In KIM-1expressing cells (A and C), a statistically steady significant decrease in the level of active Gα12
during phagocytosis was observed (n=3, p=0.015 (A), p=0.001 (C)). Cells in B and D show no
significant change (n=3, p=0.445 (B), p=0.278(D)).
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3.4.3. Gα12 is a negative regulator of KIM-1-mediated phagocytosis
Though data presented thus far demonstrate that Gα12 activity is inhibited during
phagocytosis, they do not necessarily imply a functional role for Gα12 in KIM-1-mediated
phagocytosis. To study this, HEK-293-KIM-1-GFP cells were transfected with a control vector,
vector encoding wild type Gα12 (WT Gα12), or vector encoding a constitutively active (GTPasedeficient) mutant of Gα12 (QL Gα12) (Meyer et al., 2002), and phagocytosis efficiency was
measured using flow cytometry. Overexpression of QL Gα12 significantly inhibited engulfment
of apoptotic cells, whereas WT Gα12 had little effect on phagocytosis of apoptotic cells (Figure
3.4A). We obtained similar results when transfecting KIM-1-expressing LLC-PK1 cells with QL
Gα12 (Figure 3.4B). To verify these findings, we performed confocal imaging of these cells and
counted the number of apoptotic cells in the vicinity of the KIM-1 expressing HEK-293 cells for
each condition. This analysis shows that there was a significant decrease in the number of apoptotic
cells present inside cells transfected with the constitutively active mutant (Figure 3.4C).
In order to test how suppression of Gα12 expression affected phagocytosis, we silenced
Gα12 using siRNA in HEK-293-KIM-1-GFP cells (Figure 3.4D) and performed phagocytosis
assays. We found a significant increase in the uptake of apoptotic cells (Figure 3.4E) in conjunction
with effective knockdown of Gα12 in these cells. Evaluation of phagocytosis by confocal
microscopy once again confirmed these results (Figure 3.4F). The above data suggested that active
Gα12 has a negative effect on KIM-1-mediated engulfment of apoptotic cells.
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Figure 3.4. Gα12 negatively regulates KIM-1-mediated phagocytosis.
A: HEK-293 cells stably expressing wild type KIM-1 were transfected with either control vector
encoding GFP (pcDNA-GFP), wild type GFP-tagged Gα12 (pcDNA-WT Gα12-GFP) or
constitutively active GFP-tagged Gα12 (pcDNA-QL Gα12-GFP). B: LLC-PK1 cells stably
expressing KIM-1 were transfected with the same constructs as in A. Cells in A and B were fed
apoptotic cells that are fluorescently labelled with pHrodo red for 90 minutes. The percent of
uptake of apoptotic cells was determined by flow cytometry after gating on GFP positive cells.
The ratio of phagocytosis compared to control vector was determined (n=3, *p<0.05,
***p<0.001, unpaired t-test). C: HEK-293 cells stably expressing wild type KIM-1 were grown
on cover slips and transfected with either pcDNA-GFP or pcDNA-QL Gα12-GFP and fed
fluorescently labelled (pHrodo red) apoptotic cells for 90 minutes. Confocal microscopy images
were taken to quantify the number of apoptotic cells bound to the phagocytic cells. The results
were plotted as a representation of eight sections from four independent experiments with
approximately 120 cells counted for each section (n=4, *p<0.05, unpaired t-test). D: HEK-293
cells stably expressing KIM-1 were transfected with 50 pmol of control siRNA or siRNA against
Gα12 for 24 hours, and the levels of Gα12, KIM-1 and actin were determined by
immunoblotting (IB) with the indicated antibodies. The graph showing the densitometric ratio of
Gα12 in siRNA treated samples as compared to non-transfected samples represents data from
four independent experiments (n=4, *p<0.05, ns= not significant, unpaired t-test). E: HEK-293KIM-1-GFP expressing cells transfected with either control or Gα12 siRNA were fed
fluorescently labelled (pHrodo red) apoptotic cells to measure phagocytosis as in A and B (n=5,
*p<0.05, unpaired t-test). F: cells in E were visualized with confocal microscopy to count the
number of apoptotic cells. The number of apoptotic cells bound to the cells that were seen in
each field was plotted based on analysis of eight representative sections from each of 4
independent experiments with approximately 120 cells counted for each section (n=4, *p<0.05,
unpaired t-test).
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3.4.4. RhoA is a down-stream effector in KIM-1-mediated phagocytosis
Gα12 has been shown to transduce signals from GPCR to activate RhoA via Rho GEFs
(Tanabe et al., 2004). RhoA belongs to the Rho family of GTPases (Chimini et al., 2000; Hall,
1998; Tosello-Trampont et al., 2003) that are master regulators of the actin cytoskeleton and has
been implicated in phagocytosis (Morimoto et al., 2006; Nakaya et al., 2006; Ravichandran et al.,
2007). To determine the role of RhoA in KIM-1-dependent engulfment of apoptotic cells, we
inhibited RhoA signalling using a Rho inhibitor (cell-permeable C3 transferase) (Fritz et al., 1994)
or its downstream effector Rho-associated Protein Kinase (ROCK) using Y27632 (Ishizaki et al.,
1997; Ishizaki et al., 2000). The inhibition of either RhoA or ROCK significantly increased the
uptake of apoptotic cells when compared to control treatments respectively (Figure 3.5A). The
comparable effects of both inhibitors on apoptotic cell-uptake suggested that ROCK might be a
primary RhoA effector in mediating the inhibition of phagocytosis in KIM-1 expressing cells. In
contrast, KIM-1-expressing HEK-293 cells transfected with a vector encoding either wild type
RhoA or constitutively activated RhoA mutant (Q62L) exhibited significantly reduced phagocytic
efficiency when compared to the cells transfected with a control vector (Figure 3.5B). However,
when KIM-1-expressing cells were transfected with dominant negative RhoA (T19N), there was
a significant increase in phagocytosis (Figure 3.5).
The parallel and negative effects of both activated Gα12 and RhoA on KIM-1-mediated
phagocytosis suggested that RhoA likely mediated the Gα12-inhibitory effect on phagocytosis. To
formally test if endogenous RhoA activity was regulated by Gα12 in our cells, we silenced
endogenous Gα12 expression in HEK-293-KIM-1-GFP cells and measured the RhoA activation
using a commercially available pull-down assay that employs the binding domain of Rho effector
protein (Rhotekin) fused to GST (Ishizaki et al., 1997). Endogenous RhoA activity was
significantly inhibited in HEK-293-KIM-1-GFP cells treated with Gα12 siRNA, but not control
siRNA, at baseline, at 30 minutes (early phagocytosis) and 90 minutes (late phagocytosis) after of
exposure to apoptotic cells (Figure 3.5C). Additionally, transfection of HEK-293-KIM-1-GFP
cells with a constitutively active mutant of Gα12 (QL Gα12) led to a significant increase in RhoA
activity (Figure 3.5D).
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Figure 3.5. RhoA is a down-stream effector of Gα12 in KIM-1-mediated phagocytosis.
A: HEK-293 cells stably expressing KIM-1 were treated for 4 hours with DMSO (control), Rho
inhibitor (cell permeable C3 transferase) (0.5 µg/ml), or Rho kinase (ROCK) inhibitor Y27632
(10 µM). B: Cells were transfected with CFP-tagged control vector, CFP-tagged wild type
RhoA, CFP-tagged dominant negative RhoA (T19N) or CFP-tagged constitutively active RhoA
(Q62L). These cells (A, B) were incubated with pHrodo red-labelled apoptotic cells for 90
minutes and the percentage of phagocytosis by CFP-positive cells was measured by flow
cytometry (n=3, *p<0.05, **p<0.01, ***p<0.001, unpaired t-test). C: HEK-293 cells stably
expressing KIM-1 were transfected with either control siRNA or siRNA against Gα12 for 24
hours then stimulated with apoptotic cells (ACs) for 30 or 90 minutes. D: HEK-293-KIM-1 cells
were transfected with either control vector or constitutively active Gα12 (QL Gα12). Levels of
active RhoA (in C and D) were measured using the G-LISA RhoA activation assay kit
(Cytoskeleton Inc.). Total RhoA levels in lysates were measured using RhoA ELISA kit
(Cytoskeleton Inc.). The level of normalized active RhoA were calculated and graphed (n=3,
*p<0.05, ***p<0.001, unpaired t-test).
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We also examined dynamic RhoA activity during phagocytosis. Following stimulation
with apoptotic cells, a statistically gradual significant increase in the level of active RhoA during
KIM-1-mediated phagocytosis was observed in cells, with a peak activity occurred around 90
minutes after the addition of apoptotic cells (Figure 3.6A). There was no discernible pattern to
RhoA activation observed in cells not expressing KIM-1 that were also fed apoptotic cells
(Figure 3.6B). The difference in the trend between RhoA activation and Gα12 activation during
KIM-1-mediated phagocytosis could suggest the involvement of independent proteins affecting
the level of active RhoA and Gα12. Taken together, the above results suggested that Gα12-RhoA
signalling negatively regulates KIM-1-dependent phagocytosis. Our data are consistent with
reports showing that RhoA and ROCK are negative regulators of phagocytosis mediated by other
phagocytic receptors (Nakaya et al., 2006;Tosello-Trampont et al., 2003).
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Figure 3.6. RhoA activity is increased during the course of KIM-1-mediated phagocytosis.
HEK-293 cells stably expressing KIM-1-GFP (A) or pcDNA-GFP (control vector) (B) were fed
apoptotic cells for various time points (15, 30, 60, and 90 minutes). The level of active RhoA
was measured using active RhoA pull-down assay (Cytoskeleton Inc.). Cell lysate loaded with
non-hydrolyzable GTP (GTPγS) or GDP were used as a positive or negative control,
respectively. Samples were analyzed by SDS-PAGE followed by immunoblotting (IB) with
antibodies against RhoA and actin. Densitometric analysis of the relative ratio of the active
RhoA to their respective total fractions in comparison to the non-treated sample is shown as
numbers below blots. Graphs represent the estimated marginal means for active RhoA as
determined by the analysis of covariance (ANCOVA) (n=3, p=0.009 (A), p=0.965 (B)).
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Unlike RhoA, Rac1 has been shown to have a conserved and positive role in phagocytosis
by both professional and semi-professional phagocytes regardless of which phagocytic receptor
was involved (Ravichandran, 2011; Ravichandran et al., 2007). Thus, we next sought to determine
the role of Rac1 in KIM-1-mediated phagocytosis. Consistent with these reports, transfection of
KIM-1-expressing cells with a vector encoding dominant negative Rac1 (T17N) or treatment of
KIM-1-expressing cells with a Rac1 inhibitor significantly inhibited the phagocytic uptake of
apoptotic cells compared to controls (Figure 3.7A and B). Hence, we reasoned that Rac1 is also
required for KIM-1-dependent phagocytosis and has the opposite effect to RhoA on KIM-1dependent corpse engulfment in our cell culture models.
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Figure 3.7. Rac1 is involved in KIM-1-mediated phagocytosis.
A: HEK-293 cells were co-transfected with construct encoding wild type KIM-1 and either CFPtagged control vector (control), CFP-tagged wild type Rac1 or CFP-tagged dominant negative
Rac1 (Rac1-T17N). B: HEK-293-KIM-1 cells were treated for 4 hours with DMSO (control) or
Rac1 inhibitor (NSC23766) (50 µM). Cells in (A) and (B) were fed pHrodo-labelled apoptotic
cells for 90 minutes and the percentage of uptake was measured by flow cytometry. In A, the
percentage of pHrodo red high fluorescent cells was determined for CFP-positive cells (n=3,
**p<0.01, ***p<0.001, unpaired t-test).
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3.4.5. KIM-1 is the major phagocytic receptor in primary proximal tubule epithelial cells that
control Gα12 activity
In the context of our previous report (Ismail et al., 2015) demonstrating that KIM-1 binds
directly to and suppresses Gα12 activation by blocking GTP-loading, our present data suggest that
KIM-1-suppression of endogenous Gα12 activation in cells is required for efficient phagocytosis
of apoptotic cells. To confirm the inhibitory role of Gα12 in a physiologically relevant cell type,
we studied primary tubular epithelial cells (TECs) isolated from mice kidneys. First, we aimed to
determine if KIM-1 is dispensable for phagocytosis in primary renal TECs or if its expression is
absolutely required for phagocytosis. For this, we compared the phagocytic efficiency between
primary TECs isolated from wild type (Kim-1+/+) C57BL/6 and previously generated Kim-1deficient mice (Kim-1-/-) (Wong et al., 2010). Ex vivo culturing of TECs from Kim-1+/+ mice
readily resulted in spontaneous Kim-1 upregulation, as previously reported (Ajay et al., 2014;
Humphreys et al., 2013; Ichimura et al., 2008), suggesting that cell culture condition mimics injury
induced by IRI in AKI. As expected, compared to Kim-1+/+ TECs, there was an absence of both
total Kim-1 protein level and Kim-1 cell-surface expression in TECs isolated from Kim-1-/- mice,
as determined by Western blot and flow cytometry, respectively (Figure 3.8A and B). When
apoptotic cells were fed to TECs over 24 hours to stimulate phagocytosis, we found a significant
difference between Kim-1-/- and Kim-1+/+ TECs in phagocytosis as measured by flow cytometry
(Figure 3.8C). Surprisingly, TECs deficient in Kim-1-expression were virtually defective in the
uptake of apoptotic cells. To verify these findings using an alternate method, TECs were fed
apoptotic cells for three hours and cells were stained for surface Kim-1 and imaged by confocal
microscopy (Figure 3.8D). In contrast to Kim-1-deficient TECs and in keeping with our flow
cytometry data, Kim-1-expressing TECs readily bound apoptotic cells and formed phagocytic cups
around them (arrows, Figure 3.8D). Finally, to test if Gα12 negatively regulated KIM-1-dependent
phagocytosis in primary TECs, we pretreated TECs isolated from Kim-1+/+ mice with Gα12 siRNA
or control siRNA, and compared their relative phagocytic efficiencies (Wong et al., 2010). In
keeping with what was observed in KIM-1-expressing HEK-293 cells, silencing Gα12 expression
significantly increased the phagocytic capacity of TECs and its ability to mediate engulfment of
apoptotic cells (Figure 3.8E and F).
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Figure 3.8. KIM-1 is a major phagocytic receptor in primary proximal tubular epithelial
cells and Gα12 is a negative regulator of phagocytosis.
A: Proximal tubular epithelial cells (TECs) isolated from wild type (Kim-1+/+) and Kim-1 knock
out (Kim-1-/-) mice were cultured and the expression levels of mouse Kim-1 were measured by
Western blot. B: Surface expression of mouse Kim-1 on TECs was determined by flow
cytometry using PE-conjugated anti-mouse Tim-1/Kim-1 antibody (R&D Systems Inc.) (n=3,
*p<0.05, unpaired t-test). C: TECs were fed pHrodo red-labelled apoptotic cells for various time
points (hour(s)) and the percent phagocytosis of fluorescently labelled apoptotic cells uptake by
TECs (as determined by high fluorescence staining (>104)) was measured by flow cytometry
(n=3, *p<0.05, one-way ANOVA). D: TECs were cultured on glass cover slips and fed greenlabelled apoptotic cells for 3 hours. Cells were fixed and surface stained for mouse Kim-1 using
anti-mouse Kim-1 antibody and Cy5-conjugated secondary antibody (600x, bar 10µm). E: TECs
isolated from wild type C57BL/6 mice were transfected with 50 pmol of control siRNA or
siRNA against mouse Gα12 for 24 hours and the levels of Gα12, mouse Kim-1 and actin were
determined by Western blot. F: TECs transfected with either control siRNA or Gα12 siRNA
were subjected to the phagocytosis assay and the percentage of phagocytosis of pHrodo-labelled
apoptotic cells was measured by flow cytometry (n=4, *p<0.5, unpaired t-test).
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3.5. DISCUSSION
KIM-1 is a phosphatidylserine-binding phagocytosis receptor (Freeman et al., 2010;
Ichimura et al., 2008) that is specifically upregulated by tubular epithelial cells (TECs) during
ischemic or toxic AKI (Ichimura et al., 2008; Ichimura et al., 1998; Ichimura et al., 2012).
However, the relevant intracellular signalling pathway(s) that it regulates had not been appreciated
till now. Here, we reveal for the first time that Gα12 negatively regulates KIM-1-depedent
phagocytosis. Further, we demonstrated that Gα12 mediates this inhibition through downstream
activation of RhoA and likely via ROCK. Given that KIM-1-mediated phagocytosis prevents AKI
(Yang et al., 2015), our data demonstrating that KIM-1 is indispensable for phagocytosis by renal
TECs implies that the Gα12-RhoA signalling axis plays an important role in regulating
phagocytosis by TECs in vivo during AKI.
While we did not specifically address how Gα12 is activated in TECs during phagocytosis
or the molecular mechanisms of Gα12 inhibition by KIM-1, our findings are supported by our
previous work which suggested that KIM-1, when upregulated following ischemia-reperfusion
injury (IRI), binds directly to Gα12 and inhibits its activation by ROS (Ismail et al., 2015). This
inhibition is mediated by the ability of KIM-1 to block GDP-GTP exchange onto Gα12. As a result,
we showed that Kim-1-deficient mice exhibited a higher level of active Gα12 and worse kidney
function following renal ischemic injury when subjected to renal IRI. This demonstrates that KIM1 expression protected mice from tissue damage caused by ROS-mediated activation of injury
pathways downstream of Gα12 (Yu et al., 2012). These downstream injury pathways include
activation of Src kinase and inhibition of tight junctions assembly and reassembly that are required
for tubular repair (Meyer et al., 2002; Sabath et al., 2008). Our current findings here suggest that
ability of KIM-1 to suppress Gα12 activation is also crucial for TECs to carry out phagocytosis
during AKI. This finding is particularly relevant because it was later shown that KIM-1-mediated
phagocytosis contributes to protection from AKI by curtailing immune responses (Yang et al.,
2015). Thus, aberrant Gα12 activation by ROS during AKI not only destabilizes tight junctions
(via Src kinase) (Meyer et al., 2003; Yu et al., 2012), but also impedes phagocytic clearance of
dying cells. Thus, we propose that upregulation of KIM-1 on TECs during AKI and subsequent
inhibition of Gα12 protects from renal damage during renal IRI via at least two potential
mechanisms. The first one is by blocking ROS-mediated activation of injury pathways via
activated Gα12 that leads to worse tissue damage and impaired repair (Yanamadala et al., 2007;
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Yu et al., 2012). The second mechanism is by enhancing phagocytic clearance of apoptotic and
necrotic cells by surviving TECs (Gandhi et al., 2014; Ichimura et al., 2008) via suppression of
Gα12. This inhibitory mechanism of KIM-1 on Gα12 would help regulate inflammation caused by
spillage of the intracellular contents of necrotic and secondary necrotic cells into the extracellular
milieu within the kidney (Elliott et al., 2010; Ren et al., 1998; Silva, 2010).
Actin cytoskeletal rearrangement is crucial for the engulfment of apoptotic cells
(Castellano et al., 2001; Chimini et al., 2000). Rac1 and RhoA belong to the Rho family of
GTPases that regulate actin cytoskeletal reorganization (Ridley, 2001) and have long been
implicated in phagocytosis (Ravichandran et al., 2007). The reciprocal role for Rac1 and RhoA in
KIM-1-dependent phagocytosis in TECs proposed by our work is novel for KIM-1-mediated
uptake of apoptotic cells and is consistent with what has been reported by other groups studying
additional phosphatidylserine receptors (Erwig et al., 2008; Nakaya et al., 2006; Tosello-Trampont
et al., 2003). In those studies, the inhibitory effect of RhoA on apoptotic cell-clearance was
mediated by ROCK, as was also the case in our experiments (Tosello-Trampont et al., 2003).
Activated RhoA increases the kinase activity of ROCK, which in turn phosphorylates myosin light
chain (MLC) and promotes contractility via actin stress fiber formation (Riento et al., 2003). The
latent activation of RhoA in our cells might lead to an increase in contractility, causing stress fiber
formation, which has been postulated to inhibit phagocytosis (Deery et al., 1993; Ravichandran et
al., 2007). The later has not been tested in this paper and requires future experimental work. In
contrast to RhoA, activated Rac1 has an evolutionarily conserved positive role in promoting
phagocytosis (Henson, 2005; Kinchen et al., 2005; Nakaya et al., 2008). It is generally accepted
that Rac1 is recruited to help form phagocytic cups and generate membrane ruffles that are
necessary to facilitate corpse engulfment (Kraynov et al., 2000; Nakaya et al., 2008). Rac1 is then
down regulated when the phagocytic cup closes in conjunction with abrupt disruption of the
associated actin patches. Our data are consistent with a requirement for Rac1 in phagocytosis.
Whether one or more of the conserved phagocytic signalling pathways regulates Rac1 activation
downstream of KIM-1 in TECs remains to be tested (Kinchen et al., 2005; Tosello-Trampont et
al., 2007). Moreover, the opposing roles of RhoA and Rac1 in KIM-1-mediated phagocytosis
might suggest a spatiotemporal pattern of activation. This may be better visualized in future studies
through the use of biosensors with fluorescence resonance energy transfer (FRET) that respond to
RhoA and Rac1 activation (Nakaya et al., 2008; Wong et al., 2006)
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To our knowledge, this is the first report describing any aspect of phagocytic signalling by
KIM-1, despite the fact that other members of the TIM family of phosphatidylserine receptors,
such as TIM-3 and TIM-4, have been the subjects of much research (Balasubramanian et al., 2012;
Binne et al., 2007; Curtiss et al., 2011; Freeman et al., 2010; Mariat et al., 2009; Yeung et al.,
2015). Studies on TIM-1 signalling thus far have focused primarily on the non-phagocytic
functions of KIM-1 (that is TIM-1), for instance in its role in co-stimulation of T cell responses
(Balasubramanian et al., 2012; Bonventre et al., 2011; Anjali J. de Souza et al., 2008; Lee et al.,
2010; Mariat et al., 2009). Balasubramanian et al. recently reported that TIM-1 mediates the
degradation of NUR77, a nuclear receptor implicated in apoptosis and cell survival, but did not
investigate phagocytic signalling (Balasubramanian et al., 2012). Additionally, Yang et al.
demonstrated that KIM-1 interacts with p85 in TECs and down-modulates NF-кB signalling (Yang
et al., 2015). On the other hand, TIM-3 is expressed by dendritic cells, where it mediates
phagocytosis of apoptotic cells, but very little is known regarding how it mediates phagocytic
signalling (Miyanishi et al., 2007; Nakayama et al., 2009; Sanchez-Fueyo et al., 2003). Tim-4
does not mediate phagocytic signalling directly, but has been postulated to signal via a yet
unidentified co-receptor (Park et al., 2009).
Although various GTPases make up fundamental components of the phagocytic signalling
machinery (Hochreiter-Hufford et al., 2013; Ravichandran et al., 2007), to our knowledge, our
study is the first one to implicate Gα12 in phagocytosis. Given the various fundamental processes
that Gα12 regulates, such as motility (Kelly et al., 2006), modulation of cell-cell junctions (Meyer
et al., 2003), cellular transformation (Dermott et al., 1999) and contractility (Buhl et al., 1995;
Gavard et al., 2008), our study suggests a relationship between these processes and phagocytosis
in TECs. For example, pathological activation of Gα12 during ischemic-reperfusion injury results
in activation of injury pathways via destabilization of tight junctions (Samarin et al., 2009) through
its interaction with zonula occludens-1 (ZO-1) and Src kinase (Meyer et al., 2003; Meyer et al.,
2002; Sabath et al., 2008). This disruption of the tight junction has been shown to be a hallmark
of epithelial cell damage and is believed to be a contributor to kidney dysfunction (Denker et al.,
1998; Meyer et al., 2001). The relationship between tight junction assembly and disassembly
during phagocytosis has not yet been studied and will be of major interest to our research.
Deciphering KIM-1 signalling pathway(s) may have future clinical implications in AKI.
Our work presented here and previously (Ismail et al., 2015) suggests that targeting Gα12 might
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be a potential strategy to treat AKI by enhancing clearance of apoptotic cells and simultaneously
inhibiting downstream injury pathways. Unfortunately, there is no specific Gα12 inhibitor
available to currently test this in vivo. Nonetheless, our detailed work uncovering the importance
of KIM-1 in TEC-phagocytosis and how it is regulated offers important insights into TEC biology
that might be relevant to AKI.
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4.1. SUMMARY
In this chapter, we identify and study another novel KIM-1-interacting protein. Using a
yeast two-hybrid system, we describe the identification of the 14-kDa light chain of cytoplasmic
dynein motor protein, Tctex-1, as a potential KIM-1 interacting protein. Given that Tctex-1 is
involved in microtubule and actin cytoskeletal dynamics, we hypothesized that Tctex-1 functions
to enhance KIM-1-mediated engulfment of apoptotic cells. First, we established that Tctex-1
interacts with KIM-1 via co-immunoprecipitation. When we stimulated KIM-1-expressing cells
with apoptotic cells, we observed that this interaction is significantly reduced upon longer
incubation with apoptotic cells (90 minutes). The time dependent reduction in the interaction
between Tctex-1 and KIM-1 was further confirmed by GST-Tctex-1 pull-down assay and
immunofluorescence staining. When we inhibited KIM-1-mediated phagocytosis through
inhibition of actin cytoskeleton changes by treatment with cytochalasin D or nocodazole, we
restored the interaction between KIM-1 and Tctex-1 during the later stages of phagocytosis. In
addition, we tested whether phosphorylation at Threonine-94 of Tctex-1 influenced the interaction
with or phagocytic efficiency of KIM-1. Surprisingly, a phosphomimetic mutant of Tctex-1 at
Threonine-94 (T94E) displayed a decreased ability to interact with KIM-1 without influencing
KIM-1-mediated uptake of apoptotic cells. To determine the role of Tctex-1 during KIM-1mediated phagocytosis, we silenced Tctex-1 expression via siRNA and found a significant
reduction in uptake of apoptotic cells that was accompanied by highly disorganized actin
structures. Furthermore, in a search for down-stream mediators of Tctex-1 signalling in KIM-1expressing cells, we failed to find a link between Tctex-1 and RhoGTPase. This suggest that Tctex1 might exhibit its function through different RhoGTPases that are novel to KIM-1.

4.2. INTRODUCTION
The process of programmed cell death, or apoptosis, is characterized by distinct
morphological characteristics that serve as a mechanism for removing damaged or unwanted cells
from the tissues of an organism (Kerr, 2002; Kerr et al., 1972; Wyllie et al., 1980). Phagocytosis
of apoptotic cells, termed phagocytosis (Vandivier et al., 2006), prevents the release of noxious
and immunogenic materials from dying cells, which reduces tissue damage associated with
inflammation or inappropriate autoimmune response (Ren et al., 1998). Phagocytosis is
increasingly being recognized to be important in tissue repair after acute organ injury (Juncadella
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et al., 2013; Yeung et al., 2015). The process of phagocytosis is usually carried out by professional
phagocytes (Albert et al., 1998; Duvall et al., 1985). However, emerging data suggests that
amateur phagocytes, such as fibroblasts, retinal pigment epithelial cells, sertoli cells, and more
recently renal proximal tubular epithelial cells, also play roles in this process (Finnemann et al.,
1997; Ichimura et al., 2008; Monks et al., 2002; Patel et al., 2010; Shiratsuchi et al., 1997). The
direct or indirect recognition of apoptotic cells by phagocytes involves the recognition of “eat-me”
signals that are newly (e.g. exposed or modified lipids or proteins) exposed on the surface of
apoptotic cells. One of the most well characterized “eat me” signals is phosphatidylserine (PS)
(Ravichandran et al., 2007).
Kidney injury molecule-1 (KIM-1) is a well characterized phagocytic receptor that is
expressed on renal proximal tubular epithelial cells (TECs). It recognizes phosphatidylserine on
apoptotic cells (Ichimura et al., 2008). KIM-1 was first identified in a cDNA screen looking for
genes that are upregulated in the post-ischemic rat kidney (Ichimura et al., 1998). KIM-1 is mostly
localized to the apical membrane of TECs following injury to kidney commonly caused by
ischemia or toxic insult (Ichimura et al., 2004). Structurally, KIM-1 is a type I transmembrane
glycoprotein consisting of an N-terminal immunoglobulin V (IgV) domain, a mucin domain, a
transmembrane domain and a cytoplasmic tail (Ichimura et al., 1998; Santiago et al., 2007). The
signalling mechanisms underlying KIM-1-mediated uptake of apoptotic cells are still not well
understood. Recently, KIM-1 was shown to interact with p85 following apoptotic cell binding
(Yang et al., 2015). This was shown to lead to down-regulation of the NF-кB pathway and
subsequent inhibition of inflammatory signalling during AKI. In addition, we have uncovered
another protein that KIM-1 interacts with to carry its phagocytic function, known as the α subunit
of heterotrimeric G12 protein (Gα12). Despite the fact that several proteins have been identified
to interact with KIM-1, the overall signalling mechanisms by which KIM-1 regulates the uptake
of apoptotic cells has not yet been fully elucidated.
Here we uncovered another a novel KIM-1 interacting protein, Tctex-1 (t-Complex testisexpressed-1), using a yeast two hybrid screen that exploited the cytoplasmic tail of KIM-1 as bait
and a HeLa cell cDNA library (done by Dr. Zervos, University of Central Florida, Orlando,
Florida). Tctex-1 was initially identified in a cDNA screen looking for candidate genes in the
mouse t complex whose aberrant expression maybe functionally related to sterility and
transmission ratio distortion (Lader et al., 1989). Tctex-1 is a key component of the cytoplasmic
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light chain of the dynein motor complex (King et al., 1996). Cytoplasmic dynein is a
multicomponent, microtubule-based, ATP-dependent motor unit that has several roles in
intracellular retrograde transport, mitotic spindle localization and centrosome separation (Barton
et al., 1996; Schroer, 1994; Steuer et al., 1990). Tctex-1 has diverse dynein-dependent and independent functions (Hirokawa, 1998; Hirokawa et al., 1998; Lader et al., 1989). Through
dynein-dependent functions, Tctex-1 is associated with microtubules in order to mediate a range
of intracellular motile events that are important in the intracellular targeting or sorting of proteins
(Mueller et al., 2002; Sachdev et al., 2007; Tai et al., 1999). For example, Tctex-1 interaction
with rhodopsin, a GPCR, and transports vesicles containing rhodopsin from the Golgi apparatus
to the apical cell surface via tethering of Tctex-1 to the dynein complex on microtubules (Tai et
al., 1999; Tai et al., 2001). On the other hand, Tctex-1 has been shown to function independently
of dynein, to regulate actin cytoskeletal dynamics (Chuang et al., 2005). Phosphorylation of Tctex1 at Threonine-94 (Thr-94) has been shown to promote its dissociation from the dynein light chain
and may allow it to bind to other non-dynein proteins to mediate dynein-independent functions
(Chuang et al., 2005; Song et al., 2007). In addition, Tctex-1 expression is restricted to certain
tissues, where immunoprecipitation of kidney, spleen and testis tissues lysate showed higher levels
of Tctex-1 than brain tissue lysate (King et al., 1996). Despite advances in the research regarding
Tctex-1, most of the research on this protein has focused on the role of Tctex-1 in neurogenesis,
with little information about its role in the kidney.
In this report, we uncovered a novel interaction between Tctex-1 and KIM-1 and we
investigated the role of Tctex-1 in the phagocytic uptake of apoptotic cells. Our data show that
when KIM-1 is upregulated, it interacts with Tctex-1 to enable phagocytosis. Altering actin or
microtubules polymerization leads to a restoration of interaction that is lost during later stages of
phagocytosis. When Tctex-1 is phosphorylated at Threonine-94, its interaction with KIM-1 is
severely decreased. Furthermore, Tctex-1 appears to be important in KIM-1-mediated
phagocytosis, since silencing Tctex-1 decreases the uptake of apoptotic cells. Altogether, our
findings support the idea that Tctex-1 is important in KIM-1-mediated phagocytosis and that its
interaction with KIM-1 is a very dynamic process. The mechanisms by which Tctex-1 affects
phagocytosis remains to be studied.
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4.3. EXPERIMENTAL PROCEDURES
4.3.1. Cell culture and materials
Human Embryonic Kidney 293 (HEK-293) cells and human renal adenocarcinoma cells
(769-P) were cultured at 37 °C in 5 % (vol/vol) CO2 and maintained in DMEM or RPMI media
(Invitrogen, Carlsbad, CA) containing 10 % FBS (Invitrogen). Chemicals were purchased from
Sigma (Sigma Aldrich, St. Louis, MO) unless stated. The pH-sensitive dye pHrodo™ Red
succinimidyl ester (pHrodo™ Red, SE), Alexa Fluor® 555 goat anti-mouse, Alexa Fluor® 488
goat anti-rabbit and DAPI (4',6-diamidino-2-phenylindole) were purchased from Life
Technologies (Molecular probes, Invitrogen, Carlsbad, CA). Rhodamine phalloidin stain was
purchased from Cytoskeleton Inc. (Cytoskeleton, Denver, CO). The Tctex-1/DYNLT-1 antibody
used for confocal microscopy was purchased from Proteintech Group (11954-1-AP, Proteintech
Group Inc., Chicago, IL) and was used at a dilution of 1:50. Antibodies for Western blot against
Tctex-1 (D9944, 1:800 working dilution), actin (SAB4301137, 1:1000 working dilution) were all
purchased from Sigma (Sigma Aldrich, St. Louis, MO). PE-conjugated anti-human KIM-1 (1D12,
1:100 working dilution) and PE-conjugated rat IgG2b isotype control (RTK4530, 1:100 working
dilution) were purchased from Biolegend (Biolegend, San Diego, CA). Anti-KIM-1 (cytosolic
domain) antibody was custom generated by immunizing rabbits against the cytosolic domain of
KIM-1 (PA 4145, Life technologies, Thermo Fisher Scientific, Rockford, IL) as previously
described (Bailly et al., 2002; Gandhi, et al, 2014). A monoclonal KIM-1 antibody binding against
to the mucin domain of KIM-1 (AKG7) was kindly provided by Dr. Bonventre (Harvard Medical
School, Brigham and Women's Hospital, Boston, MA). Complete Mini EDTA-free protease
inhibitor cocktail tablets were purchased from Roche (Roche Diagnostic, Basel, Switzerland).
Cytochalasin D and Nocodazole were purchased from EMD Millipore (EMD Millipore, Billerica,
MA). The plasmid constructs encoding Tctex-1 were kindly provided by Dr. Robert Rottapel
(University of Toronto, Toronto, ON) and the plasmid constructs for KIM-1 were from Dr.
Bonventre (Harvard Medical School, Brigham and Women's Hospital, Boston, MA).
Lipofectamine® 2000 (Life Technologies, Thermo Fisher Scientific, Rockford, IL) and
INTERFERin® (Polyplus-transfection Inc., New York, NY) were used for transfecting plasmid
DNA and siRNA, respectively.
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4.3.2. Immunoprecipitation and Western blot
Cells were lysed with ice-cold lysis buffer containing 50 mM Tris-HCl, pH 7.5, 150 mM
NaCl, 2 mM EDTA, 1 mM NaVO4, 1 mM NaF, 1 % Triton X-100, and complete mini EDTAfree protease inhibitor cocktail tablets (Roche Diagnostic, Basel, Switzerland). For
immunoprecipitation, cell extracts containing 1.0–1.5 mg of protein/mL were incubated with 10
µg of anti-KIM-1 antibody (PA 4145, cytosolic domain), or rabbit IgG antibody (sc-2027, control)
and 20 µl of protein-A/G Sepharose beads (Santa Cruz Biotechnology, Santa Cruz, CA) at 4 °C
overnight. Beads were centrifuged, washed three times, suspended in 20 μL of SDS sample buffer
and heated at 100 °C for five minutes. Lysates (representing 5 % of total lysate) and
immunoprecipitated samples were separated under reducing condition and transferred to
polyvinylidene difluroide (PVDF) membranes (EMD Millipore, Billerica, MA). PDVFmembranes were probed with antibodies specific to mucin domain of KIM-1 (AKG7, 1:1 working
dilution), cytosolic domain of KIM-1 (PA 4145, 1:1,500 working dilution), Tctex-1 (D9944, 1:800
working dilution) or actin (SAB4301137, 1:2,000 working dilution). The primary antibody was
visualized using the appropriate horseradish peroxidase-conjugated secondary antibodies and ECL
Western blot detection reagent (Luminata forte, EMD Millipore, Billerica, MA) by
autoradiography (Biomax; Denville Scientific, South Plainfield, NJ).
4.3.3. GST-Tctex-1 pull down
The GST-Tctex-1 construct (provided by Dr. King, (King, et al., 1996)) was transformed
into E.coli strain BL21 and expression of the fusion protein was induced by the addition of 0.3
mM isopropyl-β-D-thiogalactopyranoside (IPTG) for three hours at 37 °C. After lysing the
bacterial cells by sonication, GST-fusion proteins were purified by incubation with 1 ml of
glutathione-Sepharose beads (Thermo Fisher Scientific, Rockford, IL) overnight at 4 °C. This was
followed by three washes with 1x PBS and aliqouts of GST-Tctex-1 conjugated to glutathioneSepharose beads were kept at -80 °C for future use. Cells were lysed with ice-cold lysis buffer (50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1 mM NaVO4, 1 mM NaF, 1 % Triton X100) supplemented with complete mini EDTA-free protease inhibitor cocktail tablets (Roche
Diagnostic, Basel, Switzerland). One milligram of protein lysate and 30 µl of GST-Tctex-1
coupled glutathione-sepharose beads were incubated together at 4 °C for overnight. Beads were
washed to reduce non-specific binding and eluted using 20 μL of SDS sample buffer and heated
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at 100 °C for five minutes. For each condition, both lysate and pull-down samples were analyzed
by SDS-PAGE and Western blotting to detect total and pull-down KIM-1, respectively.
4.3.4. Immunofluorescence and confocal microscopy
HEK-293 cells were cultured at subconfluent density on poly-D-lysine hydrobromide
(Sigma Aldrich, St. Louis, MO) coated glass cover slips, and were transfected with constructs
encoding KIM-1 and flag-tagged Tctex-1. 769-P cells were grown on glass cover slips (without
coating) and fed apoptotic cells for the indicated time points (15-90 minutes). Cells were washed
three times with 1x PBS and fixed with 4 % paraformaldehyde, followed by counterstaining of the
nucleus with DAPI (0.5 µg/ml), which stained both apoptotic cells and HEK-293 or 769-P. Cells
were then permeabilized with 0.25 % Triton X-100 in 1x PBS for five minutes, and then blocked
for 1 hour at room temperature with 1 % bovine serum albumin (BSA) and 0.05 % Triton X-100
in 1x PBS. Cells were then incubated with anti-Tctex-1 antibody (11954-1-AP, 1:50 working
dilution) (Proteintech Group Inc., Chicago, IL) in 0.5 % BSA/PBS at 4 °C overnight. Coverslips
were washed three times with 1x PBS and incubated with Alexa Fluor® 488 goat anti-rabbit (1:500
working dilution) at 37 °C for 1 hour. Coverslips were washed three times with PBS and surface
staining of KIM-1 was done using an antibody against the mucin domain of KIM-1 (AKG7, 1:1
working dilution) at 4 °C overnight. Bound KIM-1 was labelled with Alexa 555 conjugated antimouse (1:1000 working dilution) at room temperature for 1 hour. The specificity of
immunostaining was demonstrated by the absence of signal in samples processed using nonspecific rabbit or mouse IgG followed by staining with the corresponding secondary antibody. For
actin cytoskeleton staining, cells were permeabilized with 0.25 % Triton in 1x PBS for five
minutes, and then stained with rhodamine phalloidin for 30 minutes according to the manufactures
instructions (Cytoskeleton, Denver, CO). Coverslips were mounted using Shandon-Mount®
permanent mounting (Thermo Fisher Scientific, Rockford, IL) and viewed with a FLUOVIEW
X83I confocal microscopy (Olympus, Tokyo, Japan). Data were acquired and analyzed using the
FLUOVIEW FV10 ASW 4.0 viewer and ImageJ software (National Institutes of Health, Bethesda,
MD) to determine the Pearson’s coefficient and Van Steensel’s score for colocalization of KIM-1
and Tctex-1. Quantification of the colocalization score was assessed in three random fields per
sample and was done in three independent experiments.
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4.3.5. Phagocytosis assay and FACS analysis
To prepare apoptotic cells for the phagocytosis assay, thymocytes were harvested from 36 week old C57BL/6 mice, and apoptosis was induced by UV exposure for five minutes followed
by incubation overnight at 37 °C in 5 % CO2 in DMEM media supplemented by 10 % FBS and 1
% penicillin-streptomycin solution (Ichimura et al., 2008). Apoptotic thymocytes were stained
with pH-sensitive dye pHrodo™ Red succinimidyl ester (pHrodo™ Red, SE) at a final
concentration of 150 nM for 30 minutes at room temperature. Labelled apoptotic cells were washed
twice with 1x PBS to remove excess dye. The cells were counted and 3x106 were added to each
well of 6-well plate (15x106 for 10 cm plates) and incubated for various time points at 37 °C in 5
% CO2 incubator. Cells were then placed on ice for 30 minutes to reduce non-specific binding of
apoptotic cells. The plates were then washed three times with ice-cold 1x PBS, and cells were
collected with 5 mM EDTA-PBS, and resuspended with FACS buffer (1xPhosphate-buffered
saline (PBS), 2 % calf serum, and 0.1 % sodium azide) for flow analysis. For KIM-1-surface
staining (or TIM-1), the cells were blocked in PBS and 10 % goat serum for 15 minutes, followed
by incubation for 30 minutes at room temperature with PE-conjugated anti-TIM-1 (1D12, human)
and respective isotype control antibody (RTK4530) at concentration of 1:100. All samples were
run on BD LSR II flow cytometer (BD Biosciences, San Jose, CA). Percentage of phagocytosis
represents the number of cells that have internalized the apoptotic cell(s) as indicated by higher
pHrodo red fluorescence (104-105 on logarithmic scale). Engulfed cells with low fluorescence were
excluded from analysis (Gandhi et al., 2014).
4.3.6. siRNA targeting of Tctex-1
ON Target plus® Smart pool siRNA against Tctex-1 and a non-targeting pool (Control
siRNA) were purchased from Dharmacon (Thermo Fisher Scientific, Rockford, IL). Cells were
transfected with 100 nM of siRNA using INTERFERin® for 24 hours before further analysis of
knockdown using Western blotting and flow cytometry.
4.3.7. Rac1 and RhoA activation
Rac1 or RhoA activation was determined using the G-LISA Rac1 or RhoA activity assay
according to the manufacturer’s instructions (Cytoskeleton, Denver, CO). Total RhoA was
determined using Total RhoA ELISA kit (Cytoskeleton, Denver, CO). About 40 µg of protein was
used for the activation assay and 20 µg of protein was used for the total assay. Treatment with 5
% serum after serum starvation overnight served as positive control for Rac1 activation (Curtiss et
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al., 2011). Treatment of cells with 10 µM Nocodazole for 15 minutes served as positive control
for RhoA activation as indicated previously (Martin et al., 2001).
4.3.8. Quantification and statistics
Western blots were scanned and band intensity quantified using Image J software (National
Institutes of Health, Bethesda, MD). Background was subtracted in these analyses and the linear
range of response was determining using a standard sample that was serially diluted. The level of
interaction between two proteins was determined by diving the intensity value (obtained from
Western blotting) of protein being co-immunoprecipitated (Tctex-1) by the intensity value of
protein being immunoprecipitated (KIM-1). Graphs obtained were generated by using GraphPad
Prism software (Graph Pad Software Inc., La Jolla, CA). Statistics were done in GraphPad Prism
(Graph Pad Software Inc., La Jolla, CA) or IBM SPSS statistic 22 (IBM, Armonk, NY). The
significance for the percentage of phagocytosis or immunoprecipitation densitometric analysis
over phagocytosis time course was determined using one-way ANOVA (as indicated). All other
analyses were done using an unpaired t-test where indicated. P-value of <0.05 was considered
significant. Error bars represent the standard error of the mean.

4.4. RESULTS
4.4.1. KIM-1 interacts with Tctex-1 during the early phase of phagocytosis
Previously, we had identified the alpha subunit of the heterotrimeric G12 protein as a novel
KIM-1 interacting protein (Ismail et al., 2015). As an alternative strategy to identify other potential
KIM-1-interacting proteins, we performed a yeast two-hybrid screening using the cytoplasmic tail
of KIM-1 as a bait plasmid and a HeLa cell cDNA library as a “fish/prey” plasmid (in collaboration
with Dr. Zervos, Burnett School of Biomedical Sciences, University of Central Florida, Orlando,
Florida). This identified two cDNA clones, one of which encoded for the dynein light chain
protein, Tctex-1 (Lader et al., 1989). Because of the important role that Tctex-1 plays in the
modulation of actin cytoskeletal dynamics (Chuang et al., 2005;Meiri et al., 2012), and the
requirement of the cytoskeleton for the formation of phagocytic arms in phagocytosis (Chimini et
al., 2000), we selected this candidate protein for further studies. To validate the results from the
yeast two-hybrid screen, we performed co-immunoprecipitation (co-IP) experiments where HEK293 cells were transfected with both human GFP-tagged KIM-1 and human flag-tagged Tctex-1
(Figure 4.1A). We further confirmed this interaction by detecting the co-localization of both
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proteins when overexpressed by HEK-293 cells via immunofluorescent labelling and confocal
microscopy imaging (Figure 4.1B).
Given the role of KIM-1 in the uptake of apoptotic cells (Ichimura et al., 2008), we sought
to determine whether the interaction between KIM-1 and Tctex-1 remains intact during the course
of phagocytosis. Using co-IP experiments, we found a significant decrease in the interaction
between KIM-1 and with Tctex-1 between 60 and 90 minutes after stimulation with apoptotic cells
(later stages of phagocytosis) (Figure 4.1C). This exogenous overexpression of both proteins in
HEK-293 cells provided evidence of the interaction, but did not necessarily reflect physiologic
relevance. To address this, we utilized human renal adenocarcinoma cells (769-P) which
endogenously and constitutively express both human KIM-1 (Bailly et al., 2002) and Tctex-1. This
confirmed the co-IP results obtained above, including the observed diminishment in interaction
between KIM-1 and Tctex-1 during the later stages of phagocytosis (Figure 4.1D, E). To
substantiate the interaction between KIM-1 and Tctex-1 in vitro, GST pull-down assays were
performed. A fusion protein consisting of GST fused to full-length Tctex-1 (GST-Tctex-1) was
used to test GST-Tctex-1 interaction with KIM-1 during the course of phagocytosis (GauthierFisher et al., 2009). As observed before, a significant reduction in the interaction between KIM-1
and GST-Tctex-1 was observed during the later stages of uptake of apoptotic cells (90 minutes)
(Figure 4.1F, G). These data confirm that the interaction between KIM-1 and Tctex-1 is dynamic
and appears to decline during the course of KIM-1-dependent phagocytosis.
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Figure 4.1. KIM-1 interacts with Tctex-1 during the early stages of phagocytosis.
A: Human embryonic kidney-293 (HEK-293) cells transfected with human KIM-1-GFP and
flag-tagged Tctex-1 were lysed for immunoprecipitation (IP) using antibody against the cytosolic
domain of KIM-1 or control non-specific mouse immunoglobulin antibody (IgG). B: Cells in A
were visualized for interaction using immunostaining for KIM-1 (red) and Tctex-1 (green) as
indicated in the experimental procedures section. Nuclei was stained with DAPI (blue) (600x,
bar represents 40 μm). C: Cells in A were stimulated with apoptotic cells for various time points
(minutes) and IP was performed using KIM-1 antibody or control mouse IgG. D: 769-P cells
were stimulated with apoptotic cells and IP was performed similarly to C. E: The level of bound
Tctex-1 to KIM-1 was determined based on densitometric values obtained by Western blotting
(n=3, **p<0.01, ***p<0.001, one-way ANOVA). F: GST and GST-Tctex-1 pull-down was
performed on 769-P cells that were left unstimulated or stimulated with apoptotic cells for
indicated time (in minutes). G: The level of KIM-1 bound to GST-Tctex-1 was determined based
on densitometric values obtained from Western blotting (n=3, **p<0.01, one-way ANOVA). All
samples in A, C, D and F were analyzed by SDS-PAGE followed by immunoblotting with
antibodies against KIM-1, Tctex-1 and actin. The input lane represents 5 % of the lysate. The
data represents three independent experiments.
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4.4.2. Intracellular colocalization of Tctex-1 and KIM-1 occurs during the early stages of
phagocytosis
Confocal immunofluorescence analysis was performed to determine the degree of
localization of both KIM-1 and Tctex-1 during the course of phagocytosis triggered by apoptotic
cells. Using an antibody directed against the extracellular domain of KIM-1 to stain for
endogenous KIM-1 expression in 769-P cells, we found KIM-1 to be distributed on the cell-surface
and within the intracellular compartments reminiscent of the golgi apparatus as previously reported
(Machacek et al., 2009). On the other hand, immunostaining for endogenous Tctex-1 revealed
diffuse cytoplasmic staining with some staining concentrated in the perinuclear region as
previously shown (Campbell et al., 1998). Double staining showed that both Tctex-1 and KIM-1
colocalized in the cytoplasmic compartment of the cells prior to adding apoptotic cells (Figure
4.2A, none). During the course of the uptake of the apoptotic cells (15-90 minutes after addition
of apoptotic cells), the colocalization between KIM-1 and Tctex-1 appears to decrease during later
stages (Figure 4.2A). In order to quantify the colocalization images of KIM-1 and Tctex-1, we
analyzed the results using JACoP software (as indicated in the experimental procedures section)
to determine the Pearson’s coefficient. We concluded that the level of colocalization decreased
significantly during the later stages of phagocytosis (Figure 4.2B). Given the fact that some
consider evaluating colocalization using Pearson’s coefficient to be ambiguous since it
incorporates noise and fluorescence intensity variation in analysis (Li et al., 2011), we also
analyzed the data according to Van Steensel’s approach (Wong et al., 2006). Similar to Pearson’s
coefficient, we found that the colocalization decreased significantly during later stages of apoptotic
cells uptake (Figure 4.2C). These results suggest that during the process of KIM-1-mediated
phagocytosis, there is a temporal decrease in the colocalization between KIM-1 and Tctex-1 in
later stages.
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Figure 4.2. KIM-1 co-localizes with Tctex-1 during the early stages of phagocytosis.
A: 769-P cells were stimulated with apoptotic cells (blue) for various time points. Both KIM-1
and Tctex-1 were visualized using immunostaining for Tctex-1 (green) and KIM-1 (red) using
Alexa-488 and Alex-555 labelled secondary antibodies as indicated in the experimental
procedures section. Nuclei was counter-stained with DAPI (blue) (600x, bar represents 40μm).
Further magnification is shown for the phagocytic cup formed by KIM-1 and apoptotic cells (bar
represents 10 μm). Vertical lines appearing at 90 minutes of apoptotic cells-stimulation are
suggestive of Tctex-1 trafficking along microtubules as indicated previously (Campbell et al.,
1998). B: Images of colocalization of both KIM-1 and Tctex-1 over the time course of
phagocytosis were analyzed using Pearson’s coefficient (n=3, **p<0.01, ***p<0.001, one-way
ANOVA). C: Colocalization of both KIM-1 and Tctex-1 during the course of uptake of apoptotic
cells was analyzed using the Van Steensel’s approach, where the cross correlation function
(CCF) was calculated with a pixel shift of ±20 (n=3, **p<0.01, ***p<0.001 compared to none
stimulated cells, one-way ANOVA). Quantification of colocalization score was assessed based
on three random fields per sample and was done in three independent experiments.
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4.4.3. Inhibition of KIM-1-mediated phagocytosis restores the KIM-1 and Tctex-1 interaction
during the later stages of phagocytosis
Previous results showed that the interaction between KIM-1 and Tctex-1 was influenced
by events occurring at later stages of phagocytosis. Generally, during later stages of the uptake of
apoptotic cells, local remodeling of the underlying actin cytoskeleton and microtubule network
was shown to be crucial for corpse uptake (Freeman et al., 2014; Harrison et al., 2002; Toda et al.,
2012). To determine the importance of actin and microtubule stability during KIM-1-mediated
phagocytosis, we pretreated 769-P cells with cytochalasin D and nocodazole, inhibitors of actin
filament polymerization and microtubule formation, respectively. These 769-P cells were
subsequently fed fluorescently-labelled apoptotic cells and the level of uptake was determined by
flow cytometry. As expected, there was a significant reduction in the level of the uptake of
apoptotic cells compared to the no treatment control cells (Figure 4.3A). In order to determine
whether actin and microtubule changes during phagocytosis contributed to the loss of KIM-1 and
Tctex-1 interaction at later stages of phagocytosis, we performed co-IP following pretreatment
with either vehicle, nocodazole or cytochalasin D and stimulated with apoptotic cells for 90
minutes. We observed a restoration of the interaction between KIM-1 and Tctex-1 following
cytochalasin D and nocodazole treatment, which occurred at a similar level to non-stimulated cells
(Figure 4.3B, C). Altogether, these results suggest that the inhibition of phagocytosis by disrupting
the actin network or microtubule cytoskeleton would strengthen the interaction between KIM-1
and Tctex-1. Thus, this disruption of the KIM-1 and Tctex-1 interaction requires phagocytosis to
proceed.
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Figure 4.3. Inhibition of actin and microtubule dynamics restores the interaction between
Tctex-1 and KIM-1 following apoptotic cell uptake.
A: 769-P cells were treated with vehicle (DMSO), nocodazole (10 µM) or cytochalasin D (1 µM)
prior to adding fluorescently labelled apoptotic cells (pHrodo red) for 90 minutes (ACs 90). The
percentage of uptake of the apoptotic cells as indicated by high pHrodo red fluorescence was
measured by flow cytometry (n=3, ***p<0.001, unpaired t-test). B: Cells in A were either
unstimulated or stimulated with apoptotic cells for 90 minutes and used for immunoprecipitation
(IP) using KIM-1 antibody as described in the experimental procedures section. All samples
were analyzed by SDS-PAGE followed by immunoblotting with antibodies against KIM-1,
Tctex-1 and actin. The input lane represents 5 % of the lysate. C: Level of Tctex-1 bound to
KIM-1 following different treatments was determined based on densitometric values obtained
from three independent Western blotting experiments (n=3, *p<0.05, unpaired t-test).
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4.4.4. Phosphomimetic mutant of Tctex-1 fails to interact with KIM-1, but does not affect
KIM-1-mediated phagocytosis
Tctex-1 partakes in dynein dependent and independent functions, where the
phosphorylation of Tctex-1 at Threonine-94 (Thr-94) has been shown to be a crucial step in the
dissociation of Tctex-1 from the dynein light chain and consequently the microtubules (Chuang et
al., 2005; Song et al., 2007). We sought to determine whether the phosphorylation status of Tctex1 and its ability to bind dynein would influence its interaction with KIM-1. HEK-293 cells were
transfected with KIM-1 and various Tctex-1 constructs. One of these plasmids is the
phosphomimetic mutant of Tctex-1 (T94E), which fails to be incorporated into the dynein
complex, resulting in a dynein-free form of Tctex-1 (Chuang et al., 2005). As a control, a construct
encoding an unphosphorylated mimic of Tctex-1 mutant (T94A) was used, since it has been shown
to have a similar action to wild type Tctex-1 in its ability to bind to dynein complex, which is the
opposite effect of T94E. We also compared the effects of these mutants to wild type Tctex-1. We
then performed co-IP experiments to detect the binding of KIM-1 to the different forms of Tctex1 either before or after stimulation with apoptotic cells for 90 minutes. The phosphomimetic
mutant of Tctex-1 (T94E) showed a significant decrease in the interaction with KIM-1 regardless
of whether the cells were stimulated with apoptotic cells or not (Figure 4.4A and B). On the other
hand, both wild type and unphosphorylated mimic mutant (T94A) forms of Tctex-1 bound KIM1 and showed no significant difference in their ability to interact with KIM-1. Next, we tested
whether the phosphorylation status of Tctex-1 would have an effect on KIM-1-mediated
phagocytosis. Following transfection of HEK-293 cells with KIM-1 and each individual Tctex-1
construct, cells were fed fluorescently-labelled apoptotic cells for 90 minutes and phagocytic
ability was measured by flow cytometry (Figure 4.4C). Remarkably, no significant differences in
phagocytic ability were seen between KIM-1-expressing HEK-293 cells that were transfected with
either wild type, unphosphorylated mimic of Tctex-1 mutant (T94A) or the phosphomimetic
mutant of Tctex-1 (T94E) (Figure 4.4D). Altogether, these results argued that the phosphorylation
of Tctex-1 at Threonine-94 had an effect on the interaction between KIM-1 and Tctex-1, but do
not impact KIM-1-mediated phagocytosis.
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Figure 4.4. Phosphomimetic mutant of Tctex-1 exhibits a reduced binding to KIM-1, but
does not influence KIM-1-mediated phagocytosis.
A: HEK-293 cells were co-transfected with GFP-labelled KIM-1 and either control vector
encoding flag-tag, wild type flag-tagged Tctex-1 (Tctex-1-WT), unphosphorylataed mimic of
flag-tagged Tctex-1 (Tctex-1-T94A) or phosphomimetic mutant of flag-tagged Tctex-1 (Tctex-1T94E). Cells were either unstimulated or stimulated with apoptotic cells for 90 minutes (ACs 90)
and extracts were used for co-immunoprecipitation using KIM-1 antibody as described in the
experimental procedures section. All samples were analyzed by immunoblotting with antibodies
against KIM-1, Tctex-1 and actin. The input lane represents 5 % of the lysate. B: The level of
Tctex-1 bound to KIM-1 was determined based on densitometric values acquired from Western
blotting (n=3, *p<0.05, **p<0.01, unpaired t-test). C: Cells in A were fed apoptotic cells that
were fluorescently labelled with pHrodo red for 90 minutes and the percent of uptake of
apoptotic cells was determined by flow cytometry as shown in pHrodo red Vs. side scatter (SSC)
plot. D: The percentage of phagocytosis was determined based on high pHrodo red fluorescence
as measured by flow cytometry (n=4, not significant data, unpaired t-test).
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4.4.5. Tctex-1 mediates phagocytosis by KIM-1
The above data characterized the interaction between KIM-1 and Tctex-1 during
phagocytosis, but did not identify whether Tctex-1 was required for phagocytosis of apoptotic
cells. To test this, we silenced Tctex-1 using siRNA in 769-P cells (Figure 4.5A) and carried out
phagocytosis assays. When we compared the phagocytic capacity between cells left untransfected
or transfected with control siRNA to the Tctex-1 siRNA treated cells, Tctex-1-silenced cells
exhibited a significant decrease in the level of uptake of apoptotic cells following 90 minutes of
incubation with apoptotic cells (Figure 4.5B and C). Since Tctex-1 had been shown to play a role
in cellular cargo trafficking through its dynein-dependent function (Mueller et al., 2002; Palmer
et al., 2011; Tai et al., 1999), we wondered whether silencing Tctex-1 inhibited phagocytosis as a
result of decreased trafficking of KIM-1 to the cell-surface. To this end, we measured KIM-1
surface expression in 769-P cells transfected with Tctex-1 siRNA and compared it to cells
transfected with control siRNA (Figure 4.5D). Importantly, we did not observe any significant
difference in KIM-1 surface expression between 769-P cells treated with Tctex-1 siRNA or control
siRNA (Figure 4.5E). The above data suggested that Tctex-1 plays an important positive role in
KIM-1-mediated phagocytosis independent of affecting surface expression of KIM-1.
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Figure 4.5. Tctex-1 expression in required for phagocytosis by KIM-1, but does not affect
its surface expression.
A: 769-P cells were left untransfected or transfected with either control siRNA or Tctex-1 siRNA
for 24 hours. Cells were lysed and protein levels of Tctex-1, KIM-1, and actin were determined
by immunoblotting. B: Cells in A and cells treated with transfection reagent only were fed
fluorescently labelled apoptotic cells (pHrodo red) for 90 minutes. The percent of uptake of
apoptotic cells was determined by flow cytometry as shown in the plots of side-scatter (SSC) vs.
pHrodo red (apoptotic cells). C: The percentage of phagocytosis by cells in B was measured by
flow cytometry and shown as representation of five independent experiments (n=5, *p<0.05,
**p<0.01, unpaired t-test). D: Cells in A were stained for surface KIM-1 using PE-conjugated
anti-KIM-1 antibody and its isotype control, without permeabilization, and the level of KIM-1surface expression was determined by flow cytometry. E: Representative graph of the mean
fluorescence intensity (MFI) of the flow cytometry data from D was shown as representative of
four independent experiments (n=4, ns= not significant, unpaired t-test).
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Since Tctex-1 had been previously shown to play a pivotal role in regulating the actin
cytoskeleton in neuronal cells, we assessed whether silencing Tctex-1 would have any effect on
actin cytoskeleton remodeling that happens during KIM-1-mediated phagocytosis. To this end, we
silenced Tctex-1 expression with siRNA, stained the cells with rhodamine phalloidin to detect Factin and took confocal microscopy images to look for cytoskeletal changes. The majority of cells
transfected with Tctex-1 siRNA exhibited highly disorganized actin fibers with poorly bundled
filaments in the center of the cells as compared to untreated cells or cells transfected with control
siRNA (Figure 4.6A). The phenotype of Tctex-1-silenced cells did not change following apoptotic
cell uptake (Figure 4.6B). To test the responsiveness of these cells to actin reorganization stimulus,
we treated 769-P with 10 nM thrombin and found a striking reorganization of F-actin and an
increase in fluorescence intensity, as previously shown (Tai et al., 1999) (Figure 4.6C). All in all,
this suggest that Tctex-1 might play an important role in KIM-1-mediated phagocytosis potentially
though its ability to modulate actin cytoskeleton.
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Figure 4.6. Silencing Tctex-1 induces changes in the actin cytoskeleton that persist after
stimulation with apoptotic cells
A: 769-P cells were transfected with either transfection reagent alone, control siRNA or Tctex-1
siRNA for 24 hours. Cells were fixed and stained for F-actin using rhodamine phalloidin (red)
and immunostained for intracellular Tctex-1 using Tctex-1 antibody and secondary Alexa-488
antibody (green), as described in the experimental procedures section. Nuclei was counterstained with DAPI (blue) (600x, bar represents 40 μm). B: Cells in A were fed apoptotic cells
(blue) for 90 minutes and actin and Tctex-1 staining was performed to detect any F-actin changes
following addition of apoptotic cells. C: As a control, 769-P cells were stimulated with thrombin
(10 nM) and actin staining was done to confirm the cells’ responsiveness to an unrelated
stimulus (thrombin).
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4.4.6. Tctex-1 modulates the actin cytoskeleton through a RhoGTPase-independent pathway
during KIM-1-mediated uptake of apoptotic cells
Based on the above experiments, it became obvious that cells transfected with siRNA
targeting Tctex-1 showed a decrease in apoptotic cell uptake and had consistently less actin
structures, similar to what was previously reported (Meiri et al., 2012). Tctex-1 has been shown
previously to modulate the actin cytoskeleton through activation of Rac1 (Albert et al., 2000;
Campbell et al., 1998; Chuang et al., 2005) and RhoA (Conde et al., 2010; McIntire et al., 2001;
Meiri et al., 2009). In term of phagocytosis, it is well established that these Rho GTPases play
important roles in actin cytoskeleton organization (Ridley, 2001; Ridley et al., 1992). RhoA and
Rac1 have been proposed to have opposing effects on the actin cytoskeleton (Hall et al., 2000;
Meyer et al., 2003; Mueller et al., 2002; Nakaya et al., 2006). In Chapter 3, we showed that
inhibition of RhoA significantly increased KIM-1-dependent uptake of apoptotic cells (Figure
3.5A and B). On the other hand, Rac1 was found to have a positive role in KIM-1-mediated
phagocytosis (Figure 3.7A and B). With this in mind, the level of Rac1 activity was measured
following 769-P cell incubation with apoptotic cells over the course of phagocytosis (0-90
minutes). Surprisingly, Rac1 activity seemed to increase minimally during uptake of apoptotic
cells (Figure 4.7A). To test whether Tctex-1 silencing modified the actin cytoskeleton via Rac1,
we measured Rac1 activation of 769-P cells with Tctex-1 siRNA or control siRNA following
stimulation with apoptotic cells. The level of Rac1 activation was not significantly altered
following silencing of Tctex-1 during the course of apoptotic cell engulfment (Figure 4.7B). To
test the role of RhoA, we first measured the level of active RhoA during KIM-1-mediated
phagocytosis. We found a steady increase in the level of active RhoA during the uptake process of
apoptotic cells by 769-P cells (Figure 4.7C). This result was consistent with our previous data
measuring the level of active RhoA during uptake of apoptotic cells in HEK-293 cells expressing
human KIM-1 (Figure 3.6 A). Moreover, upon silencing of Tctex-1 in 769-P cells, we did not
observe any change in level of active RhoA when compared to control siRNA-transfected cells
(Figure 4.7D).
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Figure 4.7. Tctex-1 regulates the actin cytoskeleton independent of Rho GTPases in KIM-1mediated phagocytosis.
A: 769-P cells were fed apoptotic cells for various time periods (15-90 minutes) and the level of
Rac1 activation was measured by G-LISA Rac1 activation kit (Cytoskeleton, Denver, CO).
(n=4, all not significant, one-way ANOVA). B: 769-P cells were transfected with either control
siRNA or Tctex-1 siRNA for 24 hours. These cells were fed apoptotic cells for various time
periods and the level of Rac1 activation was graphed (n=5, all not significant, unpaired t-test).
Treatment of 769-P cells transfected with control siRNA with 5 % serum after serum starvation
overnight served as a positive control for Rac1 activation (Curtiss et al., 2011). C: 769-P cells
fed apoptotic cells (15-90 minutes) were subjected to active RhoA and total RhoA assay
measurements as determined by the active G-LISA RhoA activation assay and the total RhoA
ELISA kit (Cytoskeleton, Denver, CO), respectively. Normalization of active RhoA was done
according to manufacturer’s recommendation and was graphed to represent data (n=3, all not
significant, one-way ANOVA). D: 769-P cells were transfected with either control siRNA or
Tctex-1 siRNA for 24 hours. These cells were fed apoptotic cells for various time periods
(minutes) and the level of normalized active RhoA was determined as in C. Cells treated with 10
µM Nocodazole for 15 minutes served as a positive control for RhoA activation (Martin et al.,
2001) (n=3, all not significant, unpaired t-test).
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4.5. DISCUSSION
KIM-1 is a phosphatidylserine receptor that is specifically upregulated by tubular epithelial
cells (TECs) during ischemic or toxic AKI and enables TECs to clear apoptotic and necrotic cell
debris (Ichimura et al., 2008; Ichimura et al., 2004). In the previous chapter, we showed that TECs
require KIM-1 expression to mediate the clearance of apoptotic cells. This necessitated an
understanding of the intracellular signalling pathway(s) downstream of KIM-1. Here we identify
a novel functional interaction between the actin cytoskeleton regulatory protein Tctex-1 (Chuang
et al., 2005; Meiri et al., 2012) and KIM-1. We have shown that the interaction between KIM-1
and Tctex-1 is a dynamic process that appears to dissipate during the later stages of apoptotic cell
engulfment. Inhibition of phagocytosis by inhibiting actin and microtubule polymerization also
restored KIM-1 binding to Tctex-1 during the later stages of phagocytosis. Furthermore, we have
shown that phosphorylation of Tctex-1 at Threonine-94 diminishes interaction between KIM-1
and Tctex-1 regardless of whether apoptotic cells were added or not. Using siRNA against Tctex1, we uncovered a novel positive role of Tctex-1 in KIM-1-mediated phagocytosis. Finally, we
found that Tctex-1 probably mediates KIM-1 function through a non-canonical pathway that is
independent of Rho GTPases.
The loss of interaction between KIM-1 and Tctex-1 during the later stages of phagocytosis
is still a puzzling observation, which may suggest a role for Tctex-1 in corpse engulfment.
Recently, it was reported that TIM-1 (or KIM-1) undergoes dynamic cycling through clathrindependent vesicles to mediate the lysosomal degradation of NUR77 (Balasubramanian, et al.,
2012), a nuclear receptor implicated in apoptosis and cell survival (Machacek et al., 2009).
Throughout our experiments, we did not find any evidence of Tctex-1 degradation during the entire
period of phagocytosis (90 minutes) as determined by Western blot. Given what is known about
Tctex-1 in the trafficking of various cell-surface receptors (Machado et al., 2003; Mueller et al.,
2002; Tai et al., 1998), it was surprising that Tctex-1 did not regulate KIM-1 trafficking to the
cell-surface.
The phosphorylation of Tctex-1 at Threonine-94 has been shown to promote Tctex-1
dissociation from the dynein light chain complex which is required to promote dynein-independent
functions (Chuang et al., 2005; Li et al., 2011). For example, phosphorylation of Tctex-1 has been
linked to enhanced neurite outgrowth activity (Chuang et al., 2005), such as cilliary disassembly,
leading to cell cycle progression and S-phase entry for neural progenitor cells (Li et al., 2011). The
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perplexing data with regards to the lack of an effect of phosphomimetic mutant of Tctex-1 (T94E)
on phagocytosis is likely reflective of the persistent expression of a low level wild type endogenous
Tctex-1, which confounded the data. This can be tested by simultaneously silencing endogenous
Tctex-1 with siRNA and then transfecting the mutant form Tctex-1 as described by others (Meiri
et al., 2012).
Cytoplasmic Tctex-1 has been shown to regulate microtubules and the actin cytoskeleton
through activation of Rac1 and RhoA, respectively (Chuang et al., 2005; Meiri et al., 2012).
Recently, it was shown that Tctex-1 sequesters a key Rho guanine exchange factor, GEF-H1 and
tethers it to microtubules allowing Rac1 to execute its function unopposed by RhoA (McIntire et
al., 2001; Meiri et al., 2012). Upon activation, Tctex-1 was shown to release GEF-H1 tethered to
microtubules, allowing it to then activate RhoA by promoting GDP exchange for GTP. Because
we previously demonstrated that Rac1 is required for KIM-1-dependent phagocytosis, we tested
whether Tctex-1 relay its signalling through Rac1 in KIM-1-expressing cells. We failed to see any
difference in the level of Rac1 activation upon stimulation with apoptotic cells or when Tctex-1
expression was silenced. Thus, we propose that Rac1 is involved in phagocytosis independently
of Tctex-1. Furthermore, our preliminary data failing to show RhoA activation downstream of
Tctex-1 suggests that RhoA is not involved in mediating Tctex-1 signalling during KIM-1mediated phagocytosis. Moreover, we propose that other GTPases (e.g. cdc42) or non-GTPase
pathways might be involved in KIM-1-mediated phagocytosis downstream of Tctex-1 (Conde et
al., 2010). Taking this into consideration, we could envision that dynein-independent Tctex-1 (or
phosphorylated Tctex-1) might have a role in these KIM-1-expressing cells.
To our knowledge, this is the first study that has explored a physiological function for
Tctex-1 in kidney cells, and moreover in phagocytosis. The logical next step would be to determine
if Tctex-1 has any role in AKI or repair. Given that Tctex-1 has been shown to be involved in
regulating cilium resorption during neurogenesis (Li et al., 2011), a potential mechanism for
involvement in AKI might be through regulation of the cilium of renal TECs, which act as flow
sensors (Kotsis et al., 2007). In fact, a number of human renal syndromes, including polycystic
kidney disease, Bardet-Biedl syndrome and nephronophthisis (Balasubramanian et al., 2012), have
been shown to involve dysfunctional cilia, a microtubule-based organelle. Interestingly, KIM-1 is
expressed on TECs during cyst development in a mouse model for autosomal dominant polycystic
kidney disease (Kuehn et al., 2002), and was later implicated in cilliary calcium signalling via its
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interaction with the cilliary protein, polycystin 2 (TRPP2) (Kotsis et al., 2007; Kuehn et al., 2007).
Our present work linking Tctex-1 to KIM-1-mediated phagocytosis by TECs for the first time is
likely to lead to new avenues of research into the role of Tctex-1 in AKI and other chronic kidney
diseases.
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General Discussion

The general discussion was written by Ola Ziyad Ismail, and edited by Dr. Gunaratnam
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5.1. SUMMARY AND GENERAL DISCUSSION
AKI is a clinically important disorder that is most commonly caused by an ischemic or
toxic insult to the kidney (Bellomo et al., 2004; Bonventre et al., 2011; Lattanzio et al., 2009;
Mehta et al., 2007). The pathophysiology of ischemic AKI is highly complicated, involving
multiple processes including inflammation, tubular injury and vascular damage (Bonventre et al.,
2011; Togel et al., 2014). Renal ischemia reperfusion injury results from the transient cessation of
blood flow to an organ with immediate oxygen deprivation, followed by restoration of blood flow
(reperfusion) (Bonventre et al., 2011; Le Dorze et al., 2009). This process leads to generation of
reactive oxygen species (ROS). ROS are a major contributor to cellular injury (Oliver et al., 1990),
where they exhibit their pathogenic effects by causing protein oxidation, lipid peroxidation, and
DNA damage (Bonventre et al., 2011; Devarajan, 2005, 2006; Kaushal et al., 2004). Depending
on the severity of cellular injury and the resiliency of affected cells, TECs can recover from sublethal injury or undergo apoptosis, necrosis or necroptosis (Linkermann et al., 2013; Vanden
Berghe et al., 2014). The failure to clear apoptotic cells can result in secondary necrosis, triggering
further inflammation and secondary tissue damage (Balasubramanian et al., 2012; Bonventre et
al., 2011; Devarajan, 2006; Yang et al., 2015). KIM-1 was identified as a non-myeloid
phosphatidylserine receptor that is expressed on injured renal proximal TECs that enables them to
clear apoptotic and necrotic cells (Ichimura et al., 2008). The aim of this thesis was to better
understand the physiological function of KIM-1 in AKI in vivo and to uncover how KIM-1
mediates direct signalling to enable phagocytosis by TECs. To this end, we identified two novel
KIM-1 interacting proteins, the alpha subunit of the heterotrimeric G12 protein (Gα12), and the
dynein light chain protein Tctex-1, and characterized their respective roles in phagocytosis by
TECs.
In Chapter 2, we discovered that the cytosolic domain of KIM-1 interacts with Gα12 to
block its activation by blocking exchange of GDP for GTP. Previously, Yu et al., demonstrated
that Gα12 is activated by ROS during IRI and that this promoted the disruption of junctional
complexes via Src activation, thereby intensifying renal tissue damage (Yu et al., 2012). This led
us to uncover that TECs and kidneys from Kim-1-deficient mice exhibit exaggerated renal Gα12
and Src activation following exposure to hydrogen peroxide, a situation that mimics renal IRI in
vitro. This resulted in worse renal dysfunction and kidney damage in Kim-1-deficient mice
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subjected to renal insult compared to wild type mice. Taken together, our findings in Chapter 2
suggest that KIM-1 protects against Gα12-mediated tissue damage during ischemic AKI.
Shortly after our findings were published, Yang et al., (2015) published that transgenic
mice expressing a mucin-domain mutant KIM-1 (Kim-1Δmucin), which is unable to recognize
apoptotic cells, are unable to down regulate innate immune responses and failed to protect mice
from ischemic or toxin (cisplatin) induced AKI (Yang et al., 2015). This group proposed two
mechanisms to explain how KIM-1 was protective in AKI: (1) via phagocytic clearance of
apoptotic debris by KIM-1-expressing tubular cells and prevention of tubular obstruction; (2) via
down-regulation of proinflammatory NF-кB signalling in tubular cells by phosphorylated KIM-1
upon recognition of apoptotic bodies. An important distinction between our Kim-1 knockout and
the Kim-1Δmucin mice is that Kim-1Δmucin mice still express a full-length Kim-1 including its
cytosolic domain (albeit lacking a portion of the mucin domain) at levels of expression comparable
to wild type Kim-1 in the injured kidney (Yang et al., 2015), whereas our mice completely lack
the expression of Kim-1 (Wang et al., 2010; Ismail et al., 2015). Also, while Yang et al., (2015)
found that tubular epithelial cells isolated from the Kim-1Δmucin mutant mice had decreased ability
to clear apoptotic cells (Yang et al., 2015), tubular cells from our Kim-1-deficient mice exhibited
a near complete defect in the clearance of apoptotic cells (Ismail et al., 2015), likely reflecting a
complete absence of the protein. As the interaction of Gα12 with Kim-1 occurs independent of
apoptotic cell recognition and via the cytosolic domain, it is more than likely that the TECs from
the Kim-1Δmucin mutant mice have intact Gα12-inhibitor capacity during renal IRI. However, this
needs to be confirmed. We propose that the more severe phenotype of the Kim-1 deficient mice
during IRI is explained by deficiencies in phagocytosis, and aberrant NF-кB and Gα12 signalling.
All in all, our findings support the growing notion that KIM-1 is protective during ischemic AKI.
In Chapter 3, we investigated the role of Gα12 in KIM-1-mediated phagocytic signalling.
We found that KIM-1 interacts with Gα12 and suppresses its activation to permit phagocytosis.
Gα12 inhibition is required for efficient phagocytosis because it negatively regulates the
phagocytic process via its known downstream mediator, RhoA. We also discovered opposing roles
of RhoA and Rac1 during KIM-1-dependent uptake of apoptotic cells. Whereas RhoA seems to
have an inhibitory role, Rac1 seems to have a stimulatory role on phagocytosis. This has also been
shown to be the case in various professional phagocytes (Caron et al., 1998; Chimini et al., 2000).
Our work is the first to demonstrate a role of Gα12 in phagocytosis and in KIM-1 signaling during
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acute injury. Since KIM-1 expression is absolutely required for uptake of apoptotic cells by
primary TECs, our findings have broad implications for understanding tubular cell behaviour after
AKI.
Taken together, our findings in both Chapter 2 and 3 suggest that KIM-1 upregulation on
TECs protects the kidney from ischemic AKI by at least two distinct mechanisms that involve
inhibition of Gα12. First, KIM-1 blocks ROS-mediated activation of damaging Gα12 signalling
via Src kinase, which may also enhance renal recovery after tissue damage as seen in Gα12 mice
(Yu et al., 2012). Second, KIM-1-suppression of Gα12 is required for efficient phagocytosis by
tubular cells to clear cellular debris and mitigate inflammation (Yang et al., 2015). These findings
are consistent with the previously proposed role for KIM-1 as a regulator of immune function
(Freeman et al., 2010) that is upregulated during ischemic or toxin induced AKI (Ichimura et al.,
2008; Ichimura et al., 2012). Our findings offer new insights into the down-stream signalling that
takes place in tubular cells during ischemia-reperfusion injury.
Gα12 has been shown to a play a direct role in tight junction complex disassembly and
thereby contributes to paracellular permeability of polarized epithelial cells (Meyer et al., 2003;
Meyer et al., 2002; Sabath et al., 2008). Once activated, Gα12 interacts with the heat shock protein
(HSP) 90 chaperone to bring about phosphorylation and activation of Src kinase (Sabath et al.,
2008). Phosphorylation of scaffolding proteins, such as zona occludens-1(ZO-1), by activated Src
is ultimately what leads to destabilization of tight junction complexes (Meyer et al., 2003; Meyer
et al., 2002). Aberrant epithelial tight junction function occurs in several kidney diseases
(Balasubramanian et al., 2012), including ischemia-reperfusion injury (Balasubramanian et al.,
2012; Yu et al., 2012). During AKI, a leaky epithelium permits the backleak of filtered or secreted
electrolytes and waste products back into the circulation.
The importance of phagocytic clearance of apoptotic cells by TECs during AKI is now
becoming more clear (Ismail et al., 2015; Yang et al. 2015) and we are beginning to realize the
full impact of aberrant Gα12 signalling during ischemic AKI, and the importance of KIM-1 in
limiting this process (Ismail et al., 2015). While Denker and colleagues have suggested that the
harmful effect of ROS generated during renal IRI is at least in part mediated by activated Gα12
(Yu et al., 2012), the mechanism of tissue damage caused by exaggerated Gα12 signalling is less
clear. Yu et al. have suggested that aberrant Gα12 activation leads to impaired renal function and
tissue damage during IRI as a result of Gα12 downstream effects on the disassembly and improper
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reassembly of tight junction complexes (Figure 5.1A and B), the latter of which can impair renal
recovery (Yu et al., 2012). Whether these tight junction abnormalities affect phagocytic clearance
of apoptotic cells by TECs is not known, but recent findings by Fornetti et al. suggest that this
might be the case (Fornetti et al., 2015). Whether KIM-1 protects from tissue damage by indirectly
blocking the disruption of tight junctions by activated Gα12 remains to be tested.
In addition to its role in deregulating tight junction proteins, activated Gα12 is also a potent
activator of RhoA signalling (Figure 5.1B) (Buhl et al., 1995). Aberrant Rho signalling has been
shown to be detrimental in AKI, and treatment with Rho kinase inhibitors can attenuate renal
ischemia-reperfusion injury (Prakash et al., 2008). The detrimental effects of activated Gα12
during AKI may be in part be caused by its effects on the actin cytoskeletal reorganization
(Molitoris, 2004). Indeed, cytoskeletal dysregulation is a hallmark of AKI (J. V. Bonventre et al.,
2011). Our work shows that following IRI, KIM-1 upregulation on TECs allows for the
suppression of Gα12 activation which inhibits Src and RhoA activation (Figure 5.1C). While
Denker and colleagues showed that the Gα12 effects on tight junction disassembly was not
mediated by RhoA (Yu et al., 2012), our work highlights the importance of inhibiting RhoA in
phagocytosis (Figure 5.1D). Given that phagocytic clearance of apoptotic cells plays a crucial
protective role in renal injury and repair during AKI (Ichimura et al., 2008; Yang et al., 2015,
Ismail et al., 2015) and that activated Gα12 inhibits this process, uncovering the detailed
mechanism of Gα12-inhibition of phagocytosis (i.e. via tight junctions) may help identify novel
therapeutic strategies for AKI.
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Figure 5.1. Working model for the KIM-1 and Gα12 signalling pathway in tubular
epithelial cells during ischemia-reperfusion injury and phagocytosis.
A: In healthy tubular epithelial cells (TECs), Gα12 is inactive and tethered to the cell inner
membrane surface through its association with the Gβγ subunit of the heterotrimeric G protein
family. This prevents any activation of down-stream signal mediators, such as RhoA and Src. B:
Reactive oxygen species (ROS) are rapidly generated during ischemia-reperfusion injury and
lead to activation of Gα12 signalling. Activated Gα12 can trigger Src activation via Src
phosphorylation, which then subsequently leads to disassembly of tight junction complexes.
Active Gα12 could also activate RhoA (Prakash et al., 2008), which play a negative role in the
uptake of apoptotic cells by TECs. C: With prolonged ischemia-reperfusion injury, KIM-1 is
gradually upregulated on TECs and this lead to suppression of Gα12 activity. Suppression of
Gα12 activity results in decreased Src activation and stops the disruption of tight junction
complexes. KIM-1-mediated suppression of Gα12 also influences RhoA activation. D: Cells that
succumb to the injury undergo apoptosis and expose phosphatidylserine (PS) on their cellsurface. PS on apoptotic cells is recognized by KIM-1 on TECs, which then rapidly engulf the
apoptotic cells to prevent secondary necrosis. The persistent suppression of Gα12 activation in
TECs and subsequent inhibition of RhoA stimulation is required to promote the efficient
clearance of apoptotic cells. Solid lines are based on evidence presented throughout this thesis.
Dotted lines represent hypothetical or predicted events based on our data and published results
from other studies not related to KIM-1.
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In Chapter 4, we explored the role of Tctex-1, yet another novel KIM-1-interacting protein,
which was identified in a yeast-two hybrid screen. We showed that KIM-1 interacts with Tctex-1
under normal baseline conditions in TECs, but that interaction decreases during the uptake of
apoptotic cells, especially at the later stages of phagocytosis (Figure 4.1 and 4.2). Silencing Tctex1 expression impaired the uptake of apoptotic cells by TECs (Figure 4.5). In addition, we showed
that phosphorylation of Tctex-1 at Threonine-94, which prevents Tctex-1 from binding to
microtubules via dynein, reduced its interaction with KIM-1 (Figure 4.4). The exact mechanisms
of how Tctex-1 regulates KIM-1-dependent phagocytosis is currently under investigation.
Our identification of Gα12 and Tctex-1 as KIM-1-binding proteins involved in
phagocytosis using entirely different approaches (mass spectrometry and yeast two-hybrid), could
suggest a possible cooperation between these proteins in mediating changes in cell behaviour
required for phagocytosis (e.g. cytoskeletal reorganization). Interestingly, a link between Gα12
and Tctex-1 has been proposed by Takesono et al., (1999), who were the first to show that Tctex1 works as an activator of G-protein signalling (AGS), independent of G-protein coupled receptors
(Takesono et al., 1999). Tctex-1 was shown to carry out this function by binding to the Gβγ subunit
of heterotrimeric G protein in order to free the alpha subunit. This leads to Gα activation and
neurite outgrowth in neurons (Sachdev et al., 2007).
Recent work by the Rottapel group in Toronto has eluded to a possible mechanism for this
interaction by showing that Tctex-1 interacts with a microtubule-associated guanine nucleotide
exchange factor, GEF-H1 (or Lfc in mice), along with dynein intermediate chain (DIC) (Conde et
al., 2010; Meiri et al., 2009; Meiri et al., 2012; Ren et al., 1999). Given that GEF-H1 is an
important protein that couples microtubules and actin together, Tctex-1 was shown to tether GEFH1 to microtubules, inhibiting its action on actin filament organization via RhoA (Meiri et al.,
2012). Even more recently, the Rottapel group demonstrated that both the Gβγ and Gα subunits of
the heterotrimeric G12 protein work together to activate or suppress GEF-H1 activity (Meiri et al.,
2014). This happens through the interaction of the Gβγ subunit with Tctex-1, which releases GEFH1 from the microtubule complex with dynein. This release allows GEF-H1 to interact with Gα12
to mediate actin cytoskeletal changes, such as stress fiber formation and focal adhesion assembly
via RhoA (Meiri et al., 2014).
Based on the above information, we hypothesize that the interaction of both Gα12 and
Tctex-1 with KIM-1 might serve to simultaneously modulate changes in actin and microtubule
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structures during phagocytosis. We speculate that the interaction of KIM-1 with Tctex-1 tethers it
via the dynein complex (along with GEF-H1) to the microtubule cytoskeleton, which has been
shown to be important for phagocytosis (Blocker et al., 1997; Blocker et al., 1996; Harrison et al.,
2002; Newman et al., 1991) (Figure 5.2A). Following from this, upon KIM-1 binding to apoptotic
cells, KIM-1 maintains its interaction with Tctex-1, which in turn is still tethered to microtubules
along with GEF-H1 and dynein intermediate chain proteins, to help bring the apoptotic cell cargo
to the phagosome (Figure 5.2B). The continued interaction with Tctex-1 and GEF-H1 would
inhibit the activation of RhoA, which we found impedes corpse uptake. Simultaneously, KIM-1
would continue to interact with and suppresses Gα12 to mediate the uptake of apoptotic cells.
During later stages of phagocytosis, the loss of interaction between Kim-1 and Tctex-1 (potentially
via Tctex-1 phosphorylation at Threonine-94) would then allow GEF-H1 to be released and to
interact with Gα12 (Figure 5.2C). This would cause RhoA activation, which has been shown to
enable phagosome formation around apoptotic targets (Ravichandran et al., 2007). This
hypothetical pathway could explain the consistent increase in RhoA activity we observed in our
studies during the later stages of phagocytosis (Figure 3.6A and Figure 4.7C). Much exciting work
lies ahead as we pursue testing this model and further study the signalling mechanisms that are
triggered in TECs by IRI and that regulate phagocytosis.
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Figure 5.2. Proposed signalling pathways of KIM-1-mediated phagocytosis.
A: Following injury to tubular epithelial cells (TECs), KIM-1 is expressed on the apical surface
of TECs. Expression of KIM-1 suppresses Gα12 activation, which leads to the inhibition of
RhoA activity. Tctex-1 is tethered to microtubules along with GEF-H1 and dynein intermediate
chain (DIC) and dynein heavy chain (DHC) component of the dynein motor protein. GEF-H1 is
inactive since it is bound to the Tctex-1-Dynein-Microtubule complex and hence, it further
inhibits RhoA activity. B: Upon apoptotic cell-binding to KIM-1, KIM-1 still interacts with
Gα12 and suppresses Gα12 activity. KIM-1 also interacts with Tctex-1 in a manner similar to
conditions without binding to apoptotic cells. This situation is predicted to last for the first 60
minutes. C: During the last stages of phagocytosis, when the phagosome is formed, KIM-1 loses
its interaction with Tctex-1 due to potential phosphorylation of Tctex-1 at Threonine-94. This
loss of interaction with KIM-1 will potentially cause the disassembly of the Tctex-1-DyneinGEF-H1 complex. This will allow GEF-H1 to be released, allowing it to interact with Gα12 and
mediate the RhoA activation that plays a role in actin cytoskeletal reorganization (Meiri et al.,
2014).
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5.2. LIMITATIONS
An important limitation that hindered our Gα12 and KIM-1 studies was the lack of cell
lines that expressed high levels of endogenous Gα12 and KIM-1. Throughout our experiments in
Chapters 2 and 3, we used human embryonic kidney 293 (HEK-293) cells that we found to express
a high level of endogenous Gα12 and which were subsequently made to stably express KIM-1. We
have confirmed that these cells engulf apoptotic cells in a manner similar to cells expressing
endogenous KIM-1. In addition, we have confirmed our findings in primary TECs isolated from
wild type and Kim-1-deficient mice. In Chapter 4, we failed to see differences in the phagocytosis
in HEK-293 cells transfected with KIM-1 and either one of the different Tctex-1 constructs (wild
type Tctex-1, phosphomimetic mutant of Tctex-1 (T94E) or unphosphorylated mimic of Tctex-1
mutant (T94A)) (Figure 4.4.C and D), yet we found a reduced interaction between KIM-1 and the
phosphomimetic mutant of Tctex-1 (T94E) (Figure 4.4A and B). Since the effects of
phosphomimetic mutant of Tctex-1 on its interaction with KIM-1 and phagocytosis were
inconsistent, this challenged our initial hypothesis which suggested that KIM-1-binding to Tctex1 served to tether the apoptotic cargo to microtubules via dynein to allow for engulfment. This
issue raises many questions that need to be addressed in future studies. For example, “What is the
regulatory mechanism between KIM-1, Tctex-1, dynein and hence microtubules?”, “Does Tctex1 modulate KIM-1-mediated phagocytosis through its interaction with dynein/microtubules?”,
“Does the phosphorylation of Tctex-1 affects its ability to interact with KIM-1 by impairing its
interaction with dynein?”
Another limitation we have struggled with is the 60 % homology between the N-terminal
cysteine-rich region of human KIM-1 and murine Kim-1 (Kuchroo et al., 2003; Santiago et al.,
2007). Even though both human and murine KIM-1 are upregulated after ischemia-reperfusion
injury (Ichimura et al., 2008; Ichimura et al., 2004), and carry out the same function of uptake of
dead cells (Ichimura et al., 2008; Kobayashi et al., 2007), there is a marked difference in the length
of the mucin domain and the number of O-linked glycosylation sites between them (Kuchroo et
al., 2003). This might explain our inability to perform co-immunoprecipitation of KIM-1 and Gα12
or Tctex-1 in primary cells using the existing antibodies against mouse Kim-1 which recognize the
mucin-domain of Kim-1. This limitation might suggest a role for the mucin domain of KIM-1 in
carrying out its signalling function.
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5.3. FUTURE RESEARCH
To date, research in AKI has primarily focused on the mechanism of apoptosis and necrosis
of TECs caused by the injury (Burns et al., 1998; Daemen et al., 1999; Kelly et al., 2001; Kelly et
al., 2003; Schumer et al., 1992). The novel findings presented in this thesis highlight a new area
of research involving the signalling mediators that are involved in phagocytic clearance of
apoptotic cells during AKI. Recently, a new pathway of regulated necrosis, known as necroptosis,
has emerged. Necroptosis is a receptor-interacting protein kinase-based necrotic cell death process
(Linkermann et al., 2012; Tait et al., 2013). Blocking the pathway leading to necroptosis via
chemical inhibition or knocking out RIPK3 has been shown to have a protective effect in ischemic
and cisplatin-induced AKI (Linkermann et al., 2013; Tristao et al., 2012; L. Zhang et al., 2013).
It would be interesting to investigate whether KIM-1 clears necroptotic cells in a similar manner
to that of apoptotic cells. In addition, newly discovered death pathways, such as mitochondrial
permeability transition-mediated regulated necrosis (Vanden Berghe et al., 2014) and ferroptosis
(Dixon et al., 2012; Linkermann et al., 2014), could also play an important role in AKI and thereby
engage KIM-1 signalling. Furthermore, it would be interesting to determine if the various types of
dead cells display phosphatidylserine or yet undiscovered “eat me” ligands for KIM-1 that mediate
clearance of these cells.
Another aspect of KIM-1 that we did not explore in this thesis work is the fact that upon
upregulation on TECs, KIM-1 undergoes spontaneous membrane-proximal cleavage leading to the
release of its soluble extracellular domain (90 kDa) and retention of a membrane-bound fragment
(14 kDa) on cells (Bailly et al., 2002). The soluble fragment is recognized as a sensitive and
specific urinary biomarker for AKI (Han et al., 2002; Vaidya et al., 2009; Vaidya et al., 2010).
KIM-1 membrane-proximal cleavage was shown to be accelerated by pervanadate via activating
ERK and p38 MAP Kinase (Bailly et al., 2002; Z. Zhang et al., 2007). Recently, our lab showed
that KIM-1-cleavage is mediated by TNF-α-converting enzyme (TACE or ADAM17) and that this
cleavage is accelerated by reactive oxygen species generated during injury to renal tubular
epithelial cells, or by the addition of apoptotic cells (Gandhi et al., 2014). Furthermore, excess
KIM-1 shedding was shown to bind to apoptotic cells, thus competitively inhibiting phagocytosis
by KIM-1-expressing TECs. It would be exciting, for example, to engineer a transgenic mouse
expressing a cleavage-defective KIM-1 mutant to determine whether these mice exhibit different
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outcomes following ischemic AKI. An equally important question is whether KIM-1 phagocytic
signalling (i.e. Gα12 and Tctex-1) would be altered by KIM-1 shedding.
Another area of interest is the multiple serine and tyrosine phosphorylation sites that have
been described within the intracellular region of KIM-1 (Meyers et al., 2005; Santiago et al., 2007).
The cytoplasmic tail of human KIM-1 is relatively short and contains two putative tyrosine
phosphorylation sites, at positions 350 and 356, which play a role in signalling (Binne et al., 2007).
For example, phosphorylation at Tyrosine-350 was shown to be required for TIM-1 (KIM-1
expressed on T cells) to mediate co-stimulatory signalling in T cells (de Souza et al., 2005). This
raises several important questions that need to be answered. For example, “What is the role of
KIM-1 phosphorylation in ischemia-reperfusion injury or the uptake of apoptotic cells?” “Does
phosphorylation of KIM-1 influence its interaction with Gα12 or Tctex-1?” “Does the
phosphorylation allow KIM-1 to suppress pathogenic Gα12 activity?” Using site-directed
mutagenesis of KIM-1, we could generate KIM-1 mutants where tyrosine residues are substituted
with phenylalanine, which mimics unphosphorylated tyrosine, or glutamic acid, which some
consider to mimic phosphorylated tyrosine. Transfecting these mutants into TECs would enable
us to test KIM-1’s ability to interact with Gα12 or Tctex-1 following additions of pervanadate, a
protein tyrosine phosphatase inhibitor, which is known to induce KIM-1-phosphorylation (Z.
Zhang et al., 2007). The studies proposed above will allow us to better understand KIM-1
signalling in TECs.
In Chapter 4, we explored another KIM-1-interacting protein, Tctex-1, and its role in
phagocytosis. Since Tctex-1 is part of the dynein motor protein which is involved in the trafficking
of proteins via microtubules (King et al., 1996), several questions remained unanswered. For
example, “What is the regulatory mechanism between KIM-1, Tctex-1, dynein and, hence,
microtubules?” “Does Tctex-1 modulate KIM-1-mediated phagocytosis through its interaction
with dynein?” “Does the phosphorylation of Tctex-1 affect its ability to interact with KIM-1 by
impairing its interaction with dynein?” These questions represent the next steps of this project.
Given that Tctex-1 has been shown to be involved in regulating the cell cycle in ciliated cells
(Chuang et al., 2005; Conde et al., 2010; Li et al., 2011), it is exciting to speculate that Tctex-1 is
involved in the cell cycle progression of KIM-1-expressing cells during renal regeneration after
AKI. Interestingly, Tctex-1 has shown to play a protective role in hypoxia through its interaction
with microtubules and voltage-dependent anion-selective channels (VDAC) on mitochondria
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(Fang et al., 2011; Schwarzer et al., 2002). In this context, silencing Tctex-1 or phosphorylation
at serine-82 has been shown to exacerbate hypoxia induced mitochondrial damage and the
disruption of microtubules (Fang et al., 2011; Xu et al., 2013). Due to time constraints, we did not
explore the role of Tctex-1 in IRI and whether IRI leads to any changes in Tctex-1 expression or
modification, such as phosphorylation, that might influence its interaction with KIM-1.

5.4. SIGNIFICANCE OF FINDINGS
This thesis presented several novel signalling pathways through which KIM-1 carries out
its protective effect during ischemia-reperfusion injury and in the clearance of apoptotic cells.
Understanding how KIM-1 functions at a mechanistic level to clear dead cells and prevent further
inflammation may allow us to identify novel therapeutic strategies to enhance its protective effects
in AKI. AKI remains a serious and common medical complication in hospitalized patients for
which there are no effective therapies (Bock, 1997; Lopes et al., 2010; Togel et al., 2014).
Incomplete recovery from AKI has been shown to lead to chronic kidney disease (CKD) or fibrosis
(Hsu, 2012; Wald et al., 2009). Both AKI and CKD have been associated with an increased risk
of death and may result in complications, such as cardiovascular disease, diminished quality of
life, and the development of end-stage renal disease (Chawla et al., 2014; Venkatachalam et al.,
2015). Understanding the signalling mechanisms of protection from AKI by KIM-1 might help
elucidate important steps leading to enhanced recovery from AKI, as well as preventing
subsequent progression to CKD or fibrosis. Moreover, given the scarcity of mechanistic data
regarding phagocytic mechanisms in non-professional phagocytes, our work contributes
significantly to advance knowledge in this growing field.
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